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Post mortem histopathological examination of brain tissue is currently the only definitive means 
of identifying transmissible spongiform encephalopathy disease status. The inability to 
accurately diagnose TSE status ante mortem, and more importantly preclinically, serves as a 
serious impediment to the provision of proper patient/family counselling and care, and in the 
future should treatment become available, to the alleviation of neurological damage and 
suffering. 
The studies described herein evaluate the application of magnetic resonance spectroscopy to the 
clinical diagnosis of scrapie in mice. Statistically significant changes were observed in cerebral 
levels of N-acetyl aspartate, glutamic acid and inositol in diseased animals. The relevance of 
these changes with respect to scrapie clinicopathological features are discussed. It is noted that 
these abnormalities are nonspecific to scrapie and thus MRS finds application to ancillary 
diagnosis but not definitive diagnosis of TSE status. 
The in vivo and in vitro application of proton MRS to the detection of intracerebral lipid 
disturbances is discussed with reference to spontaneous lipoma in a control mouse. This lipid 
accumulation, which comprised a high proportion of triglyceride, was fully characterized by in 
vitro proton MRS techniques. 
The cerebral lipid profiles of eight murine-scrapie models were investigated by high 
performance thin layer chromatography. Concentrations of cholesterol, phospholipids and 
glycolipids in control and scrapie-affected animals were unchanged in all models studied. 
Cholesteryl ester levels were elevated in those models which exhibited marked neurological 
damage and prolonged incubation periods. 
The hiotransformational process resulting in the production of PrP is believed to occur on the 
neuronal cell membrane in discrete microdomains called caveolae. Lipids associated with GPI-
anchored proteins were characterized in PrP, PrP ° and PiP°'° mice. No significant changes 
in lipid composition were observed, implying that cellular PIT depletion does not have a 
detrimental effect on the structural integrity of caveolae. Similar studies were performed in 
control and scrapic mice. These showed highly significant changes in cholesteryl esters and 
cerebroside I. It is speculated that the altered structural composition of caveolae lipids may 
cause perturbations in the cell membrane sufficient to inhibit GPI-anchor cleavage of PrP by 
phosphaticlyl inositol-specific phospholipase C. 
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1. 1 Scrapie and its relationship to bovine spongiform encephalopathy. 
Scrapie is a transmissible neurological disorder of sheep and goats (Gordon, 
1946; Pattison el al., 1959) the prevalence of which has been recognized in U.K. 
flocks for over 250 years (Parry, 1983). It belongs to a family of related diseases 
known as transmissible spongiform encephalopathies which share distinct 
histopathological features including neuronal vacuolati on, astrogi iosis, and the 
formation of amyloid plaques (Fraser, 1979; Lampert et al., 1972; Masters and 
Beyreuther, 1988). The potential for cross-species transmission of scrapie has 
been known for a number of years, as demonstrated by experimental inoculation 
studies in laboratory rodents (Dickinson and Fraser, 1977). In the mid 1980s the 
cross-species transmission of scrapie was further highlighted by the emergence of 
a novel progressive spongiform encephalopathy in cattle (Wells et at., 1987). 
This disease which closely resembles scrapie on both histological (Wells ci' al., 
1987) and biochemical (Hope etal., 1988) criteria was named bovine spongiform 
encephalopathy (BSE). 
Comprehensive epidemiological studies support the hypothesis of a food-borne 
infectious source to the disease as a result of the widespread geographical 
distribution of cases within the U.K. (Dickinson and Taylor, 1988). The cause of 
BSE has subsequently been attributed to the practice of feeding proprietary 
concentrates derived from scrapie-infected meat and hone meal to dairy cattle 
(Morgan, 1988). It is believed that changes in the rendering process in the late 
1970s, notably the shift away from solvent extraction and application of live 
steam on defatted products, allowed increasing quantities of infectious material to 
pass into ruminant feedstuffs (Wilesmith, 1990). Contaminated ruminant-derived 
meat and bone meal has also been incriminated in the occurrence of BSE-like 
conditions in African species of ruminants maintained in English zoological 
collections (Fleetwood and Furley, 1990; Jeffrey and Wells, 1988; Kirkwood et 
al., 1990). 
1. 2 Human transmissible spongiform encephalopathies. 
Human forms of the disease include kuru, Creutzfeldt-Jacob disease (CJD) and 
Gerstrnann-Sträussler Scheinker syndrome (GSS). These diseases emphasize 
mans susceptibility to variants in the family of spongiform encephalopathies. 
Kuru was discovered during the late 1950s in a remote tribal population in the 
mountainous Fore region of Papua New Guinea (Gadjusek and Zigas, 1957). 
Transmission of kuru within members of this tribe was attributed to ritualistic 
cannibalism. It is understood that during ceremonial funeral proceedings, 
infectious brain material was handled and often consumed by under-nourished 
members of the tribe, especially women and children, its transmissible and 
infectious nature was confirmed by the experimental innoculation of kuru-infected 
brain material into chimpanzees and other primates (Gadjusek ci al., 1966). The 
prognosis for kuru is very poor; the disease typically affects young adults and is 
characterized by a progressive ataxia with a shivering type of tremor, latter 
emotional instability and death within a year of onset (Gadjusek and Zigas, 1959). 
Creutzfeldt-Jacob disease is the commonest member of the human transmissible 
spongiform encephalopathy family, affecting approximately one person in a 
million per aniwin and has a random world-wide distribution (Brown, 1988). 
The disease typically has a prevalence for females between 50 and 75 years of 
age. Clinical signs are characterized by a gradual progressive mental 
deterioration, initially manifested as memory loss or errors in judgement. Mental 
deterioration and mood alterations evolve to a state of dementia and confusion. 
In some individuals visual deterioration leads to cortical blindness (often 
interspersed with hallucinations), and motor impairments progress to a complete 
lack of coordination coupled with involuntary movements such as myoclonus and 
shivering (Brown, 1988). There are no recorded cases of recovery, with most 
patients dying within six months of disease onset. Infection in humans can be 
transmitted iatrogenically by implantation of contaminated electrodes, injection of 
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growth hormone derived from contaminated pituitary glands, and transplantation 
of contaminated corneas or dura mater (Bernoulli et at., 1977; Brown et al., 
1985; Duffy et al., 1974; Will and Matthews, 1982), 
Gerstmann-Sträussler Scheinker syndrome (GSS) is a relatively rare familial 
variant of Creutzfeldt-Jacob disease associated with a codon 102 leucine for 
proline substitution in the PrP protein (Doh-ura et at., 1989; Kretzschmar et al., 
1991). The clinical course of the disease is usually protracted, extending for 
three or more years (Brown et at., 1991). 
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1. 3 Cellular biosynthesis of PrP and its key role in scrapie pathogenesis. 
The identity of the aetiological agent responsible for transmissible spongiform 
encephalopathy pathology remains unresolved. Filtration and replication studies 
indicate that the pathogen has virus-like properties (Johnson and Gibbs, 1974), 
however other findings have shown it to be remarkably resistant to a wide range 
of adverse conditions which normally damage conventional viral nucleic acid. 
Exposure of infectious tissue to dry heat (Brown et al., 1990), formalin fixation 
(Stamp, 1962), ionizing radiation (Alper et al., 1966) and ultraviolet-irradiation 
(Alper et al., 1967), does not significantly diminish infectivity. Likewise, the 
absence of attenuation after DNase and RNases treatment has led to the 
suggestion that the aetiological agent may even lack a conventional nucleic acid 
genome (Alper et al., 1967). The agent is however partially sensitive to protease 
digestion (Prusiner ci' al., 1979). In view of these unique biophysical properties, 
Griffith speculated that the agent responsible for transmissible spongiform 
encephalopathies may consist solely of a novel self-replicating protein (Griffith, 
1967). 
Electron microscopy studies of subcellular fractions from scrapie-affected brain 
material led to the discovery of abnormal fibrillar aggregates. These aggregates, 
or scrapie-associated fibrils, co-purify with scrapie infectivity (Merz et at., 198 1) 
and are observed in a number of transmissible spongiform encephalopathies 
(Gadjusek and Zigas, 1959; Hope et at., 1988; Merz ci' at., 1983). Purification 
studies showed the fibrils to be composed predominantly, if not exclusively, of a 
protease-resistant protein, designated PrP (Bolton et at., 1982). Following 
partial degradation studies and cDNA cloning (Chesebro et at., 1985), PrP was 
shown to be the product of a single copy gene in host neurones (Oesch et at., 
1985). The scrapie and normal cellular isofornis of PrP exhibit different 
biochemical properties. Whereas the cellular isoform (PrPc)  is susceptible to 
membrane release by phosphatidyl inositol -specific phospholipase C (PIPLC) and 
protease digestion, the scrapie isoform (PrP") is not (Caughey and Raymond, 
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1991). The properties of the two isoforms also differ in aqueous detergents 
wherein PrP displays marked hydrophobicity and tendency to form amyloid 
aggregates whereas PrP' does not (Meyer et al., 1986). Subsequent studies 
showed the scrapie isoform of PrP to have the same molecular weight and charge 
distribution as the normal host-encoded protein (Hope et al., 1986). In the 
absence of altered PrP rnRNA transcription/translation (Oesch et al., 1985; Stahl 
and Prusiner, 1991), the difference in physicochernical properties between the 
two PrP isoforms is proposed to be the result of a post-translational modification 
event (Chesebro et at., 1985; Hope et al., 1986; Oesch ci' al., 1985; Stahl and 
Prusiner, 1991). 
The study of normal cellular and aberrant PrP metabolism has greatly benefited 
from the development of mouse neuroblastoma (MNB) cell lines which propagate 
scrapie infectivity (Race et at., 1987). Cellular PrP biosynthesis is initiated by 
cleavage of the N-terminal signal sequence in the endoplasmic reticulum (Hope et 
at., 1986; Hope et al., 1988). A glycophosphatidyl inositol (GPI) anchor is 
attached following removal of a hydrophobic C-terminal domain and high 
mannose glycan chains are added to one or both of the two potential N-linked 
glycosylation sites (Stahl ci' at., 1990). Pulse-chase metabolic labeling studies 
show that the mature PrP' species is transported to the cell surface within 60 
minutes. Membrane-bound PrPc  has a half-life of approximately 3 to 6 hours 
(Caughey et al., 1989; Borchelt etal., 1990; Caughey and Raymond, 199 1) after 
which it is catabolized via conventional endocytic pathways (Caughey, 1991; 
Hare, 1990). 
Pulse-chase metabolic labeling studies of PrP formation strongly suggest that the 
scrapie isoform is synthesized from PrP' (Borcheldt et al., 1990; Caughey and 
Raymond, 1991). PrP is resistant to GPI-anchor cleavage from the cell 
membrane by phosphatidyl inositol -specific phospholipase C (Caughey ci' at., 
1990; Safar et al., 1991) and its formation is inhibited in PIPLC-treated cells 
(Caughey and Raymond, 1991). These observations indicate that PrVc is 
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produced from a precursor that resides on the cell surface, albeit transiently 
(Caughey, 1991). GPI-anchored proteins are directed to cholesterol- and 
g1yco1ipid-rich membrane microdomains called caveolae (Simons and van Meer, 
1988). The functional and structral integrity of caveolae is severely disrupted by 
the depletion of cholesterol (Anderson, 1992; Chang et at., 1992; Rothberg et at., 
1992). The observation that cholesterol depletion of scrapie-affected mouse 
neuroblastorna cell cultures inhibits the formation of Prr lends further support to 
the importance of these discrete lipid microdomains as key biosynthetic sites in 
the formation of PrP (Taraboulos et at., 1995). PiP and other cell membrane 
components are internalized in endosomes which upon fusing with Golgi-derived 
hydrolytic vesicles form endolysosomes and lysosomes. Protease-sensitive 
proteins are digested in these intracellular compartments and amino acid 
precursors are released (Hare, 1990). Although this mechanism accounts for the 
catabolism of ppC,  PrP is only partially sensitive to hydrolysis. Protease-
resistance must therefore be conferred prior to internalization within 
endolysosomes and lysosomes (Caughey and Raymond, 1991), thus again 
indirectly supporting the role of caveolae in PrP synthesis. 
PrP is a metabolically stable molecule with a half-life in excess of 48 hours 
(Borchelt et al., 1990; Caughey and Raymond, 1991). Despite numerous studies 
no chemical modifications in PrP structure have been found which distinguish it 
from ppC  (Hope et al., 1986; Hope et al., 1988; Meyer et al., 1986; Oesch et al., 
1985; Stahl et a!,, 1992; Stahl et al., 1993). It has therefore been proposed that 
the contrasting properties exhibited by PrPc  and PrP are the result of differences 
in tertiary protein structure. Fourier transform infrared spectroscopic (FTIR) 
studies of the two PrP isoforms provide evidence in support of this hypothesis 
(Baldwin etal., 1994; Caughey et al., 1991; Pan et al., 1993; Safar et al., 1993). 
PrPc contains a high proportion of a-helix (40%) but is devoid of 13-sheet. 
Conversely, PrP has a high content of 13-sheet (48%) which is further increased 
by limited proteolysis and N-terminal truncation. This latter process favours the 
formation of cross 13-pleated sheet arnyloid structures (Pan et al., 1993). It 
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would therefore appear that the formation of PrP involves a biotransforrnational 
process by which a protein rich in a-helix structures to converted to one in which 
13-sheet predominates. Within the last couple of months elucidation of the tertiary 
structure of PrP residues 121-231 has been provided by NMR methods (Riek et 
al., 1996). This PrP polypeptide fragment is shown to contain three a-helices 
and a two stranded antiparallel f3-sheet. Although these studies support earlier 
predictions for the high a-helix content of PrP (Pan et al., 1993; Safar et al., 
1993), the detection of a short 13-sheet structure between the amino acids 
sequences 128 to 1 3 I and 161 to 164, is unprecedented. In view of the marked 
13-sheet content of PrP, the authors propose that this novel 13-sheet region in 
PrP' may act as a nidus or 'nucleation site' for PrP formation. 
The intracellular accumulation of PrP` is believed to be a major event governing 
neuronal cell death and the speed of disease progression. The mechanism by 
which PrP has its detrimental effect may be analogous to those processes by 
which accumulation of 13/A4 amyloid protein in Alzheimer's disease (Hardy and 
Ailsop, 1991) or the accumulation of gangliosides in lysosomal storage diseases 
(Watt, 1996) cause central nervous system damage. The observation that 13-
sheet-forming fragments of PrP` possess neurotoxic properties provides an 
additional mechanism by which PrP may cause its pathological effect (Forloni et 
al., 1993; Selvaggini etal., 1993). 
The production of transgenic mice which lack a functional PrP gene, and thus the 
neuronal cell-surface protein, has provided conclusive support for the central role 
of PrP in scrapie pathogenesis. Prior to these experiments, PrP was universally 
believed to serve an essential cellular function (Bendheim etal., 1991; Hope and 
Baybutt, 1 99 1) based on the observation that its gene is highly conserved in a 
broad range of animals (Robakis et al., 1986; Sparkes et al., 1986; Westaway and 
Prusiner, 1986). However in marked contrast to these assumptions, the absence 
of PrP does not confer a lethal trait, with PrP-null mice displaying similar 
behaviour and development to their wild-type counterparts (BUeler ci' al., 1992). 
However the two genotypes differ in their susceptibility to scrapie pathogenesis. 
Following scrapie inoculation, PrP-null mice remain healthy and free of disease 
symptoms for at least 2 years whereas PrP-homozygous controls all die within 6 
months (Büeler et at., 1993). In view of these findings it has been proposed that 
the production of transgenic animals lacking the PrP gene will be a logical 
progression towards the establishment of scrapie and bovine spongiform 
encephalopathy resistant domesticated animals. Whether such an objective, 
although theoretically possible, is an ethically and financially viable proposition 
remains a matter of debate. 
we 
1. 4 Bovine spongiform encephalopathy and the threat to human health. 
The incidence of BSE (146,000 confirmed cases between 1986 and September 
1995; Patterson and Dealler, 1995) has generated a substantial amount of media 
attention with the increasing public perception of potential human health risks 
associated with greater exposure to contaminated bovine products. It has 
generally been assumed that dietary exposure to scrapie-affected animal tissue 
constitutes little risk to human health, as human forms of progressive dementia 
occur with a similar frequency in countries in which scrapie is both endemic and 
absent (Taylor, 1989). In this regard it was commonly believed that human health 
was unlikely to be prejudiced by exposure to BSE infectivity (Department of 
Health, 1989). However with the development of the BSE epidemic, control 
measures were implemented in the U.K. to eliminate further spread of BSE to 
bovines and other domesticated species, as well as to minimize the amount of 
infectious material entering the human food chain. In this respect bovine 
spongiform encephalopathy and scrapie became notifiable diseases in June 1988 
and January 1993 respectively. Also, from July 1988 the feeding of ruminant-
derived protein to ruminants was prohibited and in November 1989 it became 
illegal to use specified bovine offals (brain, intestine, spinal cord, spleen, thymus 
and tonsils) for human consumption (Taylor, 1993). 
Creutzfeldt-Jacob disease exists in three recognised forms with different 
frequencies of occurrence. The hereditary form is transmitted in an autosomal 
dominant manner and is associated with pathogenic mutations in the gene which 
encodes PrP (Collinge et al., 1989; Collinge et al., 1990; Prusiner, 1991). 
Acquired forms of the disease have been discussed above in relation to kuru and 
iatrogenic cases of transmission. The remaining 85% of CJD cases occur with a 
random distribution and unknown cause, these are classified as sporadic CJD. To 
reiterate the discussion above, this latter form of the disease has an incidence of 
approximately 1:1,000,000  per year, displays distinct clinical and 
neuropathological features (Budka et al., 1995; Bell and Ironside, 1993) and has 
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an average age of onset at around 65 years. The clinical duration is between 2.5 
and 6.5 months (Will et al., 1996). As a consequence of the BSE epidemic in 
cattle, an epidemiological surveillance unit was formed in the U.K. for the 
purpose of monitoring and identifying any changes in the incidence of 
Creutzfeldt-Jacob disease within the British human population. Within the last 
couple of months evidence has been presented detailing the emergence of a new 
variant of Creutzfeldt-Jacob disease, apparently unique to the United Kingdom. 
(Will et al., 1996). in an appraisal of 207 cases of CJD between May 1990 and 
April 1996, ten individuals were discovered to exhibit neuropathological features 
significantly different from previously described classical cases of sporadic CJD. 
In contrast to the disease characteristics displayed above, the affected individuals 
within this group (four male and six female) were much younger at disease onset, 
i.e. an average age of 29 years (range 18 to 41 years), and as opposed to the 
relatively short interval between the development of clinical signs and death 
outlined in the sporadic cases above, the mean clinical duration of this new 
variant of CJD was 12 months (range 7.7 to 22.5 months). Neuropathological 
examination of material from all ten individuals revealed spongiform change and 
PrP plaques consistent with CJD diagnosis (Bell and Ironside, 1993). However, 
the PrP plaques observed in the latter cases were found to possess features 
unusual to sporadic cases of CJD. As such these proteinaceous aggregates were 
noted to resemble kuru-type plaques in that they possessed dense eosinophilic 
centres and a pale periphery. Indeed the plaques were likened to similar features 
in scrapie-affected animals in that they exhibited a peripheral zone of florid 
spongiform change (Fraser, 1979a), a property unreported in sporadic CJD 
plaques (Will et al., 1996). The authors concluded that the observation of this 
new variant of CJD was "a cause for great concern" and proposed food-borne 
exposure to BSE as the most plausible cause of disease. 
The human PrP protein contains a common polymorphism at amino acid position 
129, where methionine or, less commonly, valine may be present. PrP genotypes 
occur in the U.K. with frequencies of 37% methionine 29 homozygotes, 5 I % 
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methionine'29-valine 29 heterozygotes and 12% valine' 29 hornozygotes (Collinge, 
1991). Interestingly iatrogenic and sporadic forms of CJD predominantly cause 
disease in specific PiP genotypes. Individuals with a valine'29 hornozygote PrP 
genotype are significantly more susceptible to iatrogenic CJD following infection 
with CJD-contaminated growth hormone (Collinge et al., 1991), whereas 
sporadic cases of CJD occur with a high frequency in both homozygote PrP 
genotypes but with a low incidence in heterozygotes (Palmer ci al., 1991). In 
marked contrast to the iatrogenic CJD predispostion described above 'new 
variant' CJD occurs in methionine129 hornozygotes (Will et al., 1996). This 
preliminary although strikingly consistent result tentatively identifies a subgroup 
of the population at particular risk from the BSE infectious agent. 
The production of transgenic mice expressing the human form of PrP (HuPrP) 
has provided an experimental model in which human susceptibility to 
transmissible spongiform encephalopathy agents can be assessed (Telling et al., 
1994). When mice expressing both murine (MoPrP) and human (valine'29 
transgene) forms of PrP are inoculated with brain homogenate from CJD patients, 
neurological disease occurs approximately 200 days latter, with the production of 
human PrPD  (Telling ci al., 1994). If the same mice are challenged with the 
BSE infectious agent they develop disease after a protracted incubation period (> 
200 days) and with the production of murine ppE  (Coiling et al., 1995). Mice 
homozygous for the human PrP transgene have not been observed to develop 
clinical signs of disease following BSE infection. This is perhaps not entirely 
unexpected in view of the reported absence of PrP vaiine'2t hornozygotes in 
individuals affected with the new CJD variant (Will et al., 1996). Although the 
above transgenic studies lead one to believe that mankind is resistant to BSE 
infection (Collinge et al., 1995) it is noted that studies involving the human 
rnethionine'29 PrP transgene, for which BSE susceptibility is suspected, have not 
yet been performed. Only when these results are available will a considered 
appraisal of the potential threat of BSE to human health be possible. 
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1. 5 Ante Mortem Diagnosis of TSE Disease Status. 
Diagnosis of transmissible spongiform encephalopathy status is confirmed by the 
histopathological examination of central nervous system tissue in which neuronal 
vacuolation, astrocytic gliosis and amyloid plaque formation are diagnostic 
hallmarks of disease. Pathology can also be confirmed by the biochemical 
detection of the disease-specific protein PrPsc. Unfortunately the above 
techniques are restricted to the analysis of post inortenz tissue. The inexistence of 
a definative ante mortem diagnostic test serves as a serious impediment to the 
positive identification of preclinically-affected animals. Availability of such a test 
would allow effective disease-eradication programs to be initiated and eliminate 
the possibility of human consumption of affected animals products. 
Ante mortem diagnosis of scrapie in sheep and BSE in cattle relies heavily on the 
presentation of clinical signs consistent with neurological damage, coupled with 
the elimination of common differential diagnoses (Scott and Henshaw, 1994). 
Scrapie-affected animals classically present in a poor body condition with areas of 
self-inflicted fleece loss over the flanks and tailhead. Cutaneous stimulation of 
the skin over the dorsal sacral area produces manic lip-smaking and swaying of 
the hindquarters in approximately 85% of affected animals. Cerebral damage is 
indicated by an altered mental state with marked depression and a vacant 
appearance but hyperaesthesia to visual, auditory and tactile stimuli. Cerebellar 
damage is exemplified by postural and gait abnormalities, typically hind-limb 
ataxia, dysmetria (most commonly hypermetria) of the fore-limbs, and a wide-
based stance. As the disease progresses affected animals spend significantly more 
time in sternal recumbancy. These behavioural and postural signs are also 
exhibited by B SE-affected cows (Hourrigan, 1990a). 
Although tentatively performed, ante mortem diagnosis of transmissible 
spongiform encephalopathy status in clinically-affected animals can be attained 
with a certain degree of accuracy, however in the absence of neurological signs 
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the identification of preclinically-affected individuals is impossible. In view of the 
considerable incubation period before clinical signs are exhibited, preclinically-
affected animals represent a significant pool of otherwise undetectable infectious 
material. This sinister feature of the spongiform encephalopathies has served to 
frustrate scrapie eradication programs in the U.S.A. (Hourrigan, 1990b), and has 
made a significant contribution to the transmission of infectious material in 
iatrogenic cases of Creutzfeldt-Jacob disease (Bernoulli et at., 1977; Brown et 
al., 1985; Duffy et al., 1974; Will and Matthews, 1982). 
Definitive diagnosis of TSE status can be performed by cerebral biopsy (Will et 
al., 1996), however this procedure is physically as well as mentally traumatic and 
involves considerable surgical expertise. The biochemical analysis of blood may 
provide an acceptible, relatively non-invasive means of clinical diagnosis. CJD 
infectivity has been isolated in and transmitted by human blood buffy coat 
constituents (Manuelidis et al., 1985) and immunoreactivity to protease-resistant 
protein has been detected in the same (Sidle, 1992). PrPc  mRNA is expressed in 
lymphocytes where the gene product, is anchored to the cell surface by a 
GPI moiety (Cashman et at., 1990). In view of the intimate association between 
PrPsc and scrapie infectivity (Bolton et at., 1982), it seems highly probable that 
this haematogenous fraction contains significant titres of the infectious agent. 
Establishment of experimental scrapie by blood-borne inoculation is very 
effective, with a high proportion of infectivity being taken up by spleen and lymph 
nodes (Kimberlin and Walker, 1988). Oral transmission of the infectious agent is 
undoubtedly directed to the same target organs via the tonsils, Peyer's patches, 
gastro-intestinal lymphatics, portal vein transport and systemic circulation. 
Studies of disease transmission in peripherally-inoculated splenectom ized (Fraser 
and Dickinson, 1970; Clarke and Haig, 1971, Dickinson and Fraser, 1972) and 
thymectomized (Fraser and Dickinson, 1978) animals suggest that B cells play a 
more important role in the establishment of infection than T cells. Splenectomy 
confers a lengthened incubation period whereas thymectomy has little to no 
effect. Further support for the role of lymphocytes in the establishment of 
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infection come from experiments of scrapie pathogenesis following experimental 
challenge with vaccinia virus (Marsh, 198 I) or methanol extracted residue of 
bacille Calmette-Guerin (Kimberlin and Cunningham, 1978). In these studies 
mitogenic stimulation of the immune response facilitated infection by shortening 
the scrapie incubation period. It is interesting to note that activation of 
lymphocytes significantly increases the surface abundance of PrPc  thereby 
increasing the availability of PrPc for biotransformation to the scrapie isoform. 
Although PrP°' is present in blood at the clinical stage of disease (Sidle, 1992), 
it has not been established at what stage of the incubation period the abnormal 
isoform of PrP is first detectable. Further studies in experimentally defined 
murine-scrapie models will clarify the suitability of this immunological technique 
to the preclinical diagnosis of TSE status. 
Brugere and colleagues recently described an electrochemical method by which 
elevated levels of a chemical were detected in the urine of scrapie-affected sheep. 
The authors proposed that a similar metabolite is found in urine from Alzheimer's 
disease patients. This substance is reduced at 850 rnV and oxidized at 1200 mV 
and is relatively unstable to the analytical technique. The identity of this 
compound has not been elucidated, however the existance of an aromatic or 
heterocyclic substance, possibly a metabolite of the catecholamines and/or 
serotonin, has been speculated (Brugere et at., 1991). Although the observation 
of this biochemical abnormality allows the detection of clinically-affected animals, 
it is not clear at what stage of the disease elevated levels of this metabolite 
become statistically significant. In addition, the test does not appear to be 
scrapie-specific as similar changes are detected in other neurological disorders 
(Alzheimer's disease). Further studies in this area are in progress and an 
appraisal of its application to the diagnosis of BSE-affected cattle is being 
performed. 
The investigation of cerebral metabolism during scrapie pathogenesis by in viva 
'H MRS permitted the detection of two prominent changes in scrapie-affected 
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mice (Bell et al., 1991). The first of these was observed as a reduction in a 
proton resonance at 1.9 ppm in clinically-affected scrapie animals. This 
resonance was assigned to N-methyl protons in N-acetyl aspartate (NAA). 
Similar reductions in NAA intensity are observed in a number of cerebral 
disorders, including acquired immunodeficiency syndrome (AIDS) (Menon et al., 
1990a), herpes simplex encephalitis (Menon etal., 1990b), cerebral demyelinating 
disorders (Arnold ci at., 1992; van der Knapp et al., 1992) and Creutzfe!dt-Jacob 
disease (Bruhn ci' al., 1991). Although the function of N-acetyl aspartate is 
unknown, its primary location in neurons (Birken and Oldendorf, 1989) makes it 
an excellent marker of neuronal status within the brain (Small ci' at., 1990). In 
this respect the reduction in N-acetyl aspartate in the above murine-scrapie model 
(ME7/VM) is believed to be indicative of extensive neuronal loss/damage 
exhibited at the terminal stage of disease (Fraser, 1969; Fraser, 1995). The 
second abnormality, which generated more interest, was observed as a broad 
multi-component resonance between 1.5 and 1.8 ppm. This signal was detected 
in scrapie-affected animals but not in age-, strain- and sex-matched controls. The 
observation of this metabolic abnormality preceeded the detection of PrP, the 
onset of vacuolation, and clinical signs of disease (Bell ci' al., 1991). As such 
these findings stressed the importance and potential application of this technique 
to the ante mortem, preclinical diagnosis of scrapie, and perhaps other members 
of the transmissible spongiform encephalopathies. In vitro MRS studies of 
cerebral perchloric acid extracts failed to detect the metabolite, it was therefore 
proposed that the multicomponent resonance was attributable to a non-aqueous 
compound, possibly lipid. Under the experimental acquisition parameters (T2 
relaxation time = 420 ms) it was reasoned that the signal was unlikely to have 
arisen from subcutaneous fat which resonates between 1.2 and 1.5 ppm and has a 
T2 relaxation time value of 47 ± 5 ms. Rather, it was speculated that the signal 
was attributable to lipids which had a mobile component and were in an 
environment different from that normally expected, or from mobile membrane-
related compounds. 
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Although there is a great deal of evidence to support claims of abnormal lipid 
profiles in Creutzfeldt-Jacob disease (Bass et at., 1974; Tamai et al., 1978), the 
same level of investigation has not been parallelled in murine-scrapie models. In 
fact, results in this area have been few and often contradictory. The lipid 
composition in membrane vesicles prepared from scrapie-affected hamster brain 
have been reported to show no difference to normal hamster brain (Dees et al., 
1985). Similarly, studies of total cerebral lipids in scrapie-affected mice found no 
changes in the content or composition of cholesterol and phospholipids (Guan et 
al., 1996), a result mirrored by earlier findings (Heitzman and Skipworth, 1969; 
Kimberlin and Millson, 1967). In contrast, others have investigated 
phospholipids in brains of scrapie- affected mice and found the total phospholipid 
content decreased, but the composition of individual phospholipids and fatty acids 
constant (Tamai et al.. 1978). Whilst others have reported the intracerebral 
accumulation of neutral lipid in scrapie-affected mice by histochernical techniques 
(Mackenzie and Wilson, 1966). In view of the earlier discussion, it was 
speculated that this latter observation may provide a source for the in vivo MRS 
multicomponent resonance. 
The primary objective of the research described herein was to confirm the 
scrapie-specificity of the novel in vivo magnetic resonance spectroscopy 
observation, reproduce the finding in vitro, and subsequently identify the 
metabolite(s) responsible for this pathological change. Studies of cerebral lipid 
abnormalities in relation to neuropathol ogical changes and protease-resistant 




2. 1 Tissue Excision. Storage and Decontamination. 
Animal Tissue. 
Cerebral tissue of murine origin was obtained from the Biotechnology and 
Biological Sciences Research Council (B.B.S.R.C.) & Medical Research Council 
(M.R.C.) Neuropathogenesis Unit, Edinburgh. This was predominantly derived 
from the inbred VM strain of mice (Sinc p7p7 genotype), infected with the ME7 
(1 35A) strain of scrapie. The mice destined for disease transmission received an 
intracerebrally inoculation of a standard dose of the scrapie agent [ME7, 6.5 ic. 
ID50  units (negative log per 0.02 ml dose)] and were sacrificed in the terminal 
stage of the disease (346 ± 3 days post inoculation) when severe symptoms of 
ataxia, myoclonus and emaciation were exhibited. Control mice of a similar 
strain, gender and age received an intracerebral inoculation of normal brain 
homogenate suspended in isotonic buffered saline (0.9% w/v, NaCI) and were 
sacrificed in an identical manner. 
Tissue Excision and Storage. 
Mice were sacrificed by cerebral dislocation and subsequent decapitation. The 
cranial cavity was exposed by the delicate removal of the upper part of the skull 
within the limits of the maxilla-frontal border rostrally, the parietal-occipital 
border caudally and the parietal-temporal border laterally. Brains were 
subsequently removed post-sectioning of the optic nerves. 
Depending upon the purpose for which the tissue was required, brains were either 
drop-frozen or freeze-clamped in liquid nitrogen. The drop-freeze method was 
used exclusively for material destined for high performance thin layer 
chromatography lipid studies. The study of aqueous metabolites by nuclear 
magnetic resonance spectroscopy demanded tissue in which post mortem changes 
in metabolite levels were minimal. For this purpose, tissue was subjected to an 
instantaneous freeze-clamp procedure in liquid nitrogen following its rapid 
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excision. A small amount of tissue was required for cholesteryl ester hydrolase 
studies, these brains were neither freeze-clamped nor drop-frozen but were 
placed directly on ice 
Disinfection of Scrapie-infected Tissue. 
Although evidence to suggest that the animal transmissible spongiform 
encephalopathies constitute a risk to humans is inconclusive, caution and 
containment were exercised at all times whenever handling tissue regardless of its 
origin, be it infectious or not. In addition to the more common precautions, i.e. 
plastic gloves and laboratory coat, all tissue was processed in a fume cupboard, 
with work spaces regularly swabbed with hypochiorite solution. All potentially 
infectious material, including hypochlorite swabs, towels, containers and test 
tubes were soaked in 2 M sodium hydroxide (Sigma Chemical Company Ltd., 
U.K.) for 24 hours (Taylor, 1991) with thorough dispersal of the contents 
ensured by periodic agitation. 
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2. 2 Acetone-Soluble Cerebral Metabolite Extraction Procedure. 
Materials. 
Acetone-d6  (99.8 atom % D), deuterium oxide (99.9 atom % D) and 3-trimethyl-
silyl-2,2',3 ,3 '-tetradeutei-oproprionic acid were from the Aldrich Chemical 
Company Ltd., U.K. 
Procedure. 
Frozen brain tissue was weighed and placed in Eppendorf tubes with 0.6 ml of ice 
cold acetone-d6, to which was added an aliquot of 100 mM 3-trimethylsilyl- 
2,2',3,3'-tetradeuteropropionic acid (TSP) in deuterium oxide (5 Ml). The 
contents were dispersed by sonication (Soniprep 150, Millipore Scientific 
Equipment) on ice with 15 second high energy bursts. Sonication was 
interspersed by 30 second periods of abstinence in order to minimize heating the 
brain extract. The procedure was repeated until the brain tissue adopted a 
creamy consistency in the solvent. The Eppendorf tube was subsequently capped 
and centrifuged (15,000 rpm x 10 minutes, Microspin 12, Sorvall Instruments). 
Following centrifugation the supernatant was removed with a glass Pasteur 
pipette and transferred to another Eppendorf tube. This primary supernatant was 
subjected to a second centrifugation as previously described and the resulting 
secondary supernatant, a clear acetone suspension, placed directly in an NMR 
tube for analysis. The acetone-d6  suspension was briefly stored between 0 to 4°C 
for a short period prior to proton NMR analysis. Low temperature storage (!~ - 
4°C) of the suspension was avoided as this proved to result in metabolite 
precipitation. 
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2. 3 Cerebral Lipid Extraction and Fractionation. 
Materials. 
Chloroform and methanol were obtained from Fisons Laboratory Reagents, U.K. 
and were of analar grade. Dry nitrogen gas was from the British Oxygen 
Company, U.K. DEAE Sephadex A-25 was obtained from Pharmacia Fine 
Chemicals, U.S.A. and sodium acetate was purchased from the Sigma Chemical 
Company Ltd., U.K. 
Procedures. 
Livid Extraction. 
The lipid extraction procedure was similar to that described by Foich et al. (1957) 
with minor modifications. All lipid extraction and storage solvents were purged 
with dry nitrogen prior to use. Frozen brains were weighed and homogenized 
with two volumes of ice cold chloroform/methanol (2: 1, v/v) by son ication 
(Soniprep 150, Millipore Scientific Equipment) over ice. In a similar manner to 
the aqueous metabolite extraction procedure, adequate periods were included to 
prevent heating of the brain extract. An additional 18 volumes of solvent were 
added and sonication was repeated. The suspension was stored for two hours at 
0°C followed by centrifugation (2300 rpm (900 g) x 15 minutes, Denley BR401 
refrigerated centrifuge). The organic supernatant was removed with a glass 
Pasteur pipette and transferred to a glass container. The extraction procedure 
was repeated a further two times with an additional 40 volumes of solvent. 
Pooled supernatants were evaporated to dryness under a stream of dry nitrogen 
and subsequently stored at -20°C. 
Fractionation of Crude Lipid Extract into Neutral and Acidic Species. 
The crude lipid extract was suspended in methanol/chloroform/water (60:30:8, by 
vol., 5 ml) [solvent A]. DEAE Sephadex A-25 columns of I nil bed volume were 
prepared for lipid fractionation as previously described (Ledeen et al., 1973). 
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Briefly, columns were washed with methanol/chloroform/0.8 M sodium acetate 
(60:30:8, by vol., 15 nil) [solvent B] followed by equilibration with solvent A (25 
ml). A proportion of the crude lipid suspension (2 ml of a 5 ml suspension) was 
applied to the column and neutral lipids eluted with solvent A (10 ml). Acidic 
lipids were subsequently eluted with solvent B (10 ml) and collected in a separate 
container. The individual fractions were evaporated to dryness with dry nitrogen 
and stored as described above. 
The acidic fraction required additional processing to remove sodium acetate (a 
component of solvent B detrimental to high performance thin layer 
chromatography lipid separation and analysis). Consequently, this fraction was 
suspended in chloroform/methanol (2: 1, v/v, 3 nil) and distilled water (0.6 ml). 
The contents were vortexed thoroughly for IS seconds (Whirlimixer 
WM/250/F/P, Fisons Scientific Equipment) and left to partition on ice. The 
upper aqueous phase was removed and discarded. Chloroform/methanol/water 
(3:48:47, by vol., 1.4 ml) was added to the organic phase and the procedure 
repeated. The resulting lower organic phase was evaporated to dryness with dry 
nitrogen and stored in a similar manner to the neutral lipid fraction. 
23 
2. 4 NMR Spectroscopy Analysis of Cerebral Metabolites. 
Proton spectra were accumulated on a Varian VXRÔOOS NMR spectrometer 
operating at a spectrometer frequency of 599.945 MHz with a Sun 4/1 10 host 
computer running VNMR (version 4. 1) under SunOS 4. 1 . I. All homonuclear 'H 
data sets were acquired using a dedicated proton probehead. Specific acquisition 
parameters relating to individual experiments are given below. 
2. 4. 1 Assignment of Acetone-Soluble Metabolites at 600 MHz. 
Materials. 
Acetic acid, N-acetyl aspartate, L-alanine, L-asparagine, y-aminohutyric acid, L-
glutamic acid, L-glutami ne, glycerophosphoryicholine, L-glycine, i nositol, lactate, 
phosphory I choline, phosphocreatine, tauri ne and L-threoni ne were from the 
Sigma Chemical Company Ltd., U.K. Acetone-d6 (99.8 atom % D) was from the 
Aldrich Chemical Company Ltd., U.K. 
Acquisition Parameters 
Control murine brain material was extracted with acetone-d6 as described in 
Section 2. 2. One-dimensional spectra were acquired over a 6 kHz sweep width 
into 36K complex data points with an acquisition time of 3 seconds using a 2 
second recycle delay. The residual water signal was suppressed by weak 
irradiation centered at the water frequency during the pulse delay. 
Two-dimensional COSY 45 data sets were acquired over a sweep width of 6 kHz 
in both dimensions with an acquisition time of 171 milliseconds and a pulse delay 
of 4.8 seconds. 16 transients were accumulated for each of 256 FIDs into 2K 
complex data points in both dimensions. Data was apodized in both dimensions 
using a pseudo-echo type weighting function prior to Fourier transformation. 
Spectra were referenced to the N-acetyl aspartate methyl singlet at 2.02 ppm (Fan 
et al., 1986). 
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Spectral assignment of acetone-soluble cerebral metabolites was normally made 
directly on tissue extracts using a combination of one-dimensional, f-resolved and 
two-dimensional COSY 45 NMR experiments. These were correlated with 
spectra of authentic compounds where possible. The identity of peaks chosen for 
quantification were verified by 'spiking' the cerebral extract with authentic 
compounds. The results thus obtained were compared with literature values if 
available. 
2. 4. 2 Comparative Analysis of Acetone-Soluble Metabolites at 360 MHz 
Levels of aqueous metabolites were compared in six terminally-ill ME7-affected 
VM mice and an equal number of age- and sex-matched controls. Proton NMR 
spectra were recorded on a BrUker WH-360 MHz spectrometer at a spectrometer 
frequency of 360.1 35 MHz. One-dimensional spectra were acquired over a 
sweep width of 4 kHz into 32K complex data points with an acquisition time of 4 
seconds and a recycle delay of 2 seconds. The residual water signal was 
suppressed by weak homogated decoupling centered at the water frequency 
during the pulse delay. A total of 64 acquisitions were found to be adequate for 
quantitative measurements. Spectra were referenced internally to the 3- 
trirnethylsilyl-2,2,3,3'-tetradeuteropropionic acid (TSP) singlet at 0.00 ppm. 
2. 4. 3 NMR Spectroscopy Analysis of Cerebral Lipids. 
Materials. 
Fully deuterated methanol (99.9 atom % D) and chloroform (99.9 atom % D) 
were from the Aldrich Chemical Company Ltd., U.K. Disodium hydrogen 
phosphate, sodium deoxychol ate and ethylene diaminetetraacetic acid (EDTA) 
were purchased from the Sigma Chemical Company Ltd. Other chemicals were 
from the sources previously stated. Lipid standards including: cardiolipin, 
cholesterol, cholesteryl oleate, diglyceride, galactocerebrosides I and II, oleyl 
alcohol, phosphatidyl choline, phosphatidyl ethanolarni ne, phosphatidyl inosi tol, 
phosphatidyl serine, sphingomyelin, sulfatides I and II and triglyceride, were 
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obtained from the Sigma Chemical Company Ltd., U.K. and wherever possible 
were from a cerebral source. 
Acquisition Parametei-s. 
Extensive Ill  13  and 31P NMR analysis was performed on the more prominent 
lipid species extracted from murine brains. Initially the investigations were 
centered on the assignment of lipid resonances and the identification of diagnostic 
lipid signals which would allow quantification of individual lipid species. Spectral 
assignment of cerebral lipids was normally made directly on tissue extracts using 
a combination of one-dimensional 'H, J-resolved, two-dimensional COSY 45, 
one-dimensional '3C, '3C-DEPT and HMQC NMR experiments. These were 
correlated with spectra of authentic compounds where possible. The identity of 
peaks chosen for quantification were verified by 'spiking' the cerebral extract 
with authentic compounds. The results thus obtained were compared with 
literature values if available. 
Lipid fractions destined for 'H and '3C NMR spectroscopy experiments were 
dissolved in 0.65 ml of deuterated chioroform/deuterated methanol (2: 1, v/v) and 
placed in NMR tubes of 5 mm internal diameter. 
Phospholipid species purposed for 3 'P NMR spectroscopy analysis required 
additional processing in order to optimize the resolution of individual lipid 
resonances. In this procedure the lipid fractions were washed with aqueous 
EDTA to remove endogenous cations and dispersed as micelles in a solution of 
deoxycholate (Capuani et al., 1992). Briefly, the lipid fractions were suspended 
in chloroform/methanol (2:1, v/v, 3 ml) and washed with an equal volume of 
aqueous 100 mM EDTA, pH 7. The aqueous layer was discarded and the 
organic phase evaporated to dryness under dry nitrogen. Sodium deoxycholate 
was added to the lipid in a 3:1 (w/w) ratio with an aliquot of 100 mM aqueous 
disodium hydrogen phosphate (20 lii) for reference purposes, and deuterium 
oxide (0.65 ml). Lipid dispersion was achieved by sonication in a bath sonicator 
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(Sonicor, Sonicor Instrument Corporation, U.S.A.) and the pH adjusted to 11.4 
with sodium hydroxide solution (0.5 M). 
'H NMR Spectroscopy Analysis of Cerebral Lipids. 
One-dimensional spectra were acquired over a 7 kHz sweep width into 41K 
complex data points with an acquisition time of 3 seconds using a 2 second 
recycle delay. The probe temperature was maintained at 25°C. J-resolved data 
sets were accumulated over a 5.48 kHz sweep width into 8K data points with a 
recycle delay of 2 seconds. 16 scans were acquired for each of 64 FIDs over an 
Fl sweep width of 30 Hz. Data was zero filled in F2 to 16K data points prior to 
Fourier transformation. 
Two-dimensional COSY data sets were acquired using a COSY 45 scheme in 
absolute value mode. 16 transients were accumulated for each of 512 FIDs into 
2K complex data points over a sweep width of 4.7 kHz in both dimensions. Data 
was apodized in both dimensions using a pseudo-echo type weighting function 
prior to Fourier transformation. Two-dimensional HMQC data was accumulated 
in a phase sensitive mode using a States method of phase cycling on a dual 
(inverse) probehead. 16 scans were acquired for each of 256 complex FIDs over 
a 4.7 kHz sweep width into 4K complex data points and an Fl sweep width of 33 
kHz. A recycle delay of 2 seconds preceded a Bird null period to allow for 
elimination of '2C attached proton signals. '3C nucleus decoupling was achieved 
during the acquisition time by 'WALTZ' decoupling. Two dimensional data were 
acquired in an interleaved manner without spinning the sample. Data were 
processed on a remote Sun 4/330GX data station using VNMR software (version 
4.1) operating under SunOs 4. 1 .1. Spectra were referenced internally to the 
methanol quintet at 3.30 ppm. 
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C NMR Spectroscopy Analysis of Cerebral Lipids. 
Due to the low sensitivity of this method, three brain lipid equivalents were used 
in the analysis without prior fractionation. 13C  spectra were accumulated at a 
spectrometer frequency of 150.869 MHz on a broadband probehead over a sweep 
width of 34 kHz with an acquisition time of 0.7 seconds and a recycle delay of 
0.5 seconds using continuous proton 'WALTZ' decoupling. '3C DEPT spectra 
were acquired concurrently using a recycle delay of 2 seconds and proton 
decoupling during the acquisition time only. Spectra were referenced internally 
to the methanol singlet at 49.0 ppm. 
31P NMR Spectroscopy Analysis of Cerebral Lipids. 
31P spectra were accumulated at 242.854 MHz over a 2.9 kHz sweep width into 
9.3 K data points with an acquisition time of 1.6 seconds and a 2 second delay. 
The sample spin frequency was 15 Hz and probe temperature was maintained at 
25°C. Spectra were referenced to the internal P043 singlet at 3.509 ppm. 
In Vivo 'H NMR Spectroscovv Analysis of Cerebral Metabolites. 
In vivo 'H NMR analysis was performed at Queen Mary and Westfield College 
(University of London) by Drs. Jimmy Bell, Jane Cox and Stephen Williams. 
Spectra were obtained at 4.7 Tesla using an Oxford 30 cm horizontal bore 
magnetic controlled by a SISCO 200 spectrometer, Data were collected from an 
8 mm diameter surface coli placed directly on the mouse head. Water 
suppression was achieved using the spin echo variant of the binomial pulse pulse 
sequence: 1331 TE/2 2662 TE/2Acq with the excitation maximum centred for 
the N-acetyl aspartate methyl singlet at 2.02 ppm. Each spectrum acquired 
represented the sum of 1024 transients using an echo time of 420 milliseconds 
and a pulse repetition time of 1.8 seconds, giving an acquision time of 
approximately 30 minutes. 
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2.5 HPTLC Analysis of Cerebral Linids. 
Materials. 
High performance thin layer chromatography silica gel 60 plates (10 x 10 cm, 
silica gel thickness 200 pm, mean particle size 5 to 6 pm, mean pore diameter 60 
A) were purchased from B.D.H. Merck Ltd., U.K. Acetic acid, cupric acetate, 
diethyl ether, diisopropyl ether, formic acid and orthophosphoric acid were 
obtained from Fisons Laboratory Reagents, U.K. Lipid standards including: 
cardiol ipin, cholesterol, cholesteryl oleate, diglyceride, gal actocerebros ides I and 
II, oleyl alcohol, phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl 
inositol, phosphatidyl serine, sphingomyelin, sulfatides I and II and triglyceride, 
were obtained from the Sigma Chemical Company Ltd., U.K. and wherever 
possible were from a cerebral source. 
Procedure. 
The high performance thin layer chromatography methodology adopted was 
essentially that attributed to Macala et al. (1983). High performance thin layer 
chromatography plates were eluted with chloroform/methanol/water (60:30:8, by 
vol.) prior to loading with lipid for the purpose of removing substances bound to 
the silica which otherwise interfered with the visualization of lipid bands upon 
charring of the plate. Following 'clearing', plates were activated by heating at 
110°C for 20 minutes and cooled in a vacuum desiccator. Authentic lipids 
obtained from the Sigma Chemical Company Ltd. were assessed for h.p.t.l.c. 
purity and subsequently used to produce calibration curves from which the 
unknown cerebral lipid quantities were calculated. A quantity of oleyl alcohol 
(2.5 pg) was applied to each lane for standardization purposes (Macala et a!,, 
1983). 
Neutral and acidic lipid fractions were applied to separate h.p.t.l.c. plates in which 
lanes were positioned 1 cm above the bottom edge of the plate, were 5 mm in 
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width and separated by 5 mm divisions. Solvent systems were equilibrated one 
hour before use in glass t.1.c, tanks (Aldrich Chemical Company Ltd., U.K.) lined 
with filter paper. Neutral lipids were eluted with chloroform/methanol/acetic 
acid/formic acid/water (35:15:6:2:1, by vol.) until the solvent front was 5 cm 
above the origin. Acidic lipids were eluted in a similar manner until the solvent 
front was 5.5 cm above the origin. Following the separation of polar lipids, the 
plates were dried in a fume cupboard for 30 minutes followed by vacuum 
desiccation for at least eight hours, ensuring the complete removal of residual 
acetic acid. The non-polar lipid components were then separated by elution with 
hexane/diisopropyl ether/acetic acid (65:35:2, by vol.) allowing the solvent front 
to run to the top of the plate. 
Following development and drying, plates were sprayed with a solution of 3% 
cupric acetate in 8% orthophosphoric acid until saturated and charred in an oven 
at 180°C for IS minutes (Macala et al., 1983). Cerebral lipids were identified by 
co-migration with authentic standards and subsequently quantified by laser 
scanning densitometry on a Molecular Dynamics Series 300 Computing 
Densitometer running the ImageQuant version 3.0 Fast Scan package. Minor 
adjustments were made to the calculations of lipid quantity to compensate for 
variations in experimental charring conditions by standardization to a known 
quantity of oleyl alcohol as described previously. 
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2. 6 Purification and Analysis of Specific Lipid Species. 
Materials. 
Aminopropyl silica SEP PAK columns were from Waters Chromatography 
Division (Millipore), U.K. Hexane was purchased from Fisons Laboratory 
Reagents Ltd., U.K. Other materials were from the sources previously stated 
Procedure. 
A number of lipid abnormalities were detected by high performance thin layer 
chromatography in the cerebral extracts from scrapie-affected and control mouse 
brains. These lipids were characterized in greater detail by mass spectrometry 
and nuclear magnetic resonance spectroscopy. The lipid species were purified 
prior to analysis by bonded phase chromatography on aminopropyl silica SEP 
PAK columns. This greatly assisted the interpretation of analytical data, a factor 
most commendable in the clarification of nuclear magnetic resonance 
spectroscopy results. 
Cholestervi esters. 
(High performance thin layer chromatography analysis of brain tissue from 
scrapie and control mice in the ME7/VM model revealed elevated levels of a non-
polar, neutral lipid in diseased animals. This appeared to co-migrate with 
authentic cholesteryl oleate and is thus referred to as the 'cholesteryl ester' 
fraction). 
Purification h' Bonded-Phase Column Chromatography. 
The 'cholesteryl ester' fraction was isolated by column chromatography on 
aminopropyl silica SEP PAK columns as described by Kaluzny et at. (1985). The 
procedure was as follows, bonded-phase columns were equilibrated with two 
quantities of hexane (2 x 4 ml) followed by the application of neutral lipid to the 
column in 200 il of hexane. The fraction containing 'cholesteryl esters' was 
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eluted with 4 ml of hexane. The limited capacity of the columns (7 mg lipid/360 
mg column) necessitated the use of several columns per brain extract to obtain a 
satisfactory yield of 'cholesteryl esters' in the absence of other lipid contaminants. 
An assessment of the degree of 'cholesteryl ester' isolation was afforded by the 
analysis of the pooled fractions by h.p.t.l.c. and confirmation that the fraction of 
interest co-migrated with cholesteryl oleate from an authentic source. 
Analysis by Chemical Ionization Mass Spectrometi (G-MS). 
Mass spectrometry was performed on a Fisons VG Analytical ZAB-T instrument 
with BEBE geometry incorporating an array detector (Rollins et al., 1990). 
Spectra were obtained in the positive chemical ionization (CI) mode using 
ammonia as the carrier gas, with a probe program of 30-620°C at 50°C per 
minute. For tandem mass spectrometry (MS-MS) the column energy was 4 kV, 
the array detector was adjusted for a mass range of 1.22: 1, attenuation was 80%, 
and argon-H20 was used as the collision matrix. 
Tri'lycerides. 
Purification by Bonded-Phase Column Chromatography. 
Following the elution of cholesteryl esters with 4 ml of hexane, the fraction 
containing the suspected triglyceride abnormality was eluted from the SEP PAK 
column with 5% ethyl acetate in hexane (4 ml). The degree of 'triglyceride' 
isolation was assessed by high performance thin layer chromatography in a similar 
manner to that described for cholesteryl esters. 
Analysis by 'H NMR Spectroscopy. 
The cerebral 'triglyceride' fraction was dissolved in 0.65 ml of deuterated 
chloroform/deuterated methanol (2:1, v/v) and placed in an NMR tube of 5 mm 
internal diameter. The experimental acquisition parameters for proton NMR 
analysis were as described in Section 2. 4. 3 with spectra referenced to the 
methanol quintet at 3.30 ppm. 
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Analysis by Chemical Ionization Mass Spectrometry. 
Production of Fatty Acid Methyl Esters. 
Materials. 
Concentrated sulphuric acid and toluene were obtained from Fisons Laboratory 
Reagents, U.K. Sodium sulphate was from the Sigma Chemical Company Ltd., 
U.K. Methanol, from Fisons, was dried over calcium hydride, from the Aldrich 
Chemical Company Ltd., U.K. 
Procedure. 
The fatty acid constituents of the triglyceride fraction underwent analysis by 
chemical ionization mass spectrometry following derivative formation to fatty 
acid methyl esters. Fatty acid methyl esters were prepared following the method 
of Hitchcock and Hammond (1980). The transmethylation reagent was prepared 
by the cautious addition of concentrated sulphuric acid (5 ml) to anhydrous 
methanol (100 ml) with stirring. To this mixture was added dry toluene (50 ml). 
Triglyceride (5 mg), from the cerebral source, was placed in a 10 ml round 
bottom flask with the transmethylation reagent (5 ml) and an antibumping 
granule. The contents were refluxed for 60 minutes in a water bath. The cooled 
solution was transferred to a separating funnel, to which was added distilled 
water (3 ml) and diethyl ether (3 ml). The contents were shaken thoroughly to 
ensure adequate recovery of the fatty acid methyl esters in the organic phase. 
The lower aqueous phase was removed and discarded. The organic phase was 
dried over sodium sulphate (5 minutes), filtered, and evaporated under dry 
nitrogen to give a residue which was stored at -20°C prior to analysis. 
Chemical Ionization Mass Spectrometry of Fam' Acid Methyl Esters. 
Mass spectroscopy was performed on a Kratos MS50TC mass spectrometer 
incorporating a magnetic sector analyzer. Spectra were obtained in the positive 
chemical ionization (CI) mode using methane as the carrier gas, an ion source 
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pressure of I Torr and a probe program of 30 to 350°C at 60°C per minute. 
Accurate mass spectroscopy was performed on the molecular ion with a in/z ratio 
of 294 and an atomic composition peak-match program run on the same. 
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2. 7 Neutral Cholesteryl Ester Hydrolase Studies in Scrapie-Affected Mice 
(ME7/VM Model). 
The determination of neutral cholesteryl ester hydrolase activity in muine 
cerebral tissue was attempted following a number of different procedures. 
Unfortunately, the primary objective of the exercise, that being to examine 
whether scrapie and control extracts exhibited different levels of activity, was not 
successful. However, the chronological progression of experiments leading to the 
optimization of incubation conditions are described herein in order that future 
investigators may avoid the same problem areas encountered by the author. 
Synthesis and Purification of Gholesteryl 19, 10-3HN) 1 oleate. 
Materials. 
[9,10-3H(N)] oleic acid and []-14C]oleic acid were purchased from Du Pont 
(U.K.) Ltd., New England Nuclear Products. Dicyclohexylcarbodiimide and 
dimethyl aminopyridine were from the Sigma Chemical Company Ltd., U.K. 
Dichiorornethane, ethyl acetate, hydrochloric acid and sodium bicarbonate were 
obtained from Fisons Laboratory Reagents, U.K. Silica gel 60 was from Fluka 
Chemika, U.K. and liquid scintillation fluid (6927-57) was from Koch-Light 
Laboratories Ltd. Other materials were from the aforementioned sources. 
Procedure. 
Cholesteryl [9,10-3H(N)] oleate was synthesized from cholesterol and [9,10-
3 H(IV)] oleic acid following the method attributed to Neises and Steglich (1978). 
[9,10-3H(N)] oleic acid (50 jimol, 0.5 Ci) and unlabelled oleic acid (50 .tmol, 
14.06 mg) were placed in a 5 ml Quickfit round bottom flask with dry 
dichloromethane (1 ml). The reagents were continually mixed with a magnetic 
stirrer on ice (B212 hotplate/stirrer, Bibby Science Products Ltd., U.K.). To the 
fatty acid was added dimethylaminopyridine (20 jimol, 2.44 mg), cholesterol (200 
lirnol, 77.34 mg) and dicyclohexylcarbodiimide (100 Mrnol, 20.63 rng). The 
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reaction mixture was kept at 0°C for 5 minutes and then at room temperature 
(20°C) for 3 hours. Upon completion of the reaction the products were filtered 
to remove precipitated urea. The filtrate was evaporated to dryness with dry 
nitrogen and resuspended in dry dichloromethane (0.5 ml). The filtration 
procedure was then repeated. The resulting filtrate was washed twice with 0.5 M 
hydrochloric acid (2 x 20 ml) and finally with a saturated solution of sodium 
bicarbonate (20 ml). The lipid solution was dried over anhydrous sodium 
sulphate (5 minutes), evaporated to dryness under dry nitrogen and stored at - 
20°C. 
Separation of radiolabelled cholesteryl oleate from the crude methylated lipid 
mixture was performed by column chromatography on silica gel 60. A 10 ml bed 
volume column was equilibrated with 1% ethyl acetate in hexane (100 ml). The 
lipid mixture was applied to the column in a small volume of eluaiit (0.50 ml) and 
non-polar lipids eluted with I % ethyl acetate in hexane. Fractions were collected 
in 0.5 ml aliquots and examined for lipids co-migrating with authentic cholesteryl 
oleate by high performance thin layer chromatography. Cholesteryl oleate eluted 
in fractions 13 to 19 (volume 6.5 to 9.5 ml), whilst what was believed to be the 
N-acylurea derivative of oleic acid eluted in fractions 21 to 24 (volume 10.5 to 12 
ml). The cholesteryl oleate fractions were pooled and evaporated to dryness 
under dry nitrogen. On the basis of weight (10.2 mg), the purified radiolabelled 
cholesteryl oleate represented a 16% yield. A 20 VI aliquot of a 5 ml suspension 
of this lipid was found to have an activity of 2.98 x 105  dpm (3.36 x 10 Ci), thus 
a specific activity of 2.15 mCi/mmol (LKB Rackbeta Liquid Scintillation 
Counter). The cholesteryl [9,10-3H(V)] oleate was subsequently diluted with 
non-radiolabelled cholesteryl oleate to give a specific activity of 0,6 mCi/mmol. 
Each incubation mixture contained 125 pg of cholesteryl oleate and an activity of 
2.5 x 10 dprn. Those in which the activity of authentic cholesteryl ester 
hydrolase (EC. 3. 1 .1. I 3, bovine pancreas) was assessed contained twice this 
amount. 
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Neutral Gholesteryl Ester Hydrolase Assay. 
Materials. 
Bovine serum albumin (>98%), cholesteryl esterase EC. 3. 1 . I . I 3 (source: bovine 
pancreas), 2-(N-morphol ino)ethanesulfonic acid, sodium phosphate, sodium 
taurocholate, suci-ose, tris[hydroxymethyl]aminornethane and Triton X-100 were 
obtained from the Sigma Chemical Company Ltd., U.K. A bicinchoninic acid 
(BCA) protein assay kit was from Pierce Ltd., U.K. Other materials were from 
the sources previously stated. 
Procedures. 
(i) Method attributed to Eto and Suzuki (/973). 
Control brain material was homogenized in 9 volumes of ice-cold 0.32 M sucrose 
(approximately 3.6 ml) in a Dounce homogenizer with a tight-fitting pestle. The 
enzyme source was either this homogenate or the supernatant produced after 
centrifugation (2,300 rpm (900g) x 15 minutes, Denley BR401 refrigerated 
centrifuge). 
A 10 Ml  aliquot of both suspensions was diluted 100 fold with 0.99 ml of ice-cold 
0.32 M sucrose. Protein determination was performed on a 0. 1 ml aliquot of the 
diluted suspension by reaction with bicinchoninic acid (BCA) (Smith et al., 
1985). Briefly, an aliquot of brain suspension was mixed with 2.0 ml of working 
reagent (sodium carbonate, sodium bicarbonate, BCA detection reagent, sodium 
tartrate in 0.2 M sodium hydroxide and 4% copper sulphate) and incubated at 
37°C for 30 minutes. The tubes were cooled to room temperature and the 
absorbance measured at 562 nm against a 0.32 M sucrose/reagent blank. The 
protein concentration of the brain suspension was determined following 
comparison with a standard calibration curve prepared from known 
concentrations of bovine serum albumin. The protein concentration of the brain 
suspension was adjusted to approximately 10 mg/mI for the enzyme assay. This 
was achieved following lyophilization and resuspension in a suitable volume of 
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distilled water. An aliquot of this crude homogenate (0.2 nil) was used as the 
enzyme source, this containing approximately 2 mg of protein. 
Cholesteryl [9,10-3H(IV)] oleate (125 Mg,  250,000 dpm) in hexane was placed in a 
glass test tube with sodium taurocholate (4 Mmol) in methanol. The contents 
were dried under dry nitrogen. To this was added sodium phosphate buffer (0. 1 
M, pH 7.0, 1 nil) and the reagents evenly dispersed by bath sonication (Sonicor, 
Sonicor Instruments Corporation, U.S.A.). The suspension was temperature 
equilibrated in a water-bath at 37°C with gentle shaking. To the reagents was 
added a 0.2 nil aliquot of the brain extract and the incubation continued for two 
hours. 
All incubation mixtures were terminated with the addition of 
chloroform/methanol (2: 1, v/v, 3.0 ml) and subsequently treated identically. 
Additional chloroform was added (2.0 ml) together with oleic acid (200 Mg)  in 
methanol and 7,500 dpm of [1-'4C] oleic acid. The two phases were vortexed 
thoroughly (15 sec), then left for 12 hours at 0 to 4°C to partition. The lower 
organic phase containing the lipid extract was removed and evaporated to dryness 
under dry nitrogen. 
Separation of [9,1 0-3H(N)] oleic acid (the hydrolysis product) from cholesteryl 
[9,10-3H(N)] oleate was performed on bonded phase aminopropyl silica SEP 
PAK columns following the procedure attributed to Kaluzny et at. (1985). The 
lipid suspended in hexane (200 Ml)  was applied to equilibrated SEP PAK columns 
(see Section 2. 6). Radiolabelled cholesteryl oleate, together with the majority of 
neutral lipids, were eluted with 15% ethyl acetate in hexane (5 nil) and discarded. 
Radiolabelled oleic acid was eluted with 2% acetic acid in diethyl ether (5 ml). 
This fraction was retained, evaporated to dryness under dry nitrogen and 
suspended in 2 nil of liquid scintillation fluid. 
Liquid scintillation counting was performed on a LKB Rackbeta Liquid 
Scintillation Counter. The oleic acid fraction obtained from the above isolation 
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procedure contained both 3H and 14C isotopes. Tritium contributed insignificantly 
to the 14C energy spectrum above the [345 - 354] energy window, this allowing 
the percentage contribution of the '4C radiolabelled compound to be determined. 
Following its correction to a 100% reading, the 3H oleic acid count was 
calculated by subtraction from the overall total. Corrections for lipid recovery, 
background emissions and counting efficiency were made and the quantity of 
[9,1 0-3H(N)] oleic acid in the lipid extract determined. 
Method attributed to Shah and Johnson (1980). 
Brains were homogenized in ice-cold 0.32 M sucrose as described previously. 
Cholesteryl [9,10-3H(N)] oleate (125 rig, 250,000 dpm) in hexane was placed in a 
glass test tube with Triton X-100 (2%, 0.2 ml) in methanol and the solvents 
evaporated under dry nitrogen. To this was added sodium phosphate buffer (0.1 
M, pH 6.5, 0.8 ml) and the reagents dispersed by bath sonication. The incubation 
reaction was initiated with the addition of the brain suspension (2 mg of protein, 
0.2 nil) and continued for three hours at 37°C. Termination of the reaction and 
processing of the lipid products has been described previously. 
Method attributed to Eto and Suzuki (/973) with Authentic Cholestervi 
Ester Hvdroiase. 
The reagents contained cholesteryl [9,10-3H(N)] oleate (250 Mg'  500,000 dpm), a 
range of sodium taurocholate concentrations (1 to 10 Mmol) and sodium 
phosphate buffer (0. 1 M, pH 7.0, 1.0 ml) which were prepared in glass test tubes 
as described above. 
To these reagents was added 10-2  units of neutral cholesteryl ester hydrolase (EC 
3.1.1 .13) in a 10 pl aliquot of distilled water. (1 unit of cholesteryl ester 
hydrolase enzyme being the quantity of enzyme that will hydrolyze I iniol of 
cholesteryl oleate per minute at 37°C and pH 7.0). The incubation was continued 
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at 37°C for 25 minutes and terminated with chloroform/methanol (2:1, v/v, 3.0 
MI). 
Modification of the Method attributed to West and Shand (1991) with 
Authentic Choleste,-vi Ester Hvdroiase. 
Cholesteryl [9,10-3H(N)] oleate (250 jig, 500,000 dpm) in hexane and various 
concentrations of sodium taurocholate (1 to 10 !irnol) in methanol were dried in a 
glass test tube under dry nitrogen. To these were added 50 mM MES/50 mM 
Tris buffer (pH 7.0, 0.8 ml) and either (a) no bovine serum albumin or (b) bovine 
serum albumin (I%, w/v. 10 mg). The reagents were thoroughly dispersed in a 
Dounce homogenizer with a tight-fitting pestle. 
An aliquot of commercial cholesteryl ester hydrolase (10-2  units, 0.2 ml) was 
added to the reagents and the incubation continued at 37°C for 25 minutes. 
Modification of the Method attributed to West and Shand (1991) with 
Murine Brain Extract. 
The incubation reagents were prepared as described above, each tube containing 
cholesteryl [9,10-3H(N)] oleate (125 jig, 250,000 dpm), 4 limol sodium 
taurocholate, 50 mM MES/50 mM Tris (pH 7.0, 0.8 ml) and bovine serum 
albumin (I %, w/v, 10 mg) with the contents dispersed in a Dounce homogenizer. 
Brains were homogenized in 9 volumes of ice-cold buffered sucrose solution 
(0.32 M, 50 mM MES/50 mM Tris, pH 7.0) with a Dounce homogenizer with 
tight-fitting pestle. Half of the homogenate was used as a crude enzyme source 
whilst the other half was centrifuged (2,300 rpm (900g) x 15 minutes, Denley 
BR40I refrigerated centrifuge) and the resulting supernatant used as the enzyme 
source. Brain suspension (2 mg of protein, 0.2 ml) was added to the reagents and 
the mixture incubated at 37°C for two hours. 
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NO Determination of the Presence of a Cholestervi Ester Hvdrolase Inhibitor(s) 
in Brain Homogenate. 
The assay system was prepared as previously described containing: cholesteryl 
[9,10-3H(IV)] oleate (250 rig, 500,000 dpm), 4 pmol sodium taurocholate, 50 mM 
MES/50 mM Tris (pH 7.0, 0.8 ml), bovine serum albumin (I %, w/v, 10 mg) and 
either (a) 0.2 ml of 50 mM MES/50 mM Tris (pH 7.0) or (b) 0.2 ml of crude 
homogenate (2 mg of protein). 
The incubation was initiated upon the addition of 102  units of authentic 
cholesteryl ester hydrolase and maintained at 37°C for 25 minutes. Termination 
of the reaction and subsequent processing of the products has been described 
above. 
Lactate Dehydro'enase Studies. 
A potential cholesteryl ester hydrolase abnormality in scrapie material was 
investigated in parallel with studies of lactate dehydrogenase activity for the 
purpose of comparison. 
Materials. 
A lactate dehydrogenase kit (Procedure No. 500) was purchased from the Sigma 
Chemical Company Ltd., U.K. Other materials were from the sources previously 
mentioned. 
Procedure. 
The lactate dehydrogenase kit comprised: pyruvate substrate (0.75 mM, I ml), 
2,4-dinitrophenylhydrazine (20 mg/dL, I nil) in 1 M hydrochloric acid, NADH 
(13-nicotinarnide adenine dinucleotide, reduced form, disodium, 1.28 jimol, I mg) 
and sodium hydroxide solution (0.40 M, 10 nil). Brain tissue was homogenized 
in 9 volumes of ice-cold sucrose solution (0.32 M, 50 mM MES/50 mM Tris, pH 
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7.0) and centrifuged (2,300 rpm (900 g) x 15 minutes, Den Icy BR40 I refrigerated 
centrifuge). The supernatant was diluted with additional buffer to give a protein 
concentration of approximately 24 ig/rn1. 
The incubation protocol is described briefly. Pyruvate substrate (0.75 mM, I ml) 
was added to a pre-weighed NADH vial (1.28 fig, I mg), and the contents placed 
in a water-bath at 37°C for a few minutes. Brain suspension (30 ig protein/ml, 
0.1 ml) was added to the reagents, and the incubation continued at 37°C for 30 
minutes. The reactions were terminated by removal of the reagents from the 
water bath and addition of 2,4-dinitrophenyhydrazine solution (20 mg/dL, I ml). 
The contents were mixed and the colour allowed to develop (room temperature, 
20 minutes). Following this period, sodium hydroxide solution (0.4 M, 10 ml) 
was added to the vials, these were capped and mixed thoroughly by inversion. 
After five minutes a sample of the solution was transferred to a cuvette and the 
absorbance read at 450 nm against a buffer/reagent blank. Lactate 
dehydrogenase activity in the brain suspension was calculated From a calibration 
curve of enzyme activity in Berger-Broida (B-B) units against the absorbance of 
the colour produced by 2,4-dinitrophenylhydrazine with various concentrations of 
pyruvate solution. (One B-B unit being defined as that amount of lactate 
dehydrogenase activity which will reduce 4.8 x 104  pmol of pyruvate per minute 
at 25°C). The results are discussed in Section 3. 4. 
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2. 8 A Study of Lipids Associated with Sucrose Gradient GPI-anchored 
Protein Float Fractions. 
Studies of membrane lipids were performed on isolates of GPI-anchored proteins 
in which protein-lipid complexes remain essentially intact (Bordier 1984; Safar, 
1990). The lipid composition of these complexes was analyzed by high 
performance thin layer chromatography as described below. 
Detection of lipids associated with GPI-anchored proteins. 
Materials. 
Sucrose In fractions were obtained from the B.B.S.R.C. & M.R.C. 
Neuropathogenesis Unit, Edinburgh. Silica gel thin layer chromatography plates 
(dimensions 20 x 20 cm, glass support, particle size S - 17 jim, gel thickness 250 
pm) were purchased from the Sigma Chemical Company Ltd., U.K. Other 
materials were from the sources previously stated. 
Procedure. 
Eight samples were presented for analysis containing different density fractions 
from a sucrose gradient separation of glycosyiphosphatidyl inositol-anchored 
proteins from a control VM mouse brain. Each of these were examined for the 
presence of lipid by thin layer chromatography. 
The aqueous sucrose fractions were extracted and washed using a procedure 
essentially identical to that employed for the removal of sodium acetate from 
acidic lipid fractions (Section 2. 3). Pellets were suspended in ice-cold 
chloroform/methanol (2: 1, v/v. 2.0 ml) and distilled water (0.4 ml). The contents 
were vortexed thoroughly (15 seconds) followed by centrifugation (2,300 rpm 
(900g) x 15 minutes, Denley BR4OI refrigerated centrifuge) at 4°C. The upper 
aqueous phase was removed and discarded. Chloroform./methanol/water 
(3:48:47, by vol., 0.9 ml) was added to the organic phase and the procedure 
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repeated. The resulting organic phase, containing the lipids of interest, was 
evaporated to dryness under nitrogen and stored at -20°C prior to analysis. 
Samples were resuspended in chloroform/methanol (1: I, v/v, 20 Ml)  of which 10 
pI was applied to a 20 x 20 cm thin layer chromatography plate. Plates were 
cleared prior to the application of lipid as described in Section 2. 5. Polar lipids 
were eluted with propanol/proprionic acid/chloroform/water (3:2:2:1, by vol.) 
and visualized by charring with 3% cupric acetate in 8% orthophosphoric acid. 
A comparison of lipids associated with GPI-aizchored proteins from PrP-
hosnozyote, -/ieterozyj,'ote and -null mice. 
Materials. 
High performance thin layer chromatography silica gel 60 plates (10 x 10 cm, 
silica gel thickness 200 pm, mean particle size 5 to 6 pm, mean pore diameter 60 
A) were purchased from B.D.H. Merck Ltd., U.K. Other materials were from the 
sources previously stated. 
Procedure. 
Sucrose gradient float fractions were obtained from each of the following: two 
PrP-homozygous, two PrP-heterozygous and two PrP-null mice. Lipids in these 
samples were extracted with ice-cold chloroform/methanol (2: 1, v/v, 2.0 ml) and 
distilled water (0.4 ml) as described previously. Lipids were fractionated over 
DEAE Sephadex A-25 and evaporated to dryness under nitrogen. It was noted 
that these extracts appeared to contain more lipid than the former fractions 
presented for analysis. Neutral lipids were dissolved in 200 M'  of 
chloroform/methanol (I: I, v/v) of which 3 M1  was applied to a high performance 
thin layer chromatography plate. Following the removal of sodium acetate, acidic 
lipids were suspended in 50 M'  of chloroform/methanol (1: 1, v/v) of which 3 M' 
was plated. 2.5 pg of oleyl alcohol was applied for standardization purposes. 
High performance thin layer chromatography plates were developed sequentially 
in chloroform/methanol/acetic acid/formic acid! water (35:15:6:2:1, by vol.) and 
hexane/diisopropyl ether/acetic acid (65:35:2, by vol.). Lipids were visualized by 
charring with 3% cupric acetate in 8% orthophosphoric acid and quantified by 
laser scanning densitometry. 
A comparison of lipids associated with GPI-anchored proteins in scrapie and 
control isolates and a scrapie-associated fibril fraction. 
Procedure. 
Seven samples were presented for high performance thin layer chromatography 
analysis. These comprised sucrose gradient float fractions of PrP obtained from 
three ME7 scrapie-affected VM mice and three VM controls, and an SAF pellet 
purified from a clinically-ill ME7/VM mouse (Somerville et al., 1989). All 
fractions were extracted with ice-cold chloroform/methanol/water as described 
above. Crude lipid was dissolved in chloroform/methanol (1: I, v/v, 20 jil) of 
which 5 jil was applied to high performance thin layer chromatography plates as 
described in Section 2. 5. Plates were developed for the visualization of non-
polar, neutral lipids and phospholipids in hexane/diisopropyl ether/acetic acid 
(65:35:2, by vol.) and in propanol/proprionic acid/chloroform/water (3:2:2:1, by 
vol.) respectively. Following charring with 3% cupric acetate in 8% 
orthophosphoric acid, lipids were quantified by laser scanning densitornetiy with 
reference to authentic standards. 
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CHAPTER THREE 
RESULTS AND DISCUSSION 
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3. 1 NMR Spectroscopy Studies of Acetone-Soluble Cerebral Metabolites. 
Recent studies of cerebral metabolism in scrapie-affected mice (ME7/VM) by in 
vivo 1 H NMR spectroscopy revealed the presence of two abnormalities (Bell et 
al., 1991). The first abnormality, a reduction in levels of N-acetyl aspartate in 
clinically-ill scrapie animals, was believed to be a reflection of the severe vacuolar 
degeneration and neuronal damage associated with this particular murine-scrapie 
model (Fraser and Dickinson, 1968). The second abnormality, which attracted 
the greater interest, was visualized as a multicomponent resonance with a broad 
chemical shift (6 = 1.5 to 1.8 ppm) which increased in intensity with scrapie 
pathogenesis. The realization that the observation of this signal preceded the in 
vitro detection of protease-resistant protein (Pi-P') and histopathological damage 
by several weeks, and the fact that the signal was not present in cerebral in ViVO 
NMR spectra of rodents with other neurological disorders (Bates et at., 1989; 
Gadian et at., 1986), emphasized the potential application of this technique to the 
non-invasive, preclinical diagnosis and study of scrapie disease progression. 
The identity of the multicomponent resonance was not elucidated by the authors, 
however it was speculated that the aforementioned signal was the result of a 
change in the mobility of intracerebral lipid (Bell etal., 1991). This hypothesis 
remained unsubstantiated. 
The research presented herein describes our independent investigation of changes 
in levels of cerebral metabolites in scrapie and control mice by in vitro NMR 
spectroscopy. 
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3. 1. 1 Assignment of H NMR Spectrum of Acetone-Soluble Cerebral 
Metabolites. 
Prior to the comparative analysis of metabolites, a combination of MRS 
experiments including one-dimensional, two-dimensional shift correlated and J-
resolved NMR spectroscopy, together with reference to literature values (notably 
Fan etal., 1986) and authentic metabolite 'spiking' experiments were applied to 
the assignment of acetone-soluble metabolite resonances. This was a necessary 
prerequisite for the identification of 'diagnostic signals' which were subsequently 
used for metabolite quantification. 
The structures of the following compounds are illustrated in Figure 3. 
Extensive reference is made to these in the following description of proton 
assignments. 
Acetate (Ac) [1]. Acetate produces a characteristic methyl proton singlet 
resonance at 1.90 ppm in the one-dimensional proton NMR spectrum (Figure 3. 
1. 2). Extracts prepared from fresh brain do not contain appreciable levels of 
acetate. The presence of a relatively intense signal in this spectrum is thus 
considered an artefact, the result of tissue storage at -70°C for several months 
(Gadian, 1990). Comparison of the above spectrum with Figures 3. 1. 6a/b, 
obtained from freeze-clamped, directly processed tissue, illustrates the effect that 
storage has on cerebral acetate concentrations. 
Alanine (Ala) [2].  Following comparison with literature values and multiplicities, 
the 3-methyl protons in alanine were assigned at 1.49 ppm, these producing a 
doublet on coupling to the a-methine proton. Examination of the two-
dimensional shift correlated spectrum revealed the f3-methyl protons to be 
coupled to a poorly resolved complex resonance at 3.72 ppm, of which the a 
proton was one component. The 3-rnethyl proton signal was used for 
characterization and quantitative purposes. 
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Figure 3. 1. 2a 'H NMR spectrum of acetone-soluble cerebral metabolites at 600 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
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Figure 3. 1. 3 Two-dimensional i-resolved spectrum of acetone-soluble cerebral metabolites at 
600 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 










Figure 3. 1 2b 'H NMR spectrum of acetone-soluble cerebra] metabolites at 600 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. 
Asparagine (Asp) [3]. 13-methylene protons in asparagine are diastereotopic 
giving rise to doublet of doublets' on coupling to the a-methine proton. In the 
following studies the methylene proton with a torsion angle of approximately 
1800 relative to the a proton was designated as 13° and was assigned at 2.65 ppm 
with 3J,3° of 9.4 Hz and 2Jud  of 17.5 Hz (Figure 3. 1. 3). The 13d  proton (with a 
torsion angle of approximately 60° relative to the a proton) was assigned at 2.80 
ppm. This had the same geminal coupling as the 1" proton resonance in addition 
to 3Ja of 3.6 Hz. Both protons were seen not only to produce cross-peaks with 
each other in the two-dimensional COSY 45 spectrum, but also with the a proton 
at 3.88 ppm (Figure 3. 1. 4). Inspection of the one-dimensional spectrum showed 
this signal to comprise a doublets of doublets with the J-resolved spectrum 
providing confirmatory coupling constants of 3Ja3° of 9.4 Hz and 
3jd  of 3.6 Hz, 
in agreement with those previously found. The pd  proton resonance at 2.80 ppm 
was sufficiently well resolved to be used for diagnostic and quantitative purposes. 
7-alninobutvric acid (GABA) [4]. GABA produces a characteristic quintet 
resonance from the f3-methylene protons at 1.91 ppm. This was observed to 
produce cross-peaks with resonances at 2.30 and 3.05 ppm in the two-
dimensional COSY 45 spectrum. These latter resonances were assigned to the a-
and y-methylene protons respectively, in agreement with literature values (Fan et 
al., 1986). The 7-methylene proton was found to lie directly tinder the creatine 
methyl proton singlet at 3.06 ppm, however the a proton resonance at 2.30 ppm 
was well resolved and was consequently used for diagnostic purposes. 
Glutainine (GIn) [5]. Glutamine resonances, although prominent, were not 
clearly distinguishable from other metabolite signals in the acetone-d6 proton 
NMR spectra. On comparison with the perchloric acid extract proton spectra of 
Fan et al. (1986) and our own two-dimensional shift correlated experiments, it 
was noted that the f3-methylene proton signal resonated under the residual 
acetone signal at 2.16 ppm. This signal was showed to couple to proton 
resonances at 2.46 and 3.76 ppm, corresponding to the y-methylene and a- 
Figure 3. 1. 4 Homonuclear shift-correlated spectrum (COSY 45' of acetone-soluble cerebral 
.metabolites at 600 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. 
methine protons respectively. Neither of these were suitable for quantitative 
purposes as they occurred in the proximity of resonances from N-acetyl aspartate 
(i3umethyIene proton, ö = 2.51 ppm, dd), alanine ((x-methine proton, ö = 3.72 
ppm, q) and glutamate (a-methine proton, ö = 3.75 ppm, t). 
Glutamate (Glu) [6]. 3-methylene protons in glutamate were observed as a 
complex signal at 2.06 ppm. These produced cross-peaks in the two-dimensional 
proton spectrum with signals at 2.39 and 3.75 ppm. These were assigned to the 
7-methylene an a-rnethine protons respectively. The latter a proton signal was 
obscured by resonances from alanine ((x-methine proton, 5 = 3.72 ppm, q) and 
glutamate (a-rnethine proton, 5 = 3.75 ppm, t), however both 3- and 'y-rnethylene 
protons were suitable for diagnostic purposes, with the 7-methylene proton triplet 
being quantified in these studies. 
Glycine (GIv) [7]. The magnetically equivalent methylene protons in glycine 
produce a distinctive singlet resonance at 3.55 ppm. This signal was 
distinguishable from the co-resonating inositol HI, H3 doublets of doublets at 3.52 
ppm and was thus considered suitable for quantitative purposes. 
Glycerophosphorvicholine (GPG,) [8]. The terminal methyl proton singlet 
resonance was assigned at 3.28 ppm, this being the most prominent of the 
choline-associated signals. This resonance provided no connectivity information 
on the remaining choline head group/glycerol backbone protons which 
consequently were not assigned. 
Inositol (mo) [9]. Inositol proton resonances were assigned following inspection 
of literature values (Fan et al., 1986; Dr. Jimmy Bell, personal communication), 
multiplicities and coupling constants, and comparing these to the test spectra. 
The H2 proton appeared to produce a triplet at 4.07 ppm in the one-dimensional 
'H spectrum. Upon inspection of the i-resolved spectrum this was seen to 
comprise a doublet of doublets with identical 3J,,2 and 3J2 3 of 2.9 Hz in close 
agreement with the values found by Bell and colleagues (2.7 Hz; Dr. Jimmy Bell, 
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Metabolite Chemical shift /ppm Multiplicity Functional group 
Acetate 1.90 s -CH3 
Alanine 
1.49*  d 
3.72 q a-CH 
Asparagine 2.65 dd 13CH
1  
2.80* dd 
3.88 dd (X-CH 
y-aminobutyrate 1.91 qu r3-CH7 
2.30 t cc-CH 
3.05 t y-CH2 
Glutamine 2,16 c 
2.46 c y-CH2 
3.76 t cx-CH 
Glutamate 2.06 c 
2.39* t y-CH2 
3.75 1 a-CH 
Glycine 355* s -CH2 
Glycerophosphory] 3.28* 
choline  
s -N(CH3)3  
Inositol 3.29 t H5 
3.52* dd H1/1-13 
3.66 t 1-14/H6 
4.07 t(dd) H2 
Lactate 1.30* d 13-CH3 
4.07 q a-Cl-I 
Table 3. 1. 1 Assignment of aqueous cerebral metabolites in 'H NMR spectrum at 600 MHz. 
Aqueous metabolites were extracted from murine brain with acetone-d6. 'H NMR spectra 
were acquired on a Varian VXRÔOOS NMR spectrometer operating at a spectrometer 
frequency of 599.945 MHz. Metabolites were referenced to the N-acetyl aspartate methyl 
singlet at 2.02 ppm (Fan et al., 1988). For a full description of the procedure see 
Experimental. 
* denotes resonances used for metabolite quantification. 
c, complex; d, doublet; dd, doublet of doublets; q, quartet; qu, quintet; t. triplet. 
personal communication). The H2 proton couples to the magnetically equivalent 
Hi and H3 protons at 3.52 ppm producing doublets of doublets with identical 3J2  
and 3J1 ,2 of 2.9 Hz in addition to another coupling constant of 10 Hz. This latter 
coupling constant was produced by coupling between the HI and H6 protons on 
the one hand and the H3 and 1-14 protons on the other, (i.e. 3J,.6 and 34,,4 = 10 Hz). 
This finding was also in agreement with those of Bell and colleagues (9.9 Hz; Dr. 
Jimmy Bell, personal communication). The two-dimensional COSY 45 showed 
the signal at 3.52 ppm to be coupled to a resonance at 3.66 ppm, this 
corresponding to the equivalent H4 and H6 protons. Lastly, the H5 proton was 
assigned at 3.29 ppm from the cross-peak produced in the COSY 45 spectrum 
upon its coupling to the equivalent H4 and H6 protons. Although inspection of 
the one-dimensional proton spectrum showed this latter signal to be partially 
obscured by the terminal methyl singlet resonance from 
glycerophosphoryicholine, the J-resolved spectrum revealed that the H5 
resonance had identical .J45 and .J5,6  of 9.5 Hz. In conclusion, the HI and H3 
protons were used for quantitative and diagnostic purposes. 
Lactate (Lac) [10]. Resonances from lactate were prominent and readily 
identifiable. The n-methyl protons produced a doublet at 1.30 ppm on coupling 
to the cL-methine proton which consequently was assigned from the two-
dimensional COSY 45 spectrum at 4.03 ppm. The 13-methyl proton signal was 
used for diagnostic and quantitative purposes. 
N-acetyl asparlate (NAA) [11]. NAA is recognized as a prominent compound in 
'H NMR spectroscopic studies of brain (Birken and Oldendorf, 1989). The 
methyl proton singlet was readily assigned at 2.02 ppm and although it lies in the 
close proximity to a complex signal from glutamate 13-methylene protons, was 
distinct enough to be used for diagnostic and quantitative purposes. The methyl 
proton singlet provided no connectivity information to assist in the assignment of 
the remaining a-methine and 13-methylene protons. These were tentatively 
identified following comparison with published results (Fan et al., 1986). The a- 
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Metabolite Chemical shift /ppm Multiplicity Functional group 
N-acetyl aspartate 2.02* s -CH3 
2.51 dd f3-CH"  
2.65 dd 
4.42 dd a-CH 
Phosphorylcholine 3.27* s 
Total Creatine 3.06 s -CH3 
3.90* s -CH, 
Taurine 3.20* t H,N-C112- 
____________________ 
3.43 1 -CH,SOH 
Threonine 1.34 d 
Table 3. 1. 1 continued. Assignment of aqueous cerebral metabolites in 'H NMR spectrum at 
600 MHz. 
Aqueous metabolites were extracted from murine brain with acetone-d6. 'H NMR spectra 
were acquired on a Varian VXR600S NMR spectrometer operating at a spectrometer 
frequency of 599.945 MHz. Metabolites were referenced to the N-acetyl aspartate methyl 
singlet at 2.02 ppm (Fan et al.. 1988). For a full description of the procedure see 
Experimental. 
* denotes 'H resonances used for metabolite quantification. 
c, complex; d, doublet; dd, doublet of doublets; q, quartet; qu, quintet; t, triplet. 
methine proton was assigned as a doublet of doublets at 4.42 ppm, in close 
agreement with the literature value of 4.38 ppm. This signal produced cross-
peaks with the diastereotopic methylene protons at 2.51 and 2.65 ppm in the two-
dimensional COSY 45 spectrum. Again, these values were in close agreement 
with those previously reported (1", 6 = 2.48 ppm; J3', 6 = 2.67 ppm). 
Confirmation of the assignments was given upon inspection of the i-resolved 
spectrum with these signals comprising doublets of doublets with and 3J1 
of 4.4 and 9.0 Hz respectively in addition to a 2  ju.p 
d  of 15.3 Hz. 
Phosphoryicholine (PC) [12]. The methyl proton resonance from 
phosphoryicholine was tentatively assigned at 3.27 ppm in the immediate 
proximity of the glycerophosphorylcholine singlet (6 = 3.28 ppm; Dr. Jimmy Bell, 
personal communication). However the presence of multiple signals over the 
3.24 to 3.31 ppm region made discrete quantification of these resonances 
difficult. 
Total creatine (Cr) [13]. Proton resonances from phosphocreatine and creatine 
were very prominent in the aqueous brain extract. The methyl proton singlet 
from 'total creatine' was assigned at 3.06 ppm and the methylene proton singlet 
at 3.90 ppm. The resonance at 3.90 ppm was used for quantitative purposes; the 
7-methylene protons from GABA being found to contribute to the signal at 3.06 In 
ppm. 
Taurine (Tau) [14]. Two sets of taurine triplets, with equal vicinal coupling 
constants and of similar intensity, were assigned at 3.20 and 3.43 ppm 
corresponding to the H2N-C112- and -CH2-S03H methylene protons respectively. 
Although the two triplet resonances appeared to be well distinguished from other 
metabolites, closer inspection of the two-dimensional COSY 45 and J-resolved 
spectra revealed that both signals were superimposed on top of doublet 
resonances from minor metabolites. These latter signals comprised two sets of 
doublets in the immediate proximity of each other, making their assignment 
difficult. The contribution of the aforementioned minor metabolites to the 
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intensity of the taurine triplets was considered minimal. Consequently, the triplet 
at 3.20 ppm was used for quantitative purposes 
Threonine (Thr) [15]. Threonine resonances were not particularly prominent in 
the acetone-d, 'H NMR spectrum. However, the 7-methyl proton doublet was 
assigned at 1.34 ppm in close agreement with the value previously reported (6 = 
1.32 ppm, Fan et al., 1986). The low concentration of this amino acid in the 
extract did not facilitate the identification or assignment of the a and 0 protons. 
Summary. 
The use of acetone-cl1, for the rapid preparation of aqueous extracts applicable to 
direct 'H NMR spectroscopy analysis merits attention. In its favour, the 
procedure for metabolite extraction is rapid, reproducible and relatively 
inexpensive. The proton spectra thus obtained are comparable in metabolite 
extraction to PCA extract spectra (see 'H NMR spectra in Bell et al., 1991) and 
afford a marked improvement in spectral resolution. The requirement for 
perchlorate neutralization and pH adjustment is not necessary, obviating the 
possibility of metabolite oxidation or hydrolysis. 
A total of 15 prominent metabolites were fully assigned in the proton spectra, of 
which 12 'diagnostic peaks' were chosen for metabolite quantification (Table 3. 
I. I). Although glutamine resonances were obscured by signals from other 
metabolites in the acetone-d6 spectra, removal of the solvent by evaporation and 
subsequent resuspension in 0.65 ml of D20 may allow the visualization of the 
methylene 
3- 
proton signal at 2.06 ppm, thus permitting its quantification. 
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Figure 3. 1. 5a 'H NIMR spectra of acetone-soluble cerebral metabolites in a control mouse at 
360 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. 
- 
Figure 3. I. 5b 1 H NMR spectra of acetone-soluble cerebral metabolites in a scrapie-affected 
mouse at 360 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. With comparison to control (facing page) 
note the reduction in the N-acetyl aspartate methyl singlet at 2.02 ppm. This observation is 
believed to be indicative of the severe neuronal degeneration exhibited in this murine-scrapie 
model. 
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3. 1. 2 Ouantitative Comparison of Metabolites in Control and Scrapie 
Mice. 
Acetone-d6  extracts were prepared from the brains of six clinically-ill ME7-
affected VM mice (360 days p.i) and an equal number of age- and sex-matched 
controls. Proton NMR spectra were acquired at 360.135 MHz as described 
previously (Section 2. 4. 2). Figures 3. 1. 5alb illustrate representative one-
dimensional proton spectra from control and scrapie-affected mice respectively. 
For the purpose of metabolite comparison, diagnostic signals were quantitatively 
referenced to (a) the chemical shift reference compound, 3-trimethylsilyl-2,2',3,3'-
tetradeuteropropionic acid (TSP) and (b) endogenous total creatine. When 
referenced to TSP, metabolites levels showed large differences between scrapie 
and control animals. The majority of these changes reflected the disease-related 
reduction in wet brain weight between scrapie and control tissue. The suitability 
of TSP as an internal reference (although used by Bell et al., 1991) was 
questioned following the finding that the proprionic acid derivative has an affinity 
for protein (Dr. Jimmy Bell, personal communication). The availability of an 
alternative quantitative standard was presented by total creatine. A review of the 
literature would suggest that the concentration of total creatine remains constant 
under a variety of abnormal metabolic conditions (Gadian, 1990) and disease 
states (Gill et at., 1990; Larsson ci at., 199]), including this model of murine-
scrapie (Bell et al., 1991). In conclusion in vitro metabolite levels were 
quantitatively referenced to endogenous creatine and levels compared. The 
results are recorded in Table 3. 1. 2. 
Results. 
A highly significant change was found in the ratio of N-acetyl aspartate/creatine in 
terminally-ill scrapie-affected animals relative to controls (control = 125.6 ± II .8, 
scrapie 96.4 ± 4. 1; P <0.001) in close agreement with the percentage reduction 
reported by Bell and colleagues (199 1) in their independent in vitro MRS studies 
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Metabolite Control Scrapie 
Alanine 14.3 ± 2.2 15.7 ± 3.2 
Asparagine 29.4±4.6 27.4±3.3 
-aminobutyrate 53.3 ± 8.7 50.2 ± 3.4 
Glutamate* 117.6 ± 8.2 103.3 ± 10.9 
Glycine 16.0 ± 2.3 14.9 ± 3.5 
Glycerophosphorylcholine 69.7 ± 4.7 73.4 ± 9.4 
Inosito1* 63.0 ± 4.7 78.7 ± 4.9 
Lactate 236.9 ± 31.0 290.3 ± 6 1. 8 
N-acetyl aspartate* 125.6 ± 11.8 96.4 ± 4.1 
Phosphorylcholine 27.1 ± 4.5 20.7 ± 5.6 
Taurine 122.3 ± 13.0 113.6 ± 6.4 
Table 3. 1. 2 'H NMR spectroscopy analysis of aqueous cerebral metabolites in control and 
scrapie-affected (ME7!VM) mice. 
Aqueous metabolites were extracted from murine brain with acetone-d. A total of six control 
and six scrapie animals were analyzed. 'H NMR spectra were acquired on a BrOker WH-360 
MHz NMR spectrometer operating at a spectrometer frequency of 360.135 MHz. Metabolites 
were referenced to the N-acetyl aspartate methyl singlet at 2.02 ppm. Metabolite values are 
given relative to total creatine concentration as mean ± scm (multiplied by an arbitary factor 
of 150). For a full description of the procedure see Experimental. 
* denotes metabolites which show statistically significant differences between control and 
scrapie groups. 
(acetone-d6 extract = 23% reduction; perchiorate extract = 28% reduction). In 
addition to this, scrapie-affected mice exhibited elevated ratios of inositol/creatine 
(control = 63.0 ± 4.7, scrapie = 78.7 ± 4.9; 25% elevation; P < 0.001) and 
reduced ratios of glutamate/creatine (control = 117.6 ± 8.2, scrapie 103.2 ± 10.9; 
12% reduction; P <0.05). Concentrations of other metabolites relative to total 
creatine remained unchanged. 
The presence of an elevated multicomponent resonance (6 = 1 .5 to 1.8 ppm) was 
not detected in the in vitro 'H NMR spectra of scrapie brain, this latter finding 
providing circumstantial support for the hypothesis that the signal was attributed 
to a change in a non-aqueous metabolite, possibly intracerebral lipid. This line of 
investigation is explored more fully in Section 3. 2. 4. 
Inferences. 
N-Acetyl aspartate. A reduction in the ratio of N-acetyl aspartate to creatine, as 
determined by in vivo 'H NMR spectroscopy, has been recorded in a wide range 
of cerebral disorders including: acquired immune deficiency syndrome (Menon et 
al., 1990a), herpes simplex encephalitis (Menon et at., 1990b), cerebral 
demyelinating disorders (Arnold et al., 1992; Larsson et at., 1991) and the 
transmissible spongiforni encephalopathies; Creutzfeldt-Jacob disease (Bruhn et 
at., 1991) and scrapie (Bell et al., 1991). The function of NAA is presently 
unclear, however it is known to be primarily located in neurons (Birken and 
Oldendorf, 1989; Koller et at., 1984) and thus presents itself as a marker of 
neuronal status within the brain (Small et at., 1990). 
Bruhn et at. (199 1 ) recently applied in vivo 'H MRS to the study of a patient in 
the late clinical stage of CJD. The proton spectra showed significant changes in 
NAA concentrations relative to creatine in both white and grey matter regions 
consistent with and indicative of neuronal loss. Frontal lobe biopsy, performed 
two days after MRS data acquisition, revealed spongiform change with a slight 
loss of neurons and g1iosis. The authors speculated that in vivo MRS could find 
application to the early diagnosis of CJD. This suggestion must be viewed with a 
degree of caution in the light of three major findings: 
The non-specific nature of an NAA reduction may equally be attributed to a 
host of different diseases (of which the examples in the paragraph above are but a 
few), in which neurological damage is a characteristic feature. Magnetic 
resonance imaging (MRI) in addition to MRS has been proposed as a means of 
clarifing early diagnosis by the visualization of brain atrophy, however the 
identification of CJD patients with apparently 'MRI-normal' brains indicates that 
this is not always a valid assumption to make (Bruhn et al., 1991; Uchino et at., 
1991). 
A considerable period of time may elapse between initial infection and signs 
of neurological damage, be they detected by histological techniques or otherwise. 
Our understanding of the limitations of monitoring changes in cerebral NAA 
concentrations for the diagnosis of neurodegeneration come from extensive 
studies in murine-scrapie models in which hi stopatho logical changes are 
consistent and well characterized. Although it is invalid to make the assumption 
that a causal relationship exists between neuronal degeneration and vacuolation 
(Gibson and Liberski. 1987; Scott and Fraser, 1984), it would appear that in the 
ME7/VM murine-scrapie model a good correlation exists between the degree of 
vacuolation and extent of degenerative nerve fibre damage both spatially and 
temporally (Fraser, 1969; Fraser, ci' al., 1995). The total lesion score in this 
model thus gives a relatively accurate prediction of the extent of neuronal loss. 
Bell and colleagues (199 1) investigated metabolic changes in the ME7/VM model 
by in vivo and in vitro proton MRS as described previously. No detectable 
differences were observed in NAA/Cr levels at the two initial time points of study 
(52 days p.i. and 108 days p.i.). In histopathological agreement, vacuolar damage 
(and thus presumably neuronal loss) is not seen before 140 days p.i. (Fraser and 
Dickinson, 1968). However, after 140 days vacuolar damage increases in 
severity and at 192 days p.i. (the third time point in the MRS study) appreciable 
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vacuolation is present in the hypothalamus and septal nuclei of the paraterminal 
body. Interestingly, Bell and colleagues found no significant depression in the 
NAA/Cr ratio at this time. It is possible that such limited, regionally-specific 
changes in NAA levels remain undetected as a result of volume averaging effects 
(van der Knaap et al., 1992). This emphasizes an important point, that for those 
contemplating early TSE diagnosis on the basis of neuronal damage, the volume 
and locality of spectral analysis are very important factors. Consideration of this 
matter highlights an additional problem as sporadic (and for that flatter 
iatrogenic) cases of CJD do not display the well defined neuropathological 
profiles of experimental murine-scrapie models with the same degree of 
consistency. 
It was only in the late clinical stage of the disease (346 days p.i.), when mice 
showed signs of ataxia and other locomotory deficits, that significant changes in 
cerebral NAA concentrations were observed. Clearly the application of this 
technique to the early diagnosis of scrapie on the basis of changes in NAA is thus 
untenable. The point at which the NAA reduction became a significant feature of 
diseased animals was not precisely determined, as studies on mice between 192 
and 325 days p.i. were not performed. 
(iii) Some mouse models of scrapie display histopathological features in which 
severe spongiform damage occurs in the absence of appreciable neuronal 
destruction (Scott and Fraser, 1984). Clearly, should some populations of human 
CJD brains display similar characteristics, the diagnosis of spongiform damage 
based upon the in viva MRS detection of NAA abnormalities would not be 
possible. 
Inositol. In addition to the NAA abnormality, Bruhn and colleagues found white 
matter regions of the CJD brain to exhibit elevated levels of inositol, notably in 
the parietal cortex. Although our studies of cerebral metabolites did not offer the 
same degree of spatial precision as those of the aforementioned authors, we too 
are able to report a highly significant elevation in levels of inositol in scrapie- 
affected mouse brain at the clinical stage of the disease. A similar finding was not 
observed by Bell and colleagues (199 1) although it is worth noting that with their 
in viva MRS experimental acquisition parameters optimized for NAA 
measurement, changes in inositol signals may have been overlooked. The 
significance of the inositol elevation is presently unclear. Whether other murine-
scrapie models exhibit a similar abnormality is not known, nor is the specificity of 
this change to the TSE disease class. However the similarity between the in vivo 
CJD and in vitro scrapie studies highlights the potential for further development 
in this area. 
Glutamate. Glutamate is widely and fairly uniformly distributed throughout the 
central nervous system where it has important excitatory effects on specific cell 
populations. The modest although significant reduction in glutamate 
concentrations may reflect a more dramatic change in localized regions of 
scrapie-affected brains. In view of the important neurotransmitter effect of 
glutamate, a reduction in its intracerebral concentration may have a marked effect 
on neuronal excitability. Although the following inferences are not deduced from 
the NMR results, it is interesting to speculate on the role of glutamate in relation 
to cation-gated channels and scrapie pathogenesis. 
Glutamate has its excitatory effect via three major subtypes of receptor (NMDA, 
AMPA and kainate) where ligand interaction causes opening of cation selective 
channels and a rapid depolarization response (Watkins and Evans, 1981). 
NMDA receptors differ from those opened by AMPA and kainate in that they 
have a larger conductance and higher permeability to calcium ions relative to 
other cations. It is these and other special pharmacological propel-ties which 
make the NMDA-channel of particular importance in long-term potentiation and 
excitotoxicity, two features which have particular relevance to the spongiform 
encephal opathies. 
Long-term potentiation describes a long lasting enhancement of synaptic 
transmission which follows a short burst of presynaptic stimulation (Anwyl, 1989; 
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Collingridge and Bliss, 1987). It has received most extensive study in the 
hippocampus where its function is believed to be of importance in learning and 
memory. In this regard it is of significance to note that the ME7/VM model 
exhibits complete destruction of the pyramidal layer of hippocampal neurons 
(Scott and Fraser, 1984). Whether NMDA-receptor specific neuronal 
populations are particularly vulnerable to TSE aetiological agents is unknown, 
however such a finding would explain the high incidence of amnesia-like 
symptoms associated with CJD, the human form of the disease (Brown, 1988). 
The relationship between selective cell death and vacuolar change may be 
explained by another property of NMDA receptors - that of excitotoxicity. 
Recent experimental evidence strongly indicates that glutamate and related EAAs 
are neurotoxic, even in low concentrations (Choi, 1988). It is now known that 
these cytotoxic actions are mediated through NMDA receptors, for they are 
blocked by NMDA antagonists such as ketarnine and phencyclidine (Rang and 
Dale, 1991), and that calcium entry is a necessary step (Olney, 1990). The 
similarity between the cytotoxic effect - endoneuronal oederna followed by global 
loss of axons (Hugen el at., 1987), is remarkably similar to vacuolar damage seen 
in the TSEs. 
Within the last couple of years it has become clear that the neuronal cell surface 
sialoglycoprotein ppC  may have functional relevance to the retention of memory 
(Biieler et al., 1992), to cation channel responsiveness to endogenous ligands 
(Kristensson et al., 1993) and to the generation of a cytotoxic effect in response 
to challenge with the neurotoxic PrP fragment, PrPl06-126 (Brown et al., 1994; 
Forloni et al., 1993). In view of these findings and the prior discussion, the 
question must ultimately be asked - does PrPc  have a modulatory effect on cation 
channels and in particular the NMDA receptor? 
Firstly, the speculative finding that PrP°'° mice have "superior spatial memory" 
(BUeler et at., 1992) may indicate that in the absence of PrPc,  hippocampal 
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neurons have long term potentials of greater duration. Does the normal cellular 
protein therefore 'dampen-down' glutamate-induced excitations? 
Secondly, scrapie infection has been shown to cause dysfunction of both 
intracellular calcium release and calcium channel opening, albeit in neuroblastoma 
cell lines and in response to the application of bradykinin (Kristensson et al., 
1993). It is noted that neither of the cell cultures in question (mouse 
neuroblastorna N2A and hamster brain HaB cells) exhibited voltage-dependent or 
glutamate-responsive calcium channels, and thus represented cell populations in 
which glutamate receptors were not expressed. Interestingly, scrapie infection 
conferred the aforesaid cell lines unresponsive to bradykinin application thus 
preventing an elevation in intracellular calcium concentration. It matters little 
that the response exhibited by the bradykinin receptor was opposite to the 
excitotoxic effect expected of the NMDA receptor; the significant finding of the 
study being that scrapie infection has a marked effect on receptor-mediated cation 
channel permeability. If scrapie status reduces bradykinin-receptor 
responsiveness in these cultured cell lines what is to say that it cannot have the 
opposite effect on the NMDA-receptor by increasing its responsiveness to 
glutamate; or for that matter on a whole host of other neurotransmitter receptors 
in as yet undiscovered ways? 
Thirdly, the presence of PrP' appears to be a necessary prerequisite for the 
neurotoxic effects of PrP106-126 on a specific population of cortical cells in 
vitro, whilst having growth factor-like properties on cells which lack PrP (Brown 
et al., 1994). How might these paradoxical differences be explained? This 21 
amino acid peptide shares some common features with PrP in that it undergoes 
in vitro polymerization into fibrils, is protease resistant and forms a 13-sheet 
structure (Selvaggini et al., 1993). In view that scrapie infection can modify 
cation channel function (as discussed above), is it not possible that the effects 
displayed by PrP 106-126 are the result of it interacting with PrP' to alter ion flux 
in neuronal cell populations with different cation channel repertoires? It is known 
63 
that PrP possesses qualities which stimulate the growth of astrocytes 
(DeArmond et at., 1 992) and that reactive astrocytic gliosis is often a prominent 
feature in the disease (Dormont et at. 198 1; Mackenzie, 1983). Thus on the one 
hand 'neurotoxic' PrP may stimulate calcium channels which influence mitotic 
activity in cell types such as glia, and on the other hand cause dysfunction of 
calcium channels in neurons leading to their subsequent degeneration. It is not 
unreasonable to assume that differences in PrP alleles (and hence PrP tertiary 
structure) as well as scrapie strain variants may modify the effect that PrP has on 
these ion channels, thus partly explaining the wide range of histopathological 
features seen in different strains of mice infected with different scrapie isolates 
(Bruce et at., 1991; Fraser and Dickinson, 1968; Kim etal., 1990a; Kim et at., 
1990b). 
Summary. 
The analysis of aqueous metabolites by in vitro 'H magnetic resonance 
spectroscopy identified abnormalities in cerebral concentrations of N-acetyl 
aspartate, inositol and glutamate in ME7-affected VM mice at the late clinical 
stage of the disease. The reduction in levels of N-acetyl asparate are believed to 
be indicative of neuronal damage (Small et al., 1990), a feature consistent with 
this murine-scrapie model (Fraser, 1969). Similarly, reduced levels of glutamate 
may reflect degenerative changes in regions of the brain in which the acidic amino 
acid has an important function, for example the hippocampus (Scott and Fraser, 
1984). The significance of the inositol elevation is presently unclear, although the 
observation of a similar abnormality in parietal white matter regions of a CJD 
patient by in viva 'H MRS (Bruhn et at., 1991) strongly merits further 
investigation. 
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3. 2 Nuclear Magnetic Resonance Studies of Cerebral Linids. 
Post mortem histopathological examination of brain tissue is currently the only 
definitive means of identifying individuals previously affected with a transmissible 
spongiform encephalopathy (Kimberlin, 1991; Wells et al., 1992). The inability 
to accurately diagnose TSE status ante mortem, and more importantly 
preclinically, is a serious impediment to the provision of proper patient/family 
counseling and care, and in the future should treatment become available, to the 
alleviation of neurological damage and suffering. The observation of a metabolic 
disturbance in the brains of scrapie-affected mice by in vivo magnetic resonance 
spectroscopy therefore created a great deal of interest, especially in the light that 
this abnormality was detected before appreciable PrP deposition and 
neurological damage (Bell et al., 1991). Although the component responsible 
was not characterized, it was speculated that its broad proton resonance (6 = 1 .5 
to 1.8 ppm) was attributed to 'mobile lipid'. The objective of the analysis 
described herein was therefore to confirm the specificity of the 'multicomponent 
resonance' to scrapie-affected mice and provide its identification. 
Recent studies of cerebral lipids by in vitro proton NMR spectroscopy have 
received relatively thorough investigation (Choi et al., 1993; Gunstone, 1992). 
This information, in addition to our own NMR experiments, allowed the complete 
assignment of proton resonances in neutral and acidic lipid fractions. Having thus 
assigned the proton spectra, diagnostic resonances were identified for prominent 
lipid species and a comparison was made of scrapie and control cerebral lipid 
extracts. 
The information provided by the assignment of proton resonances was directly 
applied to the assignment of 13C lipid resonances in a cerebral extract following 
comparison with a '3C-'H two-dimensional shift correlated spectra. The 
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Figure 3. 2. 1a Chemical structures of cerebral lipids. 
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Eigure 3. 2. 2 'H NIMR spectrum of neutral cerebral lipids at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
3. 2. 1 Assignment of 'H NMR Spectra. 
The assignment of lipid resonances and improvement in spectral resolution was 
assisted by the prior fractionation of the crude lipid extract into neutral and acidic 
lipid species by column chromatography over DEAE Sephadex A-25. The 
components present in these fractions were putatively identified by high 
performance thin layer chromatography, allowing the assignment of proton 
resonances with reference to lipid structure, literature values (Choi et al., 1993; 
Gunstone, 1992) and a variety of NMR experiments (described below). 
Structures and nomenclature for the cerebral lipids are illustrated in Figure 3. 2. 1 
and relate to the assignment of resonances in the three following sections. 
Neutral Lipids. 
Six prominent components were identified in the neutral lipid fraction by high 
performance thin layer chromatography. These were cholesterol, galacto-
cerebrosides I and II, ethanolamine phospholipids, choline phospholipids and 
sphingomyelin. Upon concentration of the fraction, a number of less abundant 
lipids were detected, these being cholesteryl esters, triglycerides and diglycerides. 
Whilst the former components were present in concentrations sufficiently high 
enough to allow spectral detection, the latter were not. The following discussion 
therefore relates to the assignment of the prominent lipid components. 
Cholesterol 1161. 
Cholesterol is the most abundant lipid in the neutral lipid fraction, giving rise to 
high intensity proton and carbon resonances in the NMR spectra of cerebral 
lipids. With reference to literature values for ' 3C resonances and a '3C DEPT 
spectrum of the crude lipid extract (Figure 3. 2. 12), 24 out of 27 of the 
cholesterol carbon signals were positively assigned. Proton resonances were 
subsequently assigned with reference to the HMQC spectrum (Figure 3. 2. 13). 





Figure 3. 2. 3 Two-dimensional J-rcsolved spectrum of cerebral lipids at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
the proton spectrum. This Cl 8 methyl proton singlet was well distinguished from 
other resonances in the proton spectrum (Figure 3. 2. 2) and was subsequently 
used for diagnostic purposes. The C19 methyl proton singlet was assigned in a 
similar manner at a chemical shift of 0.97 ppm. The C2 I, C26 and C27 methyl 
protons are each coupled to one proton and thus give rise to doublet resonances. 
Signals for the C26 and C27 protons were seen to overlap at 0.82 ppm, both 
possessing identical 3J coupling constants of 6.8 Hz (Figure 3. 2. 3). These 
resonances were not well distinguished, occurring at a similar chemical shift to 
wi-methyl proton resonances from terminally saturated fatty acids. The C21 
methyl doublet was observed at 0.88 ppm with an identical coupling constant to 
the C26 and C27 methyl proton resonances. 
The majority of cholesterol signals occur over the 1.0 to 2.2 ppm range, often 
overlapping with other lipid resonances and thus making them inappropriate for 
diagnostic or quantitative purposes. In contrast, the cholesterol C3 proton 
adjacent to the hydroxy group was observed as a complex signal at 3.41 ppm. 
The olefinic C6 proton also resonates at an appreciably different chemical shift, 
but was not distinguishable in the one-dimensional spectrum due to overlapping 
resonances from other compounds, however its existence was detected in the .1-
resolved spectrum at 5.29 ppm. Confirmation of this assignment was given by 
the HMQC spectrum which showed a carbon-proton cross-peak at [121 .99, 5.29] 
PPM. 
Galactocerebrosides 117a, 17b1. 
The complex structure of the galactocerebrosides (hereafter referred to as 
cerebroside) necessitated assignment of the spectra of authentic standards prior to 
their assignment in the cerebral lipid extract. Cerebroside I differs from its 
cerebroside II counterpart in possessing an a-hydroxy fatty acid. Examination of 
the two-dimensional COSY 45 spectrum of cerebroside I revealed a cross-peak 
between the a- (or C2 methine proton) and C3 methylene protons in the fatty 




















5.5 5.0 4.5 4.0 3.5 3.0 
F2 (ppm) 
Figure 3. 2. 4 Hornonuclear shift-correlated spectrum (COSY 45) of cerebral lipids at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
signal at 3.95 ppm and the methylene protons at 1.49 and 1.70 ppm. The C3 
protons couple into the methylene envelope at 1.22 ppm. In contrast, cerebroside 
II does not possess an a-hydroxy fatty acid and does not exhibit a cross-peak in 
the same position (Figure 3. 2. 10). In this case the coupling of the C2 methylene 
protons to the C3 methylene protons produces a cross-peak at [2. 12, 1.55] ppm. 
Neither of these signals were suitable for diagnostic purposes as they occurred at 
similar chemical shifts to C3 and C2 methylene proton resonances in other fatty 
acids. 
Olefinic proton resonances in the sphingosine (cerarnide) moiety occurred at 5.40 
and 5.65 ppm (Figure 3. 2. 5). The 5.40 ppm signal was seen as a doublet of 
doublets with a 3J/)1 of 7.5 Hz and a 3Jb U of 15.7 Hz and was assigned as CER a. 
The complex resonance at 5.65 ppm was consequently assigned as CER b. 
Additional support for these assignments was given by the two dimensional 
COSY 45 spectrum in which it was seen that the CER b resonance coupled to a 
signal at 1.97 ppm which was in turn coupled to an unresolved signal in the 
methylene envelope region at 1.30 ppm (Figure 3. 2. 8). It follows that the 
resonances at 1.97 and 1.30 ppm corresponded to methylene groups Cr and Cy 
respectively (Figure 3. 2. 5). These assignments were identical for both 
cerebrosides. 
The COSY 45 spectrum of both cerebrosides also showed coupling between CER 
a and a proton resonance at 4.05 ppm (Figure 3. 2. 8). This signal was assigned 
as CER 1. Examination of the COSY 45 spectrum showed this proton to be 
coupled to a resonance at 3.95 ppm, which was assigned as CER 2. The one 
dimensional spectra of cerebrosides I and II showed marked differences over the 
3.5 to 4.2 ppm range (Figures 3. 2. 6). In addition to cerebroside I possessing a 
C2 proton resonance from the a-hydroxy fatty acid at 3.95 ppm, doublets of 
doublets were observed at 3.69 ppm and 4.03 ppm which were not present in the 




Figure 3. 2. 5 'H NMR spectrum of a mixture of authentic galactocerebros ides (cerebrosides I 
and II) at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 13 ppm. 
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Figure 3. 2. 6 H NMR spectrum of authentic galactocerebroside I (top figure) and galacto-
cerebroside II (bottom figure) at 360 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
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Figure 3. 2. 7 Two-dimensional i-resolved spectrum of a mixture of authentic galacto-
cerebrosides (cerebrosides I and II) at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
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Figure 3. 2. 8 Homonuclear shift-correlated spectrum (COSY 45) of a mixture of authentic 
galactocerebrosides (cerebrosides I and II) at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3,3 ppm. 
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jg!re 3. 2. 9 Homonuclear shift-correlated spectrum (COSY 45) of galactocerebroside I at 600 
MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
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Figure 3. 2. 10 Homonuclear shift-correlated spectrum (COSY 45) of galactocerebroside II at 
600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
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Similarly, two signals at 3.54 and 4.14 ppm were observed in the proton spectrum 
of cerebroside II which were not present in the spectrum of cerebroside I. These 
two sets of resonances were found to couple to each other and to the CER 2 
methine proton at 3.95 ppm, which in turn coupled to the CER I proton at 4.05 
ppm and were consequently assigned to CER 3 diastereotopic methylene protons. 
In cerebroside I, with CER 3 protons resonating at 3.69 (CER 3U)  and 4.03 ppm 
(CER 3(1),  the coupling constants of the former signal were not clearly identified 
as they occurred at a similar chemical shift to the galactose GAC 6' resonance. 
The other signal at 4.03 ppm was seen to exhibit a 3J2,3(1  of 4.5 Hz in addition to a 
2j3u3d of 10,4 Hz (Figure 3. 2. 7). Similar analysis was performed on the CER 3 
proton resonances in the cerebroside H spectrum. Both of these signals gave rise 
to doublets of doublets and were clearly seen in the i-resolved spectrum. The 
signal at 3.54 ppm exhibited a 3 j2 
 
.3d of 3.3 Hz in addition to 2J3
(1 of 10.4 Hz, and 
the signal at 4.14 ppm showed a 3j2 .3U of 4.6 Hz and identical 2j1u3d  of 10.4 Hz. 
Proton NMR spectroscopy studies of rat cerebral lipids by Choi et at. (1993), 
reported the assignment of CER 3 methylene proton resonances at 3.7 and 4.1 
ppm. We believe these to correspond to a cerebroside I CER 3'  methylene 
proton [3.69 ppm] and a cerebroside II CER 3L  methylene proton [4.14 ppm] in 
our proton spectra. 
Both cerebrosides possess a galactose moiety, the GAC 1 position of which is 
covalently linked to the CER 3 position by an ether group. The Cl position 
proton of galactose (GAC 1) is coupled to a single proton at GAC 2 and thus 
produces a characteristic doublet which was observed at 4.18 ppm (Figure 3. 2. 
5). The remaining galactose proton resonances were assigned following 
examination of the two dimensional COSY 45 and f-resolved spectra. GAC 1 
couples to GAC 2 with a 3Ji,2 of 7.8 Hz. It would appear that GAC 2, GAC 3 
and GAC 5 all contribute to the multitude of signals in the 3.44 to 3.55 ppm 
region, however examination of the f-resolved spectrum showed that GAC 2 
resonates at 3.50 ppm and is coupled to GAC 3 with a 3J2. 3 of 10 Hz in addition 
to a 3J 1 . 2 of 7.8 Hz. It was predicted that the resonance arising from coupling 
73 
between GAC 3 and GAC 2/GAC 4 would be a doublet of doublets with a .J23 of 
10 Hz and a 3J 4 between 3 and 4 Hz. Such a resonance was observed at 3.44 
ppm with 3J3,4 of 3.6 Hz, allowing the assignment of GAC 4 at 3.83 ppm. The 
GAC 5 proton couples to two GAC 6 protons in addition to a GAC 4 proton. 
Understandably this gives rise to a complex signal which was observed at 3.48 
ppm. Coupling between GAC 5 and GAC 6°/GAC 6' is illustrated in the COSY 
45 spectrum of galactocerebroside II (Figure 3. 2. 10). This shows cross-peaks 
between GAC 5 and resonances at 3.70, 3.78 and 3.83 ppm, with the latter 
resonance previously assigned to GAC 4. It is noted that vicinal coupling 
between two protons with a torsion angle of 60° gives rise to a coupling constant 
in the region of 2 to 5 Hz, conversely vicinal coupling with a torsion angle of 
180°, 9 to 12 Hz (Abraham et al., 1988). Although the torsion angles and 3J 
coupling constant vary, protons at theoretical values of 60° and 180' were 
designated H1 and H respectively. The resonances at 3.78 and 3.70 ppm showed 
identical 2J of 11.8 T-Iz in addition to 3J of 7 Hz and 5,3 Hz. These were 
consequently assigned to the GAC 6u and GAC 6"  protons respectively. 
Inspection of the one dimensional proton NMR spectrum showed GAC 6° to be 
the only resonance suitable for diagnostic and quantitative purposes, with other 
galactose signals overlapping with resonances from unrelated compounds. 
Ethanolamine phospholipids [181. 
Proton chemical shifts have previously been published for phosphatidyl 
ethanolamine in deuterated methanol by Birdsall et al. (1972). A complex 
resonance was observed at 3.06 ppm in the one-dimensional proton spectrum at a 
similar chemical shift to the literature value for the ethanolamine head group C2 
methylene protons. This signal produced a cross-peak in the HMQC spectrum 
with a carbon resonance at 41.280 ppm (Figure 3. 2. 13) which was shown to 
arise from a CH, group in the '3C DEPT spectrum (Figure 3. 2. 14). The broad 
nature of the proton resonance is believed to be attributed to the presence of a 
mixture of ethanolamine components, principally phosphatidyl ethanolamine and 
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phosphatidal ethanolarnine (plasmalogen). In support of this, two marginally 
overlapping components were identified in the f-resolved spectrum at 3,09 ppm 
with similar coupling constants (Figure 3. 2. 3). The Cl head group methylene 
protons were subsequently identified in the COSY 45 spectrum from the cross-
peak at [3.09, 12] ppm (Figure 3. 2. 4). 
Values have also been reported for the glycerol part of the phospholipid (Birdsall 
et al., 1972). The methine protons at the glycerol C2 position produce a complex 
multiplet of triplets upon coupling to the methylene protons at positions I and 3 
of the glycerol backbone. A signal for both of these was seen at 5.27 ppm in 
close agreement with the literature value of 5.20 ppm. Examination of the two-
dimensional COSY 45 spectrum showed cross-peaks between this glycerol C2 
position proton and three other resonances at 3.95, 4.12 and 4.37 ppm (Figure 3. 
2. 4). The magnetically equivalent methylene protons at the glycerol C3 position 
produce a doublet when coupled to the glycerol C2 proton and upon examination 
of the f-resolved spectrum these were assigned at a chemical shift of 3.95 ppm. 
Glycerol Cl methylene protons on the other hand are diastereotopic, with 2J 
coupling in addition to 3f coupling with the glycerol C2 methine proton. The 
signal at 4.12 ppm was seen to arise from coupling between the glycerol Clu 
proton and the glycerol C2 proton, with 3J coupling of 9 Hz and 2J coupling of 
12 Hz. Conversely, the signal at 4.37 ppm was assigned to the glycerol CId 
proton coupled to the glycerol C2 proton with a 3J coupling of 3.2 Hz in addition 
to a 2f coupling of 12 Hz. A description of the 'u' and 'd' nomenclature and their 
relation to torsion angles has been given previously. 
Choline phospholipids [19, 201. 
Cerebral tissue normally contains three abundant choline phospholipids, i.e. 
phosphatidyl choline, phosphatidal choline (plasmalogen) and sphingomyelin. 
Methylene protons in the Cl and C2 positions of the choline head group were 
assigned at 4.20 and 3.56 ppm respectively in a similar manner to those of the 
ethanolamine phospholipids using a combination of literature values and the 
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COSY 45 spectrum. In addition to the Cl and C2 methylene protons, resonances 
from terminal -N(CH3)3 methyl protons were assigned at 3.17 and 3.18 ppm for 
sphingomyelin and phosphatidal/phosphatidyl choline respectively (Figure 3. 2. 
2). These values are in close agreement with those previously reported by Choi 
et al. (1993). Glycerol backbone protons from phosphatidyl choline produced 
similar resonances to those of phosphatidyl ethanolamine and were assigned in an 
identical manner. 
Plasmalogens (ether phospholipids) [211. 
Plasmalogens are phospholipids containing an a, P unsaturated ether at the 
glycerol Cl position. Both phosphatidyl ethanolarnine and phosphatidyl choline 
have their respective plasmalogens. The presence of an ether group alters the 
chemical environment of the glycerol backbone methylene protons resulting in a 
change in chemical shift values. This change is experienced least by the glycerol 
C3 methylene protons due to their greater distance from the ether group. These 
proton resonances were tentatively assigned at 3.95 ppm overlapping the 
corresponding diacyl glycerol phospholipid C3 resonances (Figure 3. 2. 2). The 
glycerol C2 methine proton (PLA 2) was assigned from the two-dimensional 
COSY 45 spectrum on the basis of a cross-peak between the glycerol C3 
methylene protons at 3.95 ppm and a proton resonance at 5.12. The CH group 
nature of this latter resonance was confirmed following inspection of the HMQC 
and '3C DEPT spectra (Figures 3. 2. 13 and 3. 2. 14 respectively). The COSY 45 
spectrum revealed two additional couplings between the glycerol C2 position and 
protons with chemical shifts at 3.84 and 3.89 ppm. The f-resolved spectrum 
showed these resonances to be doublets of doublets with coupling constants very 
similar to those of the corresponding diacyl glycerol phospholipid Cl" and CId 
protons. These were consequently assigned at chemical shifts of 3.84 and 3.89 
ppm respectively. In addition to the glycerol backbone proton resonances, 
olefinic protons from the ether linkage gave distinct, well resolved signals. The 





Figure 3. 2. Ii H NMR spectrum of acidic cerebral lipids at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. 
The vicinal coupling constant of 6.2 Hz confirmed the cis confirmation of the , 
13  olefinic protons (Figure 3. 2. 3). PLA 13  was assigned from the [PLA , PLA 
13] cross-peak at [5.85, 4311 ppm in the COSY 45 spectrum. 
Acidic Lipids. 
High performance thin layer chromatography analysis of the acidic fraction 
revealed the presence of four lipid constituents: cardiolipin, 3'-sulphate-
galactocerebrosides (sulfatides I and II), serine phospholipids and inositol 
phospholipids. 'H NMR spectroscopy analysis demonstrated that the 
fractionation process was successful with the absence of cholesterol, 
ethanolamine phospholipid and choline phospholipid diagnostic resonances at 
0.64, 3.05 and 3.56 ppm respectively. 
Sulfatides. 
Resonances from the cerarnide moiety of 3-sulphate-galactocerebrosides were 
detected at 5.40 and 5.65 ppm corresponding to the CER a and CER b olefinic 
protons, of which the latter was used for diagnostic purposes (Figure 3. 2. 11). 
Resonances from the galactose ring were not easily distinguished in the proton 
spectra due to a combination of low sulfatide concentration and spectral overlap 
with resonances from acidic phospholipids. 
Phosphatidvi serine and phosphatidyl inositol 122, 231. 
The glycerol C2 methine proton resonance from phosphatidyl serine and 
phosphatidyl inositol were observed as a broad peak at 5.18 ppm, and at a similar 
chemical shift to the glycerol C2 methine proton of phosphatidyl ethanolamine 
and phosphatidyl choline in the neutral lipid fraction. The absence of PLA a and 
PLA 2 methine proton resonances at 5.87 and 5.12 ppm respectively argued 
against the presence of acidic plasmalogens in this fraction (Figure 3. 2. 11). A 
combination of low abundance and high degree of spectral overlap with 3'- 
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sulphate-galactocerebroside signals made phosphatidyl serine and phosphatidyl 
inositol difficult to differentiate and quantify in the proton spectra. The 
application of 31P NMR spectroscopy to the quantification of phospholipids is 
discussed in Section 3. 2. 3. 
Fatty acid structures [241. 
Comparison of neutral and acidic lipid proton spectra over the 0.6 to 2.4 ppm 
chemical shift region allowed the putative identification of fatty acid resonances. 
The assignments were performed on the proton NMR spectrum of the acidic lipid 
fraction in which diagnostic fatty acyl resonances were more distingishab]e as a 
result of the absence of cholesterol signals. Terminal or col -methyl protons were 
assigned as triplet resonances at 0.82 and 0.93 ppm. The former signal arises 
from terminally saturated fatty acids, i.e. totally saturated or n-9 or n-6 family 
whereas the presence of an unsaturated bond in the close proximity of the col-
methyl group, as observed in n-3 fatty acids, causes a change in the chemical shift 
of the wi-methyl protons to 0.93 ppm. These assignments were in close 
agreement with those of Gunstone in which studies of various fatty acid methyl 
esters are described (Gunstone, 1992). The ratio of these two signals (both of 
which are distinguishable in the neutral and acidic spectra), gives a measure of the 
relative proportions of terminally saturated to n-3 fatty acids in the lipid extract. 
w2-methylene proton resonances were assigned from the COSY 45 at 1.22 
(terminally saturated) and 2.03 ppm (n-3) (Figure 3. 2. 4). The signal at 1.22 
ppm was indistinguishable from the broad multicomponent resonance which 
comprised the 'methylene envelope'. In contrast, w2-methylene protons in n-3 
fatty acids were seen at 2.03 ppm, producing a cross-peak with olefinic protons at 
5.35 ppm in the two-dimensional COSY 45 spectrum. 
Choi and colleagues assigned diagnostic resonances for arachidonic (C204) and 
docosahexaenoic (C22:6) acids in the proton NMR spectra of rat cerebral lipid 
extracts (Choi et al., 1993). We determined to assess whether these 
polyunsaturated lipid species could be identified in the proton spectra of our 
murine lipid extract. Olefinic proton resonances were observed as a broad 
multicomponent signal in the one dimensional proton spectrum at 5.35 ppm. 
These triplets with \'icinal coupling constants of 3.2 Hz, as seen in the J-resolved 
spectrum, were consistent with cis fatty acids (Figure 3. 2. 3). The same signal 
produced cross-peaks with resonances at 2.78, 2.35, 2.12, 2.03 and 1.97 ppm in 
the two-dimensional COSY 45 spectrum. Taking each of these in turn: 
The signal at 2.78 ppm coupled only to olefinic protons and was therefore 
deduced to arise from a methylene group between two vicinyl groups. 
Analysis of fatty acid species present in cholesteryl esters from a murine 
cerebral source by chemical ionization mass spectrometry (CI-MS), revealed 
arachidonic and docosaehexaenoic acids as the only polyunsaturated fatty 
acids present (Section 3. 3. 1), with linoleic acid (C18:2) also in appreciable 
quantities. We therefore concluded that the broad resonance at 2.78 ppm 
was attributable to [-CH=CH-CI-12-CH=cH-] structures in these three fatty acids. 
The signal at 2.35 ppm has been implicated to be diagnostic for C3 
methylene protons in docosahexaenoic acid (Choi et at., 1993). This 
resonance was seen to couple to a component in a broad resonance at 2.27 
ppm in the lipid extract COSY 45 spectrum (Figure 3. 2. 4), which had been 
previously assigned to C2 methylene protons. Thus, coupling between the 
resonances at 5.35, 2.35 and 2.27 ppm allowed the elucidation of the 
structure [-CH=CH-CH,-CH,-000] which is consistent with that of 
docosahexaenoic acid. Although another candidate for this combination of 
resonances does exist, that being docosapentaenoic acid (C22 ), a molecular 
ion for this fatty acid was not seen in the Cl-MS spectra (Section 3. 3. 1). In 
conclusion the signal at 2.35 ppm was believed diagnostic for the presence of 
docosahexaenoic acid in this murine lipid extract. 
The signal at 2.12 ppm produced a cross-peak with a proton resonance at 
1 .65 ppm in the two dimensional COSY 45 spectrum, which in turn coupled 
to a signal at 2.27 ppm (previously assigned to C2 methylene protons). The 
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Metabolite Assignment Chemical 
shift _/ppm  
Multiplicity Functional group 
Neutral lipids  
Cholesterol C18 0.64* s CH3 
C26/27 0.82 d CH3 
C21 0.88 d CH 
C19 0.97 s CH3 
Cl4/17 1.0-1.5 c CH 
C24 1.0-1.15 c CH, 
C8 1.4-1.5 c CH 
Cli 1.4-1.5 c CH, 
Cl 1.8 c Cl-I2 
C7/16 1.9 c Cl-i2 
C4 2.2 c CH-) 
Ga factocerebros ides CERa 5.40 dd -CH2-CH=CH- 
CERb 5.65* c -CH,-CH=CH- 
Cx 1.97 c -CH-,-CH= 
Cv 1.30 c -CH 
CERI 4.05 c -CHOH- 
CER2 3.95 c -CHNHCH2- 
GACI 4.18 d -CHOH- 
GAC2 3.50 dd -CHOH- 
GAC3 3.44 dd -CHOH 
GAC4 3.83 dd -CHOH- 
GAC5 3.48 c -CHOH- 
GAC6" 3.78 dd -CHt OH 
GAC6 3.70 dd -CH'OH 
Cerebroside I C2 3.95 dd -CFIOH- 
C3' 1.49 c -CHOH-CH°- 
________________ 
C3' 1.70 c -CHOH-CH'- 
C4 1.22 c -CH,-C112- 
________________ 
CER3d 3.69 dd -CHNHCH'- 
______________ 
CER3LI 4.03 dd CHNHCHu 
_________________ 
Table 3. 2. 1 Assignment of 'H NMR resonances in cerebral lipid extracts at 600 MHz 
Cerebral lipids were extracted from control murine tissue with chloroform/methanol (2:1. 
v/v). The crude lipid extract was fractionated into neutral and acidic lipid species over DEAE 
Sephadex-A25. 'H NMR spectra were acquired on a Varian VXR600S NMR spectrometer 
operating at a spectrometer frequency of 599.945 MHz. For a lull description of the 
procedure see Experimental. Chemical structures are illustrated in Figure 3. 2. I. 
* denotes 'H resonances used for metabolite quantification. 
c, complex; d, doublet; dd, doublet of doublets; q, quartet; qu, quintet; t, triplet. 
combination of these resonances allowed the structure [-CH=CH-CH-CHI-CH2-
000] to be elucidated. This structure is consistent with the carboxyl 
terminus of arachidonic acid and eicosapentaenoic acid (C20. 5), however as a 
molecular ion for the latter was not present in the Cl-MS spectra (Section 3. 
3. 1) the proton resonances were assigned to structures in arachidonic acid. 
Of these, the signal with a chemical shift of 1.65 ppm was clearly seen in 
both the neutral and acidic spectra and was used for diagnostic purposes. It 
is clear therefore, that should the determination be so required, the intensities 
of the signals at 1.65 and 2.35 ppm would give a measure of the relative 
proportions of arachidonic and docosahexaenoic acids respectively. 
The resonance at 2.03 ppm has previously been assigned to o)2-methylene 
protons next to an unsaturated group in n-3 fatty acids [-CH=CH-CH2-CH3], of 
which docosahexaenoic acid is the primary component in this cerebral lipid 
extract. 
The large signal at 1.97 ppm was seen to couple to methylene envelope 
protons in addition to olefinic protons (Figure 3. 2. 4). This was therefore 
assigned to methylene protons between a vinyl group and the methylene 
envelope Ii-(CH,),,-CH,-CH=CH-CH,-CH=CH-CH2-(CH2)rl. 
And finally, C3 methylene protons in terminally saturated fatty acids were 
assigned at 1.55 ppm from the cross-peaks with C2 and C4 methylene envelope 
protons at 2.27 and 1.22 ppm respectively in the two-dimensional COSY 45 
spectrum. 
To summarize the above analysis, diagnostic resonances from the component 
fatty acids are as follows: 
6 = 0.82 ppm, wl -methyl protons from terminally saturated fatty acids; 
6 = 0.93 ppm, wl -methyl protons from n-3 fatty acids; 
8 = 1.65 ppm, C3-methylene protons in arachidonic acid (C20:4); 
all 
Metabolite Assignment Chemical 
shift _/ppm  
Multiplicity Functional group 
Neutral lipids  
Cerebrosidell C2 2.12 t -CH,-CH,- 
C3 1.55 c -CH2-C112- 
CER3d 3.54 dd CHNHCHd 
CER3U 4.14 dd CHM1CHu 
Ethanolamine PL. Cl 3.98 c -CH2CH.,NI-I1 
C2 3,06* c -CH2CH2NH7 
SilL 4.12 dd CHLbOCO 
Snl' 4.37 dd CHUiOCO 
Sn2 5.27 c -CHOR- 
_____________________ 
Sn3 3.95 d -CH,0P03- 
Choline PL. Cl 4.20 C -CH7CH,N- 
____________________ 
C2 3.56 c -CH2CH-,N- 
______________________ 
 3.18* s -CH2N(CH3 ) 
Sphingomyelin  3.17* s -CH2N(CH3)3  
Plasmalogen PLAcs 5.87* ci -O-CHCH- 
_______________ 
PLAI3 4.31 l -O-CH=CH- 
________________ 
PLAILI 3.84 dd CHuOCO 
PLAP' 3.89 dd CHdOCO 
PLA2 5.12 c -CHOR- 
_________________ 
PLA3 3.95 ci -CH2OP03- 
Acidic lipids  
Sulfatides CERa 5.40 dd -CO-CHCH- 
________________ 
CERh 5.65* c -CO-CHCH- 
SerinePL. Sn2 5.18 c -CHOR- 
Inositol PL. Sn2 5.18 c -CHOR- 
Table 3. 2. 1 continued. Assignment of 'H NMR resonances in cerebral lipid extracts at 600 
MHz. 
Cerebral lipids were extracted from control murine tissue with chloroform/methanol (2: 1, 
v/v). The crude lipid extract was fractionated into neutral and acidic lipid species over DEAE 
Sephadex-A25. 'H NMR spectra were acquired on a Varian VXR600S NMR spectrometer 
operating at a spectrometer frequency of 599.945 MHz. For a lull description of the 
procedure see Experimental. Chemical structures are illustrated in Figure 3. 2. 1. 
* denotes 'H resonances used for metabolite quantification. 
c, complex; d, doublet; dd, doublet of doublets; q, quartet; qu, quintet; t, triplet. 
6 = 2.27 ppm, C2-methylene protons in all fatty acids; 
6 = 2.35 ppm. C3-methylene protons in docosahexaenoic acid (C22:6); 
6 = 2.79 ppm, [-CH=CH-cH2-dll=cH-] methylene protons in poly-unsaturated 
fatty acids. 
A comparison of the above integrals provides rapid information on the 
composition of fatty acids present in the cerebral lipid extract, i.e. saturated, 
mono-unsaturated, di-unsaturated and poly-unsaturated (arachidonic and 
docosahexaenoic acids), without the necessity for alternative analytical 
procedures. An example of the application of this analysis to the elucidation of 
triglyceride fatty acid composition is discussed below. 
Summary. 
Proton resonances from cholesterol, total ethanolamine phospholipids and total 
choline phospholipids were particularly prominent in the one-dimensional proton 
NMR spectra. High performance thin layer chromatography values for the 
percentage composition of these three lipid classes are 22.5, 21.8 and 23.5% 
respectively, indicating that they comprise over 67% of total cerebral lipids 
(Section 3. 3. 2). Cholesterol was readily characterized from its C18 methyl 
singlet signal at 0.64 ppm. Although cholesterol resonances were particularly 
prominent, it was reasoned that cholesteryl ester signals would make an 
insignificant contribution to the intensity of these resonances in normal brain 
tissue (less than 0.4%). Any change in cholesteryl esters would therefore be 
undetectable by NMR spectroscopy. Total ethanolamine phospholipids were 
quantified from the ethanolamine C2 methylene complex proton signal at 3.56 
ppm. The contribution that plasmalogens Or sphingosine derivatives made to this 
signal was not determined. Total choline phospholipids were quantified from 
their choline C2 methylene complex proton signal at 3.06 ppm. More detailed 
examination was given by comparison of the terminal methyl proton singlets at 
3.17 and 3.18 ppm corresponding to sphingomyelin and phosphatidyl choline, the 
latter probably also containing phosphatidal choline. The contribution made by 
E1l 
Assignment Chemical shift Multiplicity 
/ppm  
Functional group 
Acidic  lipids  
Fatty acids  
col (n-6, n-9) 0.84 t -CH7CH,CH3  
col (n-3) 0.93 t -CH=CHCH2CH3 
w2 (sat.) 1.22 c .CH,CH,CH3 
w2 (n-3) 2.03 c -CH=CHCH2CH3 




olefinic groups 5.35 c -CH=CH- 
PUFA 2.78 c -CH=CH(CH2CH=CH)-CH2- 
PUFA 1.97 c -(CH2)CH2CHCH- 
C18:2 2.72* t -CH=CHCH2CH=CH- 
C20.4 - C3 1 .65*  -CH=CHCH2CH2CH2COO 
C20.4 - C4 2.12 t -CH=CHCH2CH2CH2COO 
C2.6 - C3 2.35* c -CH=CHCH2CHCOO 
sat. - C2 2,27 c -CH2CH2CHCH1COU 
sat. - C3 1.55 c -CH2CH2CH,CH2COO 
sat. - C4 1.22 c -CH,CH,CH2CH2COO 
Table 3. 2. 1 continued. Assignment of 'H NMR resonances in cerebral lipid extracts at 600 
MHz. 
Cerebral lipids were extracted from control murine tissue with chloroform/methanol (2:1, 
vlv). The crude lipid extract was fractionated into neutral and acidic lipid species over DEAE 
Sephadex-A25. 'H NMR spectra were acquired on a Varian VXR600S NMR spectrometer 
operating at a spectrometer frequency of 599.945 MHz. For a full description of the 
procedure see Experimental. Chemical structures are illustrated in Figure 3. 2. I. 
* denotes 'H resonances used for metabolite quantification. 
c, complex; d, doublet; dd, doublet of doublets; q, quartet; qu, quintet; t, triplet. 
plasmalogen to total choline phospholipids was not determined. Cerebrosides, 
comprising approximately 8% of total cerebral lipids (Section 3. 3. 2) were 
identified by their galactose GAC 6' complex signal at 3.70 ppm in the neutral 
lipid proton spectrum. Choi et al. (1993) considered the galactose GAC 4 
doublet of doublets at 3.84 ppm for this purpose, however this was found to 
overlap with plasmalogen glycerol Cl' resonances in our proton spectra. The 
low concentration of this lipid did not facilitate its quantification. In addition, the 
inability to adequately distinguish cerebrosides I and II in the one-dimensional 
spectrum did not allow their separate quantification. 
On the basis of high performance thin layer chromatography results, acidic lipids 
comprise approximately 25% of the total cerebral extract (Section 3. 3. 1), 
cardiolipin, sulfatides, phosphatidyl serine and phosphatidyl inositol contributing 
5.3, 5.6, 10.3 and 3.1% respectively. The relatively smaller lipid quantities did 
not facilitate adequate quantification. Acidic sulfatides were determined from 
their sphingosine CER b olefinic proton complex signal at 5.65 ppm, it being 
found that the GAC 6' resonance overlapped with serine head group C2 
methylene protons in phosphatidyl serine (Figure 3. 2. 11). Resonances from 
phosphatidyl serine and phosphatidyl inositol were not well enough resolved to be 
used for quantitative purposes. Fatty acyl signals were particularly well 
distinguished in the acidic fraction in the absence of resonances from cholesterol, 
ethanolamine phospholipids and choline phospholipids. This assisted the 
assignment of diagnostic signals in terminally saturated fatty acids, n-3 fatty acids, 
linoleate (C182), arachidonate (C20:4), docosahexaenoate (C220) and total 
polyunsaturated fatty acids at 0.82, 0.93, 2.72, 1.65, 2.35 and 2.79 ppm 
respectively. 
In conclusion, a total of seven lipid species were identified from their diagnostic 
resonances in the one-dimensional proton NMR spectrum. Some degree of fatty 










Figure 3. 2.12 '3C and '3C-DEPT NMR spectra of cerebral lipids at 150.869 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol singlet at 51.0 ppm. 
3. 2. 2 Assignment of '3C NMR Snectra. 
Although '3C NMR spectroscopy does not lend itself to the quantitative analysis 
of metabolites, '3C NMR studies on cerebral lipids were performed for the 
purpose of completeness. Due to the relative insensitivity of 1 3c NMR 
spectroscopy, carbon resonances were assigned in a cumulative lipid extract 
obtained from three mouse brains without prior fractionation. The assignment of 
carbon signals was assisted by comparison with literature values (Gunstone, 




13 C resonances for cholesterol are available in the literature (Johnson and 
Jenkowski, 1972). In addition, the high concentration of cholesterol in the lipid 
extract facilitated the assignment of resonances in the lipid extract spectra. The 
C18 carbon was tentatively assigned at 12.25 ppm (Figure 3. 2. 12) in close 
agreement with the literature value and was identified as arising from a CH or CH3 
group from the DEPT spectrum (Figure 3. 2. 12). Summary analysis of the 
HMQC spectrum showed this resonance to be coupled to protons at 0.64 ppm. 
The combination of this data confirmed the assignment of this resonance to the 
C18 cholesterol carbon. The C19 and C21 carbons were assigned from the 
HMQC spectrum by the carbon-proton cross-peaks at [19.73, 0.971 ppm and 
[19.12, 0.88] ppm (Figure 3. 2. 13). These proton resonances are known to arise 
from C19 methyl protons (0.97 ppm, singlet) and C21 methyl protons (0.88 ppm, 
doublet) as determined in the proton spectrum (Section 3. 2. 1). Consequently 
the C19 and C21 carbon resonances were assigned at 19.73 and 19.12 ppm 
respectively, Using a similar combination of literature values, DEPT and HMQC 
spectra, coupled with inspection of multiplicities in the proton spectrum, all of the 


















Figure 3. 2. 12 13C and '3C-DEPT NMR spectra of cerebral lipids at 150.869 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol singlet at 5 1.0 ppm. 
of these C2, C7 and C8, tentatively). The majority of carbon resonances are 
observed over the broad chemical shift range 12.25 to 57.51 ppm, these being 
assigned to methyl and methylene group carbons. Three exceptions are worth 
noting, these being the carbon atoms in positions C3, CS and C6. The C3 
hydroxy position carbon resonance was assigned at 71.89 ppm, (literature value 
71.00 ppm) with the DEPT spectrum showing this signal to arise from a CH 
group and the HMQC spectrum showing coupling with a proton resonance at 
3.41 ppm. The allylic carbon atoms at positions CS and C6 resonate at 
appreciably higher chemical shifts. The literature values of 120.9 and 141.7 ppm 
for C6 and C5 corresponded closely to resonances at 121.99 and 141.57 ppm in 
the extract spectrum. Inspection of the DEPT spectrum allowed assignment of 
these signals to (CH or CH3) and C groups respectively, (the C5 signal being absent 
in the DEPT spectrum). Final support for the assignments was given by the 
HMQC spectrum in which it was seen that the carbon resonance at 121.99 ppm 
coupled to a vinyl proton at 5.32 ppm. The combination of this data allowed the 
assignment of the resonances at 141.57 and 121.99 ppm to the C5 and C6 
cholesterol carbons respectively. 
Galactocere bros/des. 
Galactocerebrosides, sulfatides and sphingornyelin possess a common sphingosine 
(ceramide) moiety and consequently these carbon resonances are shared between 
them. In the sphingosine moiety, the CER b proton produces a carbon-proton 
cross-peak in the HMQC spectrum at [134.73, 5.651 ppm allowing its assignment 
at 134.73 ppm in the carbon spectrum. The CER a carbon was less readily 
identified as this resonance appeared among a multitude of other olefinic signals 
in the 127.60 to 132.43 ppm region. Using the same system of analysis, (i.e. the 
HMQC spectrum and confirmation by the DEPT spectrum), CER I, CER 2 and 
CER 3 were assigned to resonances at 54.58, 53.94 and 69.06 ppm. The later 
signal had carbon-proton cross-peaks at [69.06, 3.69] and [69.06, 4.051 ppm in 
the HMQC spectrum. With reference to the discussion on proton NMR spectral 
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Figure 3. 2. 12 '3C and '3C-DEPT NMR spectra of cerebral lipids at 150.869 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol singlet at 51.0 ppm. 
analysis of lipids, these proton signals were consistent for a ceramide moiety 
containing an c-hydroxy fatty acid, i.e. galactocerebroside I, (Section 3. 2. 1). 
Focusing on the galactose group, GAC 1 was assigned on the basis of a carbon-
proton cross-peak at [104.34, 4.181 ppm in the HMQC spectrum which was seen 
to arise from a CH/CH3 group in the DEPT spectrum (Figures 3. 2. 13 and 3. 2. 12 
respectively). The GAC 2 carbon was identified by the carbon-proton cross-peak 
at [71.89, 3.501 ppm, however this signal was not clearly seen in the carbon 
spectra as it lay under the cholesterol C3 resonance. GAC 3 was assigned in a 
similar manner from the carbon-proton cross-peak at [74. 17, 3.44] ppm. GAC 4 
and GAC 5 were also assigned from the carbon-proton cross-peaks at [69.71, 
3.82] ppm and [75.93, 3.481 ppm respectively. GAC 6 was identified by the two 
carbon-proton cross-peaks produced with the diastereotopic protons 6' and 6" at 
[62.11, 3.96] ppm and [62.11, 3.751 ppm. The GAC 6 signal was not clearly 
seen in the carbon spectra, it being found to resonate at the same chemical shift as 
the phosphatidyl ethanolamine Cl head group signal. 
Ethanolainine phospholipids. 
Proton and carbon assignments have been performed on chloroform solutions of 
synthetic phosphatidyl ethanolamines and phosphatidyl cholines by Gu nstone 
(1992). Using a combination of the data from these studies, proton and HMQC 
spectra and confirmatory DEPT analysis, the carbon resonances in phosphatidyl 
ethanolamine and phosphatidyl choline were assigned in the lipid extract spectra. 
The Cl methylene protons of the ethanolamine head group were observed as a 
broad resonance at 3.98 ppm, which produced a cross-peak in the HMQC 
spectrum at 62.11 ppm (Figures 3. 2. 13). The CH, nature of this signal was 
apparent from the DEPT spectrum. The C2 head group carbon was assigned at 
41.280 ppm in the same way. Glycerol carbon resonances have been reported to 
fall in the chemical shift range 63.0 to 70.9 ppm (Gunstone, 1992). In the proton 
spectrum, the glycerol backbone protons were observed at 3.95, 4. 12, 4.37 and 
5.18 ppm corresponding to the C3, Cl,' Cid and C2 protons. Cross-peaks with 
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Figure 3.2. 13 Two-dimensional HMOC spectrum of cerebral lipids at 150.869 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol singlet at 51 .0 ppm. 
these resonances were observed in the HMQC spectrum at 64.26, 63.14, 63.14 
and 71.17 ppm respectively (Figure 3. 2. 13) in close agreement with those 
previously reported (64. 1, 63.0 and 70.9 ppm). Interestingly, a number of 
resonances were observed over this region in the one-dimensional carbon 
spectrum which coupled to the glycerol backbone protons in the HMQC 
spectrum. For example, two possible resonances for Cl glycerol backbone 
carbons were observed at 63.14 and 63.29 ppm, the later being at least twice as 
large as the former (Figure 3. 2. 12). Gunstone found glycerol Cl carbons in 
phosphatidyl ethanolamine and phosphatidyl choline to differ in chemical shift by 
0.01 ppm. Therefore, the possibility exists that the resonance at 63.29 ppm arises 
from the combined C I carbons of phosphatidyl ethanolamine and phosphatidyl 
choline and that the other resonance at 63.14 ppm arises from phosphatidyl serine 
and phosphatidyl inositol Cl glycerol carbons. On the basis of our h.p.t.l.c. 
results (Section 3. 3. 2) we observed the former two lipids to occur in appreciably 
greater quantities than the latter two. It is noted however, that without further 
purification of this crude lipid extract, positive assignment of these resonances 
cannot be made. A similar situation exists for the glycerol carbon atoms at 
positions 2 and 3. As previously mentioned in this section the glycerol C2 proton 
resonance couples to carbon signals at a chemical shift of 71.2  ppm. In reality 
three signals are present, at 71.12, 71.17 and 71.27 ppm, all of which are CH or 
CH3 in character as evinced in the DEPT spectrum. Although glycerol C2 carbon 
resonances in phosphatidyl ethanolamine and phosphatidyl choline have been 
reported at 70.9 and 70.65 ppm (Gunstone, 1992), this did not assist their 
assignment in our lipid extract. The glycerol C2 carbon in phosphatidyl 
ethanolamine was however tentatively assigned at 71 .17 ppm and that of 
phosphatidyl choline at 71.12 ppm. Some justification for these assignments is 
given by the observation that the former resonance is slightly more intense than 
the signal at 71 .12 ppm and that phosphatidyl ethanolamine is present in the 
sample at a slightly higher concentration than phosphatidyl choline (Section 3. 2. 
2). Multiple cross-peaks occur for the C3 glycerol carbon over the 64.26 to 
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Figure 3.2. 13 Two-dimensional HMOC spectrum of cerebral lipids at 150.869 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol singlet at 51.0 ppm. 
nature of phospholipids present in the extract. These signals could not be 
individually assigned, however all were CH, signals as determined from the DEPT 
spectrum. 
Choline yhospholipids. 
The terminal methyl head group carbon resonance was assigned following 
examination of the HMQC spectrum. The large methyl proton signal at 3.18 ppm 
was seen to couple to a carbon signal at 54,58 ppm which was CHICH3 in 
character as determined from the DEPT spectrum. Closer examination of the 
HMQC spectrum showed the signal to be due to two carbon-proton couplings, at 
3.17 and 4.05 ppm in addition to the phosphatidyl choline signal at 3.18 ppm 
(Figure 3. 2. 13). These former two signals were assigned to the terminal methyl 
head group protons in sphingomyelin and the sphingosine Cl position proton 
CER I as discussed earlier (Section 3. 2. 1). The Cl choline head group carbon 
was assigned directly from the HMQC spectrum following the visualization of a 
carbon-proton cross-peak at [59.70, 4.201 ppm. The C2 head group resonance 
was assigned at 67.13 ppm in a similar manner. 
Sphingomyelin shares common choline and sphingosine moieties with 
phosphatidyl choline and galactocerebroside respectively. Carbon resonances for 
these two structural groups have been assigned previously. No differences were 
detected in the chemical shifts of carbon resonances in these two moieties in the 
three lipid species examined. 
Piasnalogens (ether phospholipids). 
As previously stated in the assignment of proton NMR lipid spectra (Section 3. 2. 
1), plasmalogens possess an a, P unsaturated ether at the glycerol Cl position. 
The effect that this group has on carbon resonances at the glycerol C I and C2 
positions provides well distinguished signals. The glycerol C I position methylene 
protons produce carbon-proton cross-peaks in the HMQC spectrum at [70.78, 
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Figure 3. 2. 13 Two-dimensional HMOC spectrum of cerebral lipids at 150.869 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 




















3.84] and [70.78, 3.89] ppm, reflecting coupling between the glycerol Cl carbon 
(defined as PLA I) and the glycerol Cl' and Cid  diastereotopic protons 
respectively. Two carbon signals were observed at 70.779 and 70.88 ppm 
suggesting the presence of two species of plasmalogen, notably phosphatidal 
ethanolamine and phosphatidal choline. Analysis of the proton spectra of neutral 
and acidic lipids support this claim, with acidic plasmalogens unidentified in the 
acidic lipid fraction (Figure 3. 2. 11). The glycerol C2 carbon (defined as PLA 2) 
was identified in a similar manner from the HMQC spectrum by the presence of a 
carbon-proton cross-peak at [72.50, 5.121 ppm. A number of CH or CH3 carbon 
resonances lie in close proximity to this signal with these coupling to proton 
resonances at 3.98 and 4.07 ppm Their assignment was not performed. The 
plasmalogen glycerol C3 carbon signal (defined as PLA 3) was found to virtually 
overlap the glycerol C3 carbon resonances from other phospholipids in the 64.26 
to 64.49 ppm chemical shift region. Resonances from the PLA a and PLA J3 
vinyl ether carbons were assigned at 145.34 and 108.38 ppm respectively from 
the carbon-proton cross-peaks at [145.34, 5.87] and [108.38, 4.31] ppm in the 
HMQC spectrum. The CH nature of these signals was confirmed by the DEPT 
spectrum. 
Acidic lipids. 
Phosphatidvi serine, phospharidvi inositol and sulkitides. 
The low concentration of the acidic phospholipids in the cerebral lipid extract, i.e. 
phosphatidyl serine and phosphatidyl inositol, made the assignment of head group 
resonances difficult. Distinguishable signals from the lipids were not discerned in 
the HMQC spectrum. It is assumed that glycerol backbone carbon resonances 
would appear in the same regions as those of the neutral phospholipids. Sulfatide 
carbon resonances were not distinguished from those of galactocerebros ides. 
0. 
Fatty acid structures. 
Carbon resonances in acylglycerols and fatty acid methyl esters have received 
considerable attention in the review by Gunstone (1992). In our studies, carbon 
resonances in fatty acid structures were assigned in the lipid extract with 
extensive reference to literature values and the NMR experiments outlined above. 
0)1-methyl protons in terminally saturated fatty acids produce a cross-peak with a 
carbon resonance at 14.31 ppm in the HMQC spectrum, confirmation of the CH3 
character of this signal being given by the DEPT spectrum. Gunstone found 
corresponding 0)1 carbon resonances from n-3 fatty acids to resonate 
approximately 0. 12 ppm downfield (i.e. at a higher chemical shift) of the 
aforesaid signal, however the only resonance seen in this region was at 14.51 
ppm, which proved to arise from a CH, group. Consequently the 0)1 carbon from 
n-3 fatty acids was not assigned in our lipid extract carbon spectra. In a similar 
manner, the w2 carbon in terminally saturated fatty acids was assigned at 23.21 
ppm from the cross-peak in the HMQC spectrum with w2-methylene protons. A 
CH2 carbon was observed at 23.11 ppm which may have arisen from an n-6 fatty 
acid (Gunstone, 1992). 0 carbons were assigned from the cross-peak with o3-
methylene protons in the HMQC spectrum over the 31.78  to 32.97 ppm region. 
The signal at 31.78  ppm was similar in intensity to the wl and 0)2 carbon 
resonances previously assigned, supporting the tentative assignment of this signal 
to that of the w3 carbon in terminally saturated fatty acids. It is noted however 
that without further purification to remove interfering cholesterol resonances, the 
positive assignment of these 0 carbons remains unclear. 
Methylene envelope protons were seen to produce a cross-peak with a large 
number of carbon resonances over the 29.52 to 30.25 ppm chemical shift region 
in the HMQC spectrum. Resolution of these signals to specific carbon atoms was 
not attempted. 
me 
Signals for allylic carbons at each end of a monoene or polyene system were seen 
at 27.74 ppm, these being assigned on the basis of the carbon-proton cross-peak 
at [27.74, 2.03] ppm in the HMQC spectrum. In a similar manner, resonances 
from the [-CH=CH-CH,-CH=CH-] group of methylene interrupted polyenes were 
assigned in the range 26.09 to 26.21 ppm (Figure 3. 2. 13). These comprised 
three signals which were all coupled to the broad proton resonance at 2.76 to 
2.82 ppm. On the basis of our chemical ionization mass spectrometry results 
(Section 3. 3. 1), we believed the majority of these to be attributable to the poly-
unsaturated fatty acids lirioleic (C1 82), arachidonic (C204) and docosahexaenoic 
acid (C22.6). 
Resonances for olefinic carbon atoms were observed over the 127.60 to 132.43 
ppm range, however without further purification to separate individual fatty acids 
and two-dimensional shift correlated 13C COSY 45 experiments, the identity of 
these numerous signals remain largely unassigned. 
Gunstone reported the assignment of Cl resonances from quaternary carbon 
atoms at 173.2 ppm (glycerol 1/3) and 172.8 ppm (glycerol 2) (Gunstone, 1992). 
Four signals were identified in our one-dimensional carbon spectrum, a large 
resonance at 174.49 ppm, a small resonance at 173.38 ppm and two signals of 
approximately equal intensity at 174.10 and 174.13 ppm. The former signal at 
174.49 ppm was presumed to arise from the carboxylate carbons attached to the 
glycerol 1/3 positions since it was greater in intensity than the other signals. 
These other signals were not positively assigned. A similar difficulty in assigning 
signals to specific fatty acid carbon atoms was found with the C2 and C3 carbons, 
although the general chemical shift regions of these resonances were determined. 
A large proton-carbon cross-peak was observed for the C2 carbon at [34.64, 
2.26] ppm in the HMQC spectrum. Four distinct resonances existed in this 
region, at 35.22, 24.79, 34.64 and 34.21 ppm, all of which were CH, signals 
(Figure 3. 2. 12). These resonances were believed to include signals from the C2 
acyl positions of phospholipids, gal actocerebros ides and sulfatides present in the 
Ii] 
Metabolite Assignment Chemical shift Ippm Functional group 
Neutral lipids  
Cholesterol C18 12.25 CH3  
C21 19.12 CH3  
C19 19.73 CH3 
Cli 21.72 CH3  
C26 22.82 CH3 
C27 23.06 CH3  
C23 24.43 CH, 
C15 24.85 CH, 
C25 28.56 CH 
C12 28.80 CH, 
C20 36.44 Cl-I 
C22 36.84 CH, 
CIO 37.16 C 
Cl 37.99 Cl-I2 
C24 40.14 Cl-I2 
C16 40.53 Cl-I 
C4 42.48 Cl-I. 
C13 42.98 C 
C9 50.99 CH 
C17 56.92 CH 
C14 57.51 CH 
C3 71.89 CH 
CÔ 121.99 C 
C5 141.57 CH 
Galactocerebrosides CERa 127.60 - 132.43 -CH=CH- 
__________________ 
CERb 134.77 -CH=CH- 
_________________ 
CERI 54.58 Cl-i 
CER2 53.94 Cl-I 
CER3 69.06 CH 
GACI 104.34 CH 
GAC2 71.89 CH 
GAC3 74.17 CH 
GAC4 69.71 CH 
GAC5 75.93 CH 
GAC6 62.11 CH, 
Table 3. 2. 2 Assignment of '3C NMR resonances in cerebral lipid extracts at 600 MHz. 
Lipids were extracted from three pooled murine brains. '3C NMR spectra were acquired on a 
Varian VXR600S NMR spectrometer operating at a spectrometer frequency of 150.869 MHz. 
For a full description of the procedure see Experimental. Chemical structures are illustrated 
in Figure 3.2. 1. 
* denotes 13C resonances used for metabolite quantification. 
lipid extract. In a similar manner C3 carbons were assigned from the carbon-
proton cross-peak in the HMQC spectrum at [25.48, 1.55] ppm. Three signals 
were present in this region lying very close to each other, however without 
further experiments on purified compounds they also remain unassigned. 
Swnmarv. 
The low percentage abundance and consequent lack of sensitivity inherent in 13C 
NMR makes this technique of limited value in the quantitative analysis of 
metabolites, however the information contained in the 13C  spectrum does provide 
an additional form of structural information on the lipid species present. 
Cholesterol being the most prominent of the cerebral lipids in the murine extract, 
gave well distinguished signals in the carbon spectra. Twenty-four of the twenty-
seven carbons were positively assigned, the remaining three tentatively. 
Carbon sphingosine resonances in galactocerebros ides, sulfatides and 
sphingomyelin were fully assigned, however it was not possible to distinguish 
between the three lipid species on this basis. Similarly, galactose carbon signals 
were assigned for galactocerebrosides and sulfatides, but again these did not 
allow distinction between the two galactocerebrosides. 
Carbon head group resonances in ethanolamine phospholipids were assigned in 
the carbon spectrum and were indistinguishable from phosphatidyl and 
phosphatidal compounds. The same was found for head group resonances in the 
choline-containing phosphol ipids: phosphatidyl choline, phosphatidal choline and 
sphingomyelin. However some differences were detected in the glycerol 
backbone carbons of these lipid species allowing their assignment from the two-
dimensional HMQC spectrum and subsequently the one-dimensional '3C 
spectrum. 
The assignment of resonances in the acidic lipids phosphatidyl serine and 
phosphatidyl inositol was not assisted by their low concentration in the cerebral 
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Metabolite Assignment Chemical shift /ppm Functional group 
Neutral lipids  
Ethanolamine PL. Cl 62.11 -CH,CH,NR2 
C2 41.28 -CH7CH2NH2 
Sn 1 63.14 -CH,OCOCH,- 
______________ 
Sn2 71.17 -CI-IOR-CH,O- 
________________ 
Sn3 64.26 -CHOCH2OP03- 
Choline PL. CI 59.70 -CH7CH7N- 
_______________ 
C2 67.13 -CH,CH2N- 
____________________ 
 54.58 -CH2N(CF13)3 
Plasmalogen PLAu 145.34 -O-CH=CH- 
_______________ 
PLAI3 108.38 -O-CH=CH- 
_________________ 
PLA 1 70.78 -CH2O-CH= 
PLA2 72.50 -CHOR-CHO- 
___________________ 
PLA3 64.26 - 64.49 -CHOCH2OP01- 
Acidic lipids  
Fatty acids  
(sat., n-6, n-9) w1 14.31 -CH,CHCH3 
(sat.. n-6, n-9) w2 23.21 -CH7CH2CHI 
(sat., n-6, n-9) w3 31.78-32.97 -CH1CH7CH3 
29.52 - 30.25 methyl envelope 
27.74 =CHCH2(CH2)- 
C1 82, C20:4, C226  26.09 - 26.21 =CHCH2CH= 
127.6 - 132.43 -CH=CH- 
__________________ 
Cl 173.38 - 174.49 -CH7CH2COO 
C2 34.21 - 35.22 -CH2CH2COO 
C3 25.41 - 25.52 -CH,CH2COO 
Table 3. 2. 2 continued. Assignment of ' 3C NIlvIR resonances in cerebral lipid extracts at 600 
MHz. 
Lipids were extracted from three pooled murine brains. 13C NIMR spectra were acquired on a 
Varian VXR600S NMR spectrometer operating at a spectrometer frequency of 150.869 MHz. 
For a full description of the procedure see Experimental. Chemical structures are illustrated 
in Figure 3.2.1. 
* denotes 13C resonances used for metabolite quantification. 
Ivy" If, 
lipid extract. Carbon resonances in fatty acyl groups were not assigned in great 
detail as the result of the spectra containing multiple resonances from the broad 
and diverse fatty acid groups present. It was concluded that in order for more 
precise assignments to be made the lipid extract would require further 
fractionation to allow characterization of individual lipid species. 










Figure 3. 2. 14 31P NMR spectrum of neutral cerebral lipids in aqueous deoxycholate at 242.854 
MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
P043 singlet at 3.54 ppm. 
3. 2. 3 Assiinment of 31P NMR SDectra. 
Poor spectral resolution of phospholipid species in Bligh-Dyer organic phase 
extracts (chloroform/methanol, 2:1, vlv), has been an impediment to their 
quantitative and qualitative analysis by 31P NMR spectroscopy. Recently, 
Capuani and colleagues described a technique in which phospholipids were 
processed to remove endogenous cations and dispersed as aqueous micelles in a 
deoxycholate/D20 mixture (Capuani et al., 1992). These two processes, i.e., 
removal of metal cations, formation of aqueous micelles and subsequent 
adjustment of pH to I 1 .4, resulted in well resolved spectra for all the major 
phospholipid species thus allowing the aforesaid analysis to be performed. The 
authors assigned five cerebral phospholipid resonances in a rat extract by 
comparison with standard lipid samples. 
The improvement in spectral resolution that this procedure appeared to offer over 
'H NMR analysis of phospholipids merited its application to the study of murine 
cerebral lipids in scrapie and control animals. In the studies described here, 
neutral and acidic lipid fractions were analyzed by 31P NMR spectroscopy. Prior 
fractionation of the crude lipid extract allowed better discrimination of lipid 
species in the 31P NMR spectrum. The results of the analysis are discussed 
below. 
Neutral Lirjids. 
The 31P NMR spectrum of the neutral lipid fraction contained prominent 
resonances at -0.10 and 0.93 ppm relative to the exogenous P043 standard at 
3.52 ppm (Figure 3. 2. 15). With reference to authentic 31P NMR lipid spectra, 
and the results reported by Capuriai et al. (1992), these two prominent lipid 
resonances were assigned to phosphatidyl choline and phosphatidyl ethanolamine 










Figure 3. 2. 15 31P NMR spectrum of acidic cerebral lipids in aqueous deoxycholate at 242.854 
MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
PO,  3 singlet at 3.54 ppm. 
Four additional resonances were seen in the neutral lipid fraction, at 0.23, 0.34, 
0.79 and 1.35 ppm. These were not positively identified. It is possible that the 
signals at 0.34 and 1.35 ppm arise from phosphatidal choline and phosphatidal 
ethanolarnine respectively, both occurring approximately 0.43 ppm downfield of 
their corresponding diacyl phospholipid resonances. The signal at 0.79 occurs at 
a similar chemical shift to that of phosphatidyl serine in the acidic fraction (Figure 
3. 2. 15), and may represent a small proportion of this acidic lipid which was 
eluted in the neutral fraction. 
Acidic Lipids. 
Four resonances were detected in the 31 P NMR spectra of the acidic lipid fraction 
(Figure 3. 2. 15). All of these were assigned with reference to authentic 
standards. The signals at 0.09, 0.83, 0.92 and 4.70 ppm were seen to arise from 
phosphatidyl inositol, phosphatidyl serine, cardiolipiri and phosphatidic acid 
respectively. Cardiolipin was observed to co-resonate with the signal arising 
from phosphatidyl ethanolamine, thus illustrating the necessity for lipid 
fractionation prior to quantitative analysis. 
General Summary - NMR Lipid Analysis. 
Application of proton and phosphorus NMR spectroscopy to the study of 
cerebral lipids offers a novel, non-destructive form of analysis from which 
structural information may be obtained on individual lipid species. In the studies 
described here, diagnostic resonances were assigned for a number of murine 
cerebral lipids allowing their comparative quantification. NMR spectroscopy was 
however not adopted for general lipid analysis, the primarily objection being the 
large amount of NMR time required for the detailed analysis of numerous brain 
samples and secondly because an alternative technique, high performance thin 
layer chromatography, offered a distinct advantage in that it afforded a relatively 
inexpensive form of lipid analysis with a high degree of sensitivity and lipid 
resolution. In addition it allowed the quantification of lipids in relatively low 
concentrations, notably galactocerebrosides I and II, sulfatides I and II, 
cholesteryl esters, triglyceride and diglyceride. 
M vitro NMR spectroscopy did however find application to the comparative 
analysis of cerebral lipids in scrapie and control mice. This was primarily 
performed to investigate the hypothesis that the 'multicomponent resonance' 
detected by in vivo MRS in ME7-affected VM mice was attributed to lipid. It 
was proposed that having identified this component in vitro the improvement in 
spectral resolution would allow the nature and origin of the metabolite to be 
deduced. In view of this particular attention was given to the 1.5 to 1.8 ppm 
chemical shift region in the proton spectra, and secondly to relative peak 
intensities of diagnostic lipid resonances. A discussion of the findings is given is 
Section 3. 2. 4. 
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Metabolite Chemical shift /ppm Control Scrapie 
'H NMR  _analysis  
Neutral lipids  
Cholesterol 0.64 90 ± 5 87 ± 3 
Ethanolamine PL. 3.06 138 ± 15 143 ± 9 
Sphingomyelin 3.17 43±33 40±3 
Phosphatidyl choline 3.18 158 ± 10 164 ± 9 
Galactocerebrosides 5.65 15 ± 2 16 ± 3 
Plasmalogen 5.87 23 ± 2 21 ± 3 
Acidic lipids  
Total fatty acids 2.27 120 ± 11 t22 ± 9 
Linoleic (C,.2) 2.72 7 ± 1 6 ± 2 
Arachidonic (C10:4) 1.65 19 + 2 20 ± 3 
Docosahexaenoic (C22:6) 2.35 45 ± 2 41 ± 4 
31P NMR analysis  
Ptd. choline -0.10 34 ± 1 33 ± 2 
Ptd. ethanolamine 0.93 46 ± 4 43 ± 4 
Sphingomyelin 0.34 II ± 2 12 ± 2 
Ptd. inositol 0.09 17 ± 2 17 ± I 
Ptd. serine 0.83 14 ± 1 14 ± I 
Table 3. 2, 3 In vitro NMR spectroscopy analysis of cerebral lipid extracts from control and 
scrapie mice at 600 Mhz. 
For description of procedure see Experimental. Values are expressed as mean ± sem in units 
proportional to the intensity of diagnostic' 'H and 3P  lipid resonances and subsequently 
standardized to wet brain weight. Five control and five scrapie animals were analyzed in each 
group. 
Neither 1 H nor 31P NMR analysis revealed statistically significant difference between the two 
groups. 
3. 2. 4 Comparative Analysis of Cerebral Lipids in Scrapie-Affected and 
Control Mice by NMR Spectroscopv. 
The detection of a scrapie-specific in vivo MRS multicomponent resonance and 
its potential application to the non-invasive, pre-clinical diagnosis of a 
transmissible spongiform encephalopathy disease state has received earlier 
discussion. The primary objective of the research described here was to 
reproduce these novel findings in vitro and subsequently identify the metabolite(s) 
responsible for this pathological change. The absence of the signal in aqueous 
perchlorate and acetone-d6 cerebral extracts argued strongly against the 
compound having a hydrophilic nature. Attention was therefore focused on 
changes in hydrophobic compounds and most notably lipid. For the purpose of 
these studies, cerebral lipid extracts were prepared from a small number of 
terminally-ill scrapie mice (ME7IVM) and an equal number of age- and sex-
matched controls. Following resuspension in the appropriate deuterated solvents 
(Section 2. 4. 3) the lipid fractions were analyzed by a combination of proton and 
phosphorus NMR spectroscopy. Representative one-dimensional spectra of 
scrapie and control cerebral lipids for the aforementioned techniques are 
displayed in Figures 3. 2. 16a/b and 3. 2. 1 7alb respectively. 
Results. 
Upon initial examination of the in vitro proton spectra, the absence of an intense 
multicomponent resonance over the 1.5 to 1.8 ppm chemical shift region was 
immediately evident in scrapie as well as control lipid extracts. Although more 
detailed quantitative comparison of diseased and control lipid profiles was 
afforded by high performance thin layer chromatography (Section 3. 3), the above 
proton and phosphorus spectra provided complementary data to support past 
findings that no appreciable differences exist in the major cerebral lipids or their 
fatty acid components between scrapie and control mice (Dees et al., 1985; 
Heitzman and Skipworth, 1969; Kimberlin and Millson, 1967) (Table 3. 2. 3). 
Figure 3. 2. 16a 1 H NMR spectra of cerebral lipids from control mice at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. In a comparison between control and scrapie-affected 
samples, no differences were detected in lipid composition relative to wet brain weight. 
Figure 3. 2. 16b 'H NMR spectra of cerebral lipids from scrapie-affected mice at 600 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to the 
methanol quintet centred at 3.3 ppm. In a comparison between control and scrap ie-affected 
samples, no differences were detected in lipid composition relative to wet brain weight. 
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Figure 3. 2. I7a 31P NMR spectra of cerebral lipids from control mice at 242.854 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to P043  
singlet at 3.54 ppm. In a comparison between control and scrapie-affected samples, no 
differences were detected in lipid composition relative to wet brain weight. 
Figure 3. 2. 17b 31P NMR spectra of cerebral lipids from scrapie-affected mice at 242.854 MHz. 
Spectra where acquired as described in Experimental. Lipid resonances were referenced to P043  
singlet at 3.54 ppm. In a comparison between control and scrapie-affected samples, no 
differences were detected in lipid composition relative to wet brain weight. 
Inferences. 
In the absence of a quantitative lipid change, the multicomponent resonance was 
speculated to arise from lipid which had undergone a disease-related 
environmental disturbance. Under the experimental in vivo 'H MRS acquisition 
parameters incorporating a T2 relaxation time of 420 milliseconds, lipid signals 
are markedly attenuated and thus not observed (Bell et al., 1991). The 
visualization of lipid resonances under the aforesaid conditions would therefore 
indicate a change in lipid mobility or environment, with an associated increase in 
the time for the radiofrequency excitation of protons to decay. Bell and 
colleagues thus proposed that the multicomponent resonance "may arise from 
lipids which have a mobile component and are in an environment different from 
that normally expected, or from mobile membrane-related compounds" (Bell et 
al., 1991). Although this was an interesting hypothesis, it was one for which the 
validity was difficult to evaluate. 
The attribution of the multicomponent resonance to lipid was questioned 
following a review of the limited articles on the detection of intracerebral changes 
in lipid flux by in vivo 'H MRS (Davie et al., 1993; Larsson et al., 1991; 
Koopmans et al., 1993). Demyelination and cholesteryl ester elevation are 
prominent events in white matter regions of patients suffering from multiple 
sclerosis (Ghosh and McLean Grogan, 1991; Maggio etal., 1972). The former 
authors recorded the observation of resonances between 1.2 and 1.4 ppm in white 
matter regions which they speculated to be attributed to lipid disturbances. 
Comparison of these documented in vivo lipid signals with the scrapie-specific 
multicomponent resonance (1.5 to 1.8 ppm) highlighted a striking disparity in the 
frequency at which the two sets of signals were observed. Our in vitro 'H MRS 
lipid studies support the independent findings above in that methylene envelope 
proton resonances produce prominent signals over the 1.2 to 1.4 ppm region 
(Figure 3. 2. 2). In contrast the observation of the scrapie multicomponent peak 
we 
at an appreciably higher frequency to that expected for methylene envelope 
signals did not support its lipid origin. 
A suitable non-invasive means of testing the association between the 
multicomponent resonance and changes in intracerebral lipid concentration or 
relaxation properties was not immediately forthcoming. However, during the 
process of analyzing cerebral lipids from three murine-scrapie models (ME7/VM, 
87V/VM and 301 V/VM) during their disease progression by h.p.t.l.c., a very 
marked abnormality was detected in levels of triglyceride in one control mouse. 
In vitro lipid analysis was performed as part of a collaborative study in which 
scrapie and control mice underwent routine in vivo 'H MRS examination at 
Queen Mary and Westfield College, London. In vivo proton MRS spectra of the 
aforesaid abnormal mouse and a littermate control in which no h.p.t.l.c. lipid 
abnormality was detected are illustrated in Figure 3. 2. 18. The proton spectrum 
of the mouse with a lipid abnormality clearly exhibits an intense resonance 
between 1. 1 5 and 1.40 ppm in agreement with the lipid signals previously 
described in multiple sclerosis plaques (Davie et al., 1993; Larsson et al., 1991; 
Koopmans et of., 1993). A similar signal was not observed in the normal mouse. 
This incidental finding provided evidence in disproof of the hypothesis that the 
1.5 to 1.8 ppm multicomponent resonance was attributable to lipid, be it mobile 
or otherwise. The failure to detect a 'multicomponent peak' in either aqueous or 
non-aqueous solvents raised considerable uncertainty as to the origin of this 
abnormality. The importance and scrapie-specificity of the multicomponent peak 
was later discounted when repeated studies found the signal in control as well as 
scrapie mice in an apparently haphazard distribution and at all stages of disease 
progression (Progress Report AFRC Grant LRG 103/503 - April 1993). The 
validity of the original results were understandably viewed with a degree of 
caution and further studies in this area were suspended pending clarification of 
the original results by the Queen Mary and Westfield College group - a pursuit 
which has been unfruitful to date. 
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Figure 3. 2. ISa In vivo 'H NMR spectra of control murine brain at 200 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl asparlate methyl singlet at 2.02 ppm. 
Figure 3. 2. 18b In t'h'o 'H NMR spectra of lipomateous abnormality in murine brain at 200 
MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. With comparison to control (facing page), this 
spectra displays a broad signal between 1.15 and 1.4 ppm. This resonance was believed to he 









Figure 3. 2. 19a In vitro 1 H NMR spectra of neutral cerebral lipids at 600 MHz. The same 
tissues were used as in Figure 3. 2. 18. Control sample. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 










Figure 3. 2. I9b In vitro 'H NMR spectra of neutral cerebral lipids at 600 MHz. The same 
tissues were used as in Figure 3. 2. 18. Lipomateous abnormality sample. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. With comparison to control (facing page), the 
presence of two sets of doublets of doublets at 4.08 and 4.25 ppm are in agreement with Sni and 
SO methylene protons in the glycerol backbone of triglyceride. In addition, resonances at 2.69 






Figure 3. 2. 20 1 H NMR spectrum of isolated lipomateous abnormality at 600 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. This spectrum confirms the identity and allows 
the elucidation of the fatty acid composition of the purified triglyceride. 
3. 2. 5 Detection and Characterization of a Cerebral Lipid Abnormality by 
in Vivo and in Vitro 'H and 31P NMR Spectroscopy. 
The detailed purification and subsequent characterization of the aforementioned 
triglyceride abnormality is described as an example of the application of in vitro 
'H and 31P NMR spectroscopy to the characterization of a cerebral lipid change. 
Results. 
High performance thin layer chromatography analysis of murine cerebral lipids 
identified a control individual which exhibited a marked elevation in a non-polar, 
neutral lipid. This was seen to co-migrate with authentic triglyceride under 
conditions for non-polar lipid separation (hexane/diisopropyl ether/acetic acid, 
65:35:2, by vol.). H.p.t.l.c. studies were performed as a sequel to in vivo 'H 
MRS analysis, the latter providing circumstantial proof of the ability to non-
invasively detect intracerebral lipid accumulations as broad resonances over the 
1.15 to 1.40 ppm chemical shift region. Consideration of this finding and its 
implications for the 'scrapie-specific multicomponent peak - mobile lipid' 
hypothesis have received prior discussion. 
Neutral and acidic cerebral lipid fractions from the 'abnormal' mouse and a 
littermate control in which no abnormality was observed, were evaporated to 
dryness under dry nitrogen and resuspended in fully deuterated 
chloroform/methanol (2: 1, v/v) for in vitro 'H MRS analysis and subsequently in 
aqueous deoxycholate solution for in vitro 3 'P MRS analysis (Section 2. 4. 3). 
One-dimensional proton NMR spectroscopy of the neutral fraction revealed 
quantitative changes in the intensities of hitherto undetected cerebral lipid 
resonances. These were seen as two prominent sets of 'doublets of doublets' 
centered at 4.11 and 4.28 ppm and two sets of triplets at 2.73 and 5.23 ppm 
(Figure 3. 2. 19). The former two signals were believed to originate from Sni 
and Sn3 glycerol methylene protons in triglyceride in close agreement with those 
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Ficure 3. 2. 21 Two-dimensional i-resolved spectrum of isolated lipornateousabnormalitv at 600 
MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. This spectrum confirms the identity and allows 
the elucidation of the fatty acid composition of the purified triglyceride. 
assigned to the Sn2 methine proton between the Siil and Sn3 methylene protons 
and the triplet at 2.73 ppm was believed to be indicative of a high concentration 
of linoleic acid (C jg:2) in the neutral lipid fraction (Section 3. 2. I). Whether this 
latter finding was associated with the triglyceride abnormality was not determined 
at this stage, however it was noted that the signal was not observed in the 
corresponding control lipid spectrum (Figure 3. 2. 2). In addition to these 
changes the intensity of methylene envelope proton resonances over 1.24 to 1.32 
ppm were markedly elevated in the 'abnormal' extract. It was noted that similar 
changes in signal intensity (although less well resolved) were observed in this 
region in the in vivo 'H MRS spectrum (Figure 3. 2. 18). Levels of other lipids 
appeared unchanged relative to each other as determined from the intensities of 
their diagnostic proton resonances. Likewise, 3P  NMR spectroscopy analysis 
revealed insignificant changes in phospholipids in agreement with the h.p.t.1.c. and 
'H MRS results. 
Extensive 'H MRS analysis of the lipid abnormality was performed following its 
purification over aminopropyl silica SEP PAK columns (Section 2. 6 - 
Triglyceride). On the basis of weight (8.3 g) this isolate represented 18% of total 
cerebral lipid and just over 2% of wet brain weight. Diagnostic proton 
resonances in the triglyceride glycerol backbone were assigned from the one 
dimensional and two-dimensional COSY 45 proton spectra (Figures 3. 2. 20 and 
3. 2. 22 respectively). The signal at 5.20 ppm was assigned to the triglyceride 
glycerol Sn2 methine proton in close agreement with Sn2 methine protons in 
corresponding diacyl phospholipids (Section 3. 2. I). This resonance was 
observed to couple to signals at 4.08 and 4.25 ppm in the COSY 45 spectrum, 
both of which were doublets of doublets with geminal coupling constants of 12.4 
Hz in addition to vicinal coupling constants of 6.6 and 4.4 Hz respectively (Figure 
3. 2. 21). Consequently these signals were assigned to the Snlu/Sn3u  and 
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Figure 3. 2. 22 Homonuclear shift-correlated spectrum (COSY 45) of isolated lioomateous 
abnormality at 600 MHz. 
Spectra where acquired as described in Experimental. Metabolite resonances were referenced to 
the N-acetyl aspartate methyl singlet at 2.02 ppm. This spectrum confirms the identity and allows 
the elucidation of the fatty acid composition of the purified triglyceride. 
Proton NMR spectroscopy analysis provided additional information on 
triglyceride fatty acid composition. With reference to in vitro proton NMR 
spectroscopy studies of acidic lipids (Section 3. 2. 1 .): 
the observation of an wi-methyl proton resonance at 0.80 ppm confirmed the 
presence of terminally saturated fatty acids; 
the absence of a signal at 0.92 ppm argued against the presence of n-3 fatty 
acids such as docosahexaenoic acid (C226); 
the absence of a signal at 1.65 ppm argued against the presence of 
arachidonic acid (C 0.4); 
the absence of a broad signal at 2.79 ppm argued against the presence of 
poly-unsaturated fatty acids; 
the observation of a triplet resonance at 2.69 ppm suggested the presence of 
linoleic acid (C18 1). 
The total degree of unsaturation was afforded by the integral of the signal at 5.27 
ppm and in the absence of resonances from poly-unsaturated fatty acids at 2.79 
ppm the degree of mono-unsaturation was determined by subtracting the area of 
the peak at 2.69 ppm (di-unsaturated linoleic acid) from that at 5.27 ppm. The 
resonance at 2.25 ppm afforded a measure of total fatty acids present. Thus, 
following adjustment for proton contributions to signal intensities the relative 
proportions of saturated and unsaturated fatty acids were calculated. 
Two-dimensional COSY 45 NMR spectroscopy of the above purified lipid 
extract, in addition to mass spectrometry analysis of fatty acid methyl ester 
derivatives (results not shown), provided support for the inference that linoleic 
acid was the most probable candidate for the prominent di-unsaturated fatty acid 
resonance at 2.69 ppm. The ratio of the vinyl peak at 5.27 ppm to the C2 fatty 
acid methylene resonance at 2.25 ppm indicated that linoleic acid was not the 
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Chemical shift /ppm Functional group Proton intensity 
0.80 col-CH3 (sat., n-6, n-9) 104 
1.18- 1.22 methylene envelope nd 
1.54 -CHCH7CH7COO nd 
1.94 -CH,CH=CHCH,- 70 
1.97 -(CH,)CH,CH=CH- 31 
2.25 -CH2CH2CH,C00 71 
2.69 -CH=CHCH2CH=CH- 14 
4.08 Sn ith/Sn3u nd 
4.25 Sn 1d/Sn 3( nd 
5.19 Sn2 nd 
5.26 -CH=CH- 66 
Table 3. 2. 4 In vitro 'H NMR spectroscopy analysis of purified triglyceride from a suspected 
case of spontaneous lipoma at 600 MHz. 
In vivo cerebral 'H NMR analysis of a control mouse revealed a broad resonance over 1.2 to 
1.35 ppm. HPTLC analysis suggested the presence of high levels of triglyceride in the same. 
Cerebral lipids from this mouse were subsequently analyzed by in vitro 'H NMR spectroscopy. 
For description of procedure see Experimental. The intensity of the proton resonances 
tabulated above are expressed in arhitary units. 
The presence of two sets of doublets of doublets at 4.08 and 4.25 in the 'H NMR spectrum 
strongly supported the HPTLC diagnosis of triglyceride. 
nd, not determined. 
With reference to proton contributions to the above peaks, the fatty acid composition of the 
isolated triglyceride was deduced: 
Total fatty acids contribute 71 units (-CH2CH2COO-); 
Total unsaturated fatty acids contribute 66 units (-CH2-CH=CH-CH,); 
Poly-unsaturated fatty acids - absent; 
Linoleic acid (C,8.2) contributes 14 units (-CH=CH-CH,-CH=CH-), and thus 28 units to total 
unsaturated fatty acids (-CH=CH-CH,-CH=CH-); 
By deduction mono-unsaturated fatty acids comprise (66 - 28) = 38 units: 
By deduction saturated fatty acids comprise (71 - 14- 38) = 19 units; 
Therefore the ratio of saturated: mono-u,i sat u rated: di- unsaturated = 19:38:14 
only unsaturated fatty acid present with mono-unsaturated fatty acids also in 
appreciable quantities. On the basis of relative peak intensities (Figure 3. 2. 20), 
it was speculated that part of the broad resonance centered at 1.95 ppm was 
attributed to methylene protons on either side of the vinyl groups in linoleate [-
CH2-CH2-CH=CH-CH7-CH=CH-CH,-CH2-], and that the slightly more intense signal 
centered at 1.94 ppm was attributed to similar protons in mono-unsaturated fatty 
acids [-CH2-CH2-CH=CH-C2-CH2-]. Thus comparison of the integrals of the signals 
at 1.97 and 1.94 ppm gave a measure of the relative proportions of di-unsaturated 
and mono-unsaturated fatty acids respectively. Finally in the absence of 
appreciable poly-unsaturated fatty acid signals, the proportion of saturated fatty 
acids was assessed by subtracting the contribution made by unsaturated fatty acid 
resonances to the total fatty acid signal at 2.25 ppm. This revealed that saturated 
components made a significant contribution to the proton spectrum of the 
triglyceride. A summary of the above findings is given in Table 3. 2. 4. 
Inferences. 
The origin of the triglyceride abnormality is speculative, however its visualization 
by in vivo proton MRS would suggest that the lipid accumulation occurred in an 
environment markedly different to that normally experienced by intracerebral 
lipid. It is considered that this property coupled with the relatively large 
proportion present (18% of total cerebral lipid) made its non-invasive detection 
possible. 
An increase in lipid methylene envelope 'H MRS T2 relaxation time behaviour has 
been noted in suspensions of cancer cells and excised tumours following the 
acquisition of metastatic competence, i.e. ability to generate secondary tumours 
(Mountford ci' al.. 1984). Chemical analysis of the above adenocarcinoma cell 
lines showed triglyceride to comprise a significant proportion of plasma 
membrane lipids (May et al., 1986). In this respect it was interesting to note that 
the frequency incidence of the triglyceride abnormality (approximately I %) was 
similar to that reported for spontaneous astrocytoma in VM mice (Fraser, 1986). 
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A hypothesized relationship between the occurrence of astrocytoma and an 
elevation in triglyceride was investigated by the examination of cerebral lipid 
profiles in twelve VM mice which had received an intracei-ebral inoculation with 
an aliquot of a cell suspension derived from a case of spontaneous astrocytoma 
(Fraser, 1980). Brains were divided sagittally, one half was examined 
histologically to confirm the presence of astrocytoma and the other half 
underwent solvent extraction and high performance thin layer chromatography 
analysis. Although histological examination confirmed that all brains exhibited 
astrocytomas, h.p.t.l.c. analysis failed to identify any lipid abnormalities (results 
not shown). It was therefore concluded that spontaneous astrocytoma was not a 
probable cause for this pathology-linked elevation in triglyceride. 
An alternative explanation for the incidence of a large triglyceride deposition is 
offered by the occurrence of a relatively benign spontaneous intracerebral liporna. 
Such tumour-like lesions have been reported to be the most commonly occurring 
neoplasms in the brains of laboratory mice (Morgan et at., 1984) and in this 
particular strain ranking second only to the occurrence of spontaneous 
astrocytoma (Fraser, 1980). Lipomas, consisting of lobules of adipose tissue 
separated by fibrous bands and septa, are the result of dysraphic malformations 
during early embryogenesis (Greenfield, 1976). Embryonic cell lines have been 
reported to display properties of high resolution NMR relaxation behaviour (May 
et al., 1986). It is thus presumed that morphogenic accumulations of adipose 
tissue could possess similar properties. As such this hypothesis provides the most 
plausible explanation for the origin of the lipid abnormality observed by in vivo 
'H NMR spectroscopy. 
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3. 2. 6 A Summary of the MRS Analysis of Cerebral Metabolites in Scrapie-
Affected and Control Mice. 
Acetone-Soluble Metabolites. 
The study of acetone-soluble metabolites in scrapie-affected and control mice 
revealed three statistically significant differences. A reduction in cerebral levels 
of N-acetyl aspartate in scrapie animals is believed to be indicative of neuronal 
loss/dysfunction, likewise a more modest reduction in levels of glutamate may 
mirror extensive damage to regions of the brain in which this excitatory amino 
acid serves an important function, e.g. in the hippocampus. Both inferences are 
consistent with the neuropathology exhibited by this murine-scrapie model 
(Fraser and Dickinson, 1968). An explanation for the observation of a prominent 
elevation in cerebral inositol concentration was not forthcoming, however the 
report of a similar finding in parietal white matter regions of a patient with CJD 
(determined by in vivo MRS) raises an important question as to the significance 
of this abnormality with regards to TSE disease status. 
Although an aqueous extraction protocol was developed which afforded a high 
degree of spectral resolution and reproducibility, the presence of the 'scrapie-
specific multicomponent peak' was not detected and attention was therefore 
focused on changes in non-aqueous metabolites - with special reference to lipids. 
Non-aqueous Metabolites. 
Extensive attention was given to the assignment of cerebral lipid resonances in in 
vitro 'H, '3C and 31 P NMR spectra. Comparison of scrapie and control non-
aqueous extracts by a combination of the aforementioned techniques failed to 
identify any significant changes in the concentrations of prominent cerebral lipids. 
In addition, the inability to detect a quantitative lipid change over the 1 .5 to 1.8 
ppm region served as a serious impediment to the elucidation of the nature and 
origin of the component(s) responsible for the in viva signal. Although it was 
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speculated that the multicomponent signal was attributed to mobile lipid, it was 
noted that the frequency over which this broad resonance was detected was 
significantly downfield (i.e. at a higher chemical shift) of documented lipid 
disturbances detected by similar in vivo 'H MRS experiments (Davie et al., 1993; 
Larsson et al., 1991; Koopmans et al., 1993). Additional support in disproof of 
the 'mobile lipid' hypothesis was afforded by the detection of what was 
speculated to be a spontaneous lipoma in a control VM mouse. This lipid 
abnormality was detected by in vivo 'H MRS and subsequently characterized 
following in vitro 'H MRS, high performance thin layer chromatography and 
mass spectrometry analysis. 
The incidental occurrence of the above triglyceride abnormality presented a 
unique opportunity to assess the ability of in vitro NMR spectroscopy to 
characterized an intracerebral lipid change. However of considerable importance 
to these studies was the finding that this marked lipid disturbance could be 
detected non-invasive by in vivo proton MRS. As such this broad signal over the 
.15 to 1.40 ppni chemical shift region was entirely consistent with the position 
of resonances from methylene envelope protons as assigned in in vitro lipid 
spectra (Section 3. 2. 1). The attribution of the 'scrapie-specific' 
multicomponent resonance to lipid, be it mobile or otherwise, was consequently 
viewed with sceptism. The absence of an alternative hypothesis for the origin of 
the scrapie-specific signal coupled with our frustrating inability to detect the 
signal in vitro did not assist further studies. It was at this stage of perplexity that 
Bell and colleagues reported the presence of the multicomponent peak in control 
as well as scrapie animals with a random and haphazard distribution (Progress 
Report AFRC Grant LRG 103/503 - April 1993). Understandably the 
continuation of investigations in this area were suspended pending clarification of 
the original results. 
Further lipid analysis was performed by high performance thin layer 
chromatography. This line of investigation is explored in Section 3. 3. 
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3. 3 High Performance Thin Layer Chromatography Analysis of Cerebral 
Lipids. 
The study of cerebral lipid changes in the transmissible spongiform 
encephalopathies Creutzfeldt-Jacob disease and scrapie have received earlier 
discussion (Section 1). Although it would appear that various lipid abnormalities 
are present in OD-affected brain tissue from human patients (Ando et al., 1984; 
Bass etal., 1974; Korey etal., 1961), chimpanzees (Yu et al., 1974) and guinea 
pigs (Yu and Manuelidis, 1978), similar findings are not observed in scrapie-
affected hamsters (Dees etal., 1985) or mice (Tamai etal., 1978). 
The ability to draw constructive conclusions from the aforementioned scrapie 
studies have been hampered by the singular number of hamster- and murine-
scrapie models examined and by the relatively non-precise analytical techniques 
employed. In addition, contradictory reports of lipid abnormalities in the same 
scrapie models by other authors (Di Martino et al., 1993; Mackenzie and Wilson, 
1966) raise serious questions as to the consistency and validity of the earlier 
findings. 
In view of these discrepancies and in the light of the speculated detection of a 
scrapie-specific lipid abnormality by in vivo NMR spectroscopy, the cerebral lipid 
composition of a number of murine-scrapie models were investigated in a 
quantitative and comparative manner. For this purpose high performance thin 
layer chromatography was employed in conjunction with the in vitro NMR 
spectroscopy experiments described previously. In our consideration h.p.t.1.c. 
offered distinct advantages over NMR spectroscopy in that lipid species were 
readily separated, observed and quantified. In addition the improved sensitivity 
of lipid detection associated with this technique permitted the observation of a 
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Figure 3. 3. 1 I-IPTLC analysis of neutral (top figure) and acidic (bottom figure) cerebral lipids. 
Cerebral lipid fractions were analyzed as described in Experimental. Lanes I - 3 cerebral lipid 
extracts, lane 4 authentic lipids. CARD, cardiolipin; CB I. cerebroside I; CB II, cerebroside 11; 
CE. cholesteryl ester; CHOL, cholesterol; DAG, diacylglycerol; FA, fatty acid; OA, oleyl alcohol 
(internal standard); PC, phosphatidyl choline; PE, phosphatidyl ethanolamine; P1, phosphatidyl 
inositol; PS, phosphatidyl serine: SPH, sphingomyelin; SULF I, sulfatide I; SULF 11, sulfatide II; 
TAG, triacylglycerol. 
3. 3. 1 Detection and Characterization of a Lipid Abnormality in Scrapie-
Affected Mice. 
Results. 
High performance thin layer chromatography studies were performed on VM 
mice affected with the ME7 scrapie strain at the late clinical stage of the disease 
(346 ± 3 days p.i.). Cerebral lipids from these animals were compared with an 
equal number of age- and sex-matched controls. Lipid species were identified on 
the basis of polarity and acidity by their co-migration with authentic lipids on an 
h.p.t.l.c. silica plate (Macala et al., 1985). The neutral lipid fraction contained: 
cholesteryl esters, triglycerides, diglycerides, cholesterol, gal actocerebros ides I 
and II, ethanolamine phospholipids and choline phospholipids (including 
sphingornyelin) (Figure 3. 3. la), and the acidic lipid fraction: cardiolipin, 
sulfatides I and II, serine phospholipids and inositol phospholipids (Figure 3. 3. 
lb). Quantification of cerebral lipids was performed following charring by laser 
scanning densitometry and with reference to standard lipid calibration curves 
(Macala et al., 1985; Section 2. 5). 
A comparison of scrapie and control animals showed that the majority of 
cerebral lipids remain essentially unchanged, indeed no statistical difference was 
detected in levels of the prominent neutral lipids: cholesterol, cerebrosides, 
ethanolamine phospholipids and choline phospholipids (including sphingomyelin), 
or in the prominent acidic lipids: cardiolipin, sulfatides, serine phospholipids and 
inositol phospholipids (Table 3. 3. 1). In contrast a highly significant elevation 
was detected in the concentration of a minor, non-polar, neutral lipid in scrapie-
affected material which co-migrated with authentic cholesteryl oleate (Figure 3. 
3. 2). As such, this lipid abnormality provided a candidate compound for the 
neutral fat accumulations observed in mice affected with scrapie by histological 
techniques (Mackenzie and Wilson, 1966) and which were speculated to arise 
from the breakdown of brain lipids (Kimberlin and Millson, 1967). In this regard, 
and consistent with the above combination of features, an elevation in cholestery] 
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Figure 3. 3. 2 HPTLC demonstration of a non-polar, neutral lipid abnormality in scrapic-
affected mice. 
Cerebral lipid fractions were analyzed as described in Experimental. Lanes I - 4 control cerebral 
lipid extracts, lanes 5 - 8 scrapie cerebral lipid extracts. Lipid abbreviations are as previously 
listed. Note the elevated levels of cholesteryl esters. 
esters was initially hypothesized to be the most probable source of the scrapie-
specific multicomponent resonance detected by in i,hyo 'H NMR spectroscopy 
(Bell et al., 1991). 
The nature of this lipid was confirmed to comprise cholesteryl esters following its 
isolation by bonded phase column chromatography on arninopropyl silica SEP 
PAK columns and subsequent characterization by chemical ionization mass 
spectrometry (Section 2. 6). Preliminary electron impact studies of the purified 
material revealed the presence of an ion fragment with a in/z ration of 369. 1. A 
similar ionic species was identified in the electron impact mass spectrum of 
authentic cholesterol and was attributed to the 'cholesterol minus water' 
molecular ion. The possibility of this lipid abnormality being attributed to free 
cholesterol was considered negligible in view of the fact that the isolated lipid 
eluted more readily than cholesterol in a non-polar solvent system (R1  purified 
lipid = 0.76, Rcholesterol = 0.12; hexane/diisopropyl ether/acetic acid (65:35:2, 
by vol.). As such these results provided circumstantial evidence to suggest that 
the elevated lipid was cholesterol-containing. 
Subsequent studies were performed on pooled fractions isolated from three 
scrapie (ME7/VM) and three control (VM) mouse brains of similar age and 
gender. Chemical ionization mass spectrometry of the above samples revealed 
high mass ions with in/z ratios between approximately 600 and 740, these being 
particularly well distinguished in the scrapie fraction as a result of the elevated 
quantity of lipid present (Figures 3. 3. 3a/b). Tandem mass spectrometry (MS-
MS) of the prominent ions at 614.6, 642.6 and 668.6 showed all to possess a 
daughter (or product) ion with a m/z ratio of 369, which was also present in the 
MS-MS spectrum of authentic cholesteryl oleate and consistent with the 
'cholesterol minus water' structure described above. This information provided 
conclusive evidence that the molecular ions with n,/z ratios between 614.6 and 
7 14.6 were attributable to cholesteryl esters. In view of this finding the scrapie- 
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Figure 3. 3. 3 Cl-MS of cholesteryl esters from control (top figure) and scrapie-affected (bottom 
figure) mice. 
Cholesteryl esters were purified and analyzed by Cl-MS as decribed in Experimental. Scrapie 
fractions contain appreciably more cholesteryl esters than controls. Significant changes were 
observed between the two fractions in cholesteryl myristate, cholesteryl oleate, cholesteryl 
linoleate, cholesteryl arachidonate and cholesteryl docosahcxaenoate. Levels of cholesteryl 
palmitate, cholesteryl palmitoleate and cholesteryl stearate remained essentially unchanged. 
specific cholesteryl ester abnormality was quantified by h.p.t.l.c. with reference to 
the staining properties exhibited by cholesteryl oleate (Table 3. 3. 1). 
Having confirmed the nature of the lipid abnormality it was found that normal 
adult control VM mice contain low levels of cholesteryl esters in their brains (60 
± 5 ig cholesteryl ester/g wet brain weight), representing less than 0. 1 % of total 
brain lipids and approximately 0.33% of the concentration of cerebral cholesterol. 
In contrast, VM mice affected with the ME7 strain of scrapie exhibit elevated 
levels of cholesteryl esters (250 ± 40 jig cholesteryl ester/g wet brain weight) 
representing 0.33% total brain lipids and 1.6% of the concentration of cerebral 
cholesterol. 
The molecular ions with ,n/z ratios of 614.6, 642.6 and 668.6 in the Cl-MS 
spectra, were attributed to cholesteryl myristate (C14.0), cholesteryl palmitate 
(C16:0) and cholesteryl oleate (C18:1) respectively. A number of less prominent ion 
species were also present, these corresponding to cholesteryl palmitoleate (C161, 
m/z 640.6), cholesteryl linoleate (C132, m/z 666.6), cholesteryl stearate (C18.0, m/.z 
670.6), cholesteryl arachidonate (C204, m/z 690.6), cholesteryl arachidate (C201 , 
rn/z 696. 1) and cholesteryl docosahexaenoate (C22:6, 171/z 714.6). The percentage 
contribution that these esters made to the cerebral lipid fraction was calculated as 
a proportion of the endogenous cholesteryl oleate peak (Table 3. 3. 2). The 
composition of prominent esters, notably cholesteryl stearate, oleate, palmitate 
and palmitoleate, appear relatively constant between samples. However a 
reduction in the proportion of cholesteryl linoleate was noted in the scrapie 
isolate with respect to control levels. The significance of this latter finding is 
unclear. 
Inferences. 
The cholesteryl ester abnormality was initially viewed with a degree of interest as 
it presented a potential candidate for the in vivo MRS observation (Bell et al., 
1991). This hypothesis, although attractive, was discounted on the basis of two 
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ME7/VM 87VIVM 301 V/VM VM 
Neutral lipids  
Cholesteryl esters 0.25 ± 0.04 0.12 ± 0.02 0.06 ± 0.03 0.06 ± 0.01 
Cholesterol 22.68 ± 1.69 21.72 ± 3.48 20.38 ± 1.16 21.22 ± 2.67 
Cerebroside 1 9.89 ± 0.39 9.59 ± 1.31 7.33 ± 0.70 8.56 ± 1.24 
Cerebrosidefl 3.77±0.19 3.49±0.44 2.91 ±0.44 3.51 ±0.48 
Ethanolamine 22.43 ± 3.38 
PL.  
21.56± 2.52 26.63 ± 3.35 24.13 ± 0.88 
Choline PL. 23.79 ± 0.50 20.25 ± 1.72 27.93 ± 6.88 21.00 ± 1.92 
Sphingomyelin 2.23 ± 0.08 2.85 ± 0.31 2.99 ± 1.16 2.57 ± 0.23 
Acidic _lipids  
Cardiolipin 4.62 ± 0.93 5.78 ± 1.16 4.07 ± 1.31 5.33 ± 1.48 
Sulfatidel 3.18±0.82 2.76±0.55 1.39±0.28 1.70±0.63 
Sulfatide II 4.19 ± 0.94 3.67 ± 0.80 2.28 ± 0.38 2.91 ± 1.03 
Seri nePL- 12.09 ±3.48 12.33 ±2.35 13.04± 1.76 10.78±4.99 
Inosito1PL. 3.75± 1.12 3.88±0.76 3.88±0.67 3.01 ± 1.33 
Wet brain weight 336 ± 1 
/g  
378 ± 17 406 ± 2 415 ± 36 
Incubation period 346 ± 3 
/days  
290 ± 4 120 ± 7 350 
Table 3. 3. I I-IPTLC analysis of cerebral lipids in three murine-scrapie models with 
comparison to controls. 
Cerebral lipids were extracted from between four and five mice per group. The above values 
are expressed as mean ± sem in pg lipid/- wet brain weight. Lipids were quantified with 
respect to calibration curves of authentic lipid standards as described in Experimental. 
Levels of cholesteryl esters in ME7-affected VM mice are markedly elevated in the late-
clinical stage of the disease. This change in cholesleryl esters is perhaps unsurprising when 
one considers that this murine-scrapie model exhibits highly significant neurological damage 
as indicated by depreciation in wet brain weight. Levels of other lipids remained essentially 
unchanged between control and scrapie animals. 
facts. Firstly, the quantitative change in cholesteryl esters was very small, i.e. in 
the region of 190 .ig lipid/- wet brain weight. In consideration of the relative 
insensitivity of the NMR technique, an abnormality of this magnitude would not 
be readily detected by in viva proton NMR spectroscopy. Secondly, the chemical 
shift range over which methylene protons in cholesteryl esters resonate in a 
proton spectrum is considerably upfield (i.e. at a lower chemical shift) of that 
reported for the in viva scrapie multicomponent signal. In conclusion, the above 
features did not support the case for a cholesteryl ester origin to the in viva 
multicomponent MRS signal, indeed the latter observation argued strongly 
against the presence of lipid in the hypothesized 'mobile lipid' signal (Section 3. 
2.4). 
Cholesteryl esters accumulate in a wide range of neurodegenerative disorders 
(Borri et al., 1969; Maggio, et al., 1972; Mezei, 1970; Norton et al., 1966). In 
these, the central event culminating in the accumulation of neutral lipid involves 
damage to myelin. Myelin is a lipid-rich extension of the oligodendrocyte cell 
body arranged as a multilamella spiralling structure around an axon. As such, this 
structure functions to insulate the axon and facilitates saltatory conduction along 
the same (Landowne et al., 1975). Demyelination typically takes one of two 
forms, either primary or secondary, depending on whether the pathological insult 
is to the myelin sheath or the neuronal cell body. Irrespective of the cause, the 
process of demyclination always presents the same features. The earliest 
recognizable histological change is swelling of the myelin sheath followed by the 
appearance of intracellular vacuoles. As the myelin sheath disintegrates, lipids are 
released in the extracellular space and are subsequently engulfed by phagocytic 
cells of the central nervous system - microglia and/or macrophages. Cholesterol 
released from the breakdown of myelin is converted into cholesteryl esters by 
combination with fatty acids released from phospholipids and stored as 
intracellular droplets (Ramsey, 1973). The accumulation of cholesteryl esters is 
likely to arise from an imbalance between the rate of lipid flux in myelin formation 
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Cholesteryl ester fatty acid 
composition  
Control Scrapie 
C14.0 2.7 5.9 
C160 25.8 29.4 
C16.1 7.6 9.8 
C18.0 1 0.4 11.4 
C181  27.1 31.3 
C182 19.0 7.4 
C20.1 0.8 1.9 
C204 3.6 1.6 
C22 6 3.0 1.3 
Table 3. 3. 2 A comparison of the fatty acid composition of cerebral cholesteryl esters from 
control and scrapie-affected (ME7IVM) mice. 
Cholesteryl esters from pooled control and pooled scrapie tissue were purified over 
aminopropyl silica SEP PAK columns and analyzed by chemical ionization mass spectrometry 
(see Experimental). Values represent the percentage proportion that individual cholesteryl 
esters made to the total cerebral cholesteryl ester isolate. 
Significant changes were observed between control and scrapie fractions in cholesteryl 
myristate, cholesteryl oleate, cholesteryl I inoleate, cholesteryl arachidate, cholesteryl 
arachidonate and cholesteryl docosahexaenoate. Levels of cholesteryl pal mitate, cholesteryl 
palmitoleate and cholesteryl stearate remained essentially unchanged. 
and maintenance on the one hand, and degenerative changes resulting in 
demyelination on the other. 
Animals affected with scrapie typically exhibit pathological changes consisting of 
neuronal vacuolation, loss of neurons and astrocytosis (Fraser, 1969). The 
histopathological features of brain lesions in the ME7/VM murine-scrapie model 
have been extensively documented (Fraser, 1969; Fraser & Dickinson, 1968). In 
this, lesions in the form of neuronal vacuolation are initially evident after an 
incubation period of approximately 21 weeks. The distribution and concentration 
of the lesions increases in grey matter regions, notably the thalarnus (inasa 
interinedia and central nuclei) and septa] nucei of the paraterminal body until 
approximately 49 weeks when animals die. In view of the intimate association 
between axons and oligodendrocytes within the CNS, such neurodegenerative 
changes must be accompanied by some degree of Wallerian degeneration 
(secondary demyelination), The extent of the cholesteryl ester change (0.08% 
total lipids, control mice; 0.33% total lipids, scrapie mice) would suggest that 
demyelinating events are minimal. In support of this presumption, Fraser and 
Dickinson (1968) reported negligible vacuolation in white matter regions in this 
model. In addition, changes in levels of cholesterol, cerebrosides and 
phospholipids (the major components of myelin) are insignificant as determined 
by h.p.t.l.c. (Table 3.3. 1). 
Although the process of secondary dernyelination provides the most logical 
explanation for the accumulation of cholesteryl esters, an alternative mechanism 
culminating in their production may exist. Evidence for this alternative 
hypothesis focuses on the fatty acid composition of cholesteryl esters in a number 
of aetiologically unrelated demyelinating disorders (Borri et at., 1969; Gerstl et 
at., 1966; Norton et al., 1966; Suzuki et at., 1969; Sweasey & Patterson, 1974). 
It would appear that regardless of the nature of the disease the fatty acid 
composition of the esters are remarkably similar (Eto & Suzuki, 1971; Ramsey, 













VM(control) 60± 10 415±36 none - 
ME7IVM 250 ± 35 366 ± 1 4, 5, 7. 9 346 ± 3 
87VIVM 120 ± 20 378 ± 17 (2.73 to 5) 290 ± 4 
301V/VM 60±30 406±2 (2.67to1) 120±7 
SV (control) 40 ± 10 468 ± 4 none - 
ME7/SV 50±10 457±10 7 178±1 
79AISV 140±40 423 ±28 P, 3* 153 ±2 
22AISV 40±10 424± 2 none 441±2 
C57BL (control) 60 405 none - 
79A1C57BL 340 291 3* 161±2 
22L/C57BL 60 367 none 170 ± I 
Table 3. 3. 3 A comparison of cerebral cholesteryl ester concentrations in three murine-
scrapie models and its relationship to neuropathological damage and disease incubation 
period. 
Cholesteryl ester concentrations were determined in eight murine-scrapie models by HPTLC 
(see Experimental). Values are expressed as mean ± sem. Cholesteryl ester concentration is 
given as ig lipid/g wet brain weight. Wet brain weight is given in grammes. Incubation 
period is given in days. 
The vacuolar degeneration scores are based on the Fraser and Dickinson (1968) system. The 
above grey matter areas are: I, dorsal medulla; 4, hypothalamus; 5, medial thalamus; 7. 
septum; 9 medial cerebral cortex at the level of the septum. The above white matter areas are: 
1* cerebellar white matter; 3* pyramidal tract. 
Statistically significant changes in cholesteryl ester concentration were detected in the 
ME7/VM, 87V1VM, 79AISV and 79A/C57BL murine-scrapie models with respect to their 
comparative controls. 
Patterson, 1974). A comparison of the major cholesteryl esters present in 
cerebral tissue from a 90 day old piglet (control), VM mice (control), ME7/VM 
mice, and the demyelinating disorders: multiple sclerosis, chronic scierozing 
panencephalitis, border disease, delayed swayback, congenital tremors types All 
and API, sudanophilic leucodystrophy and Tay-Sachs disease clearly indicates 
that although concentrations of cholesteryl oleate are markedly elevated in the 
demyelinating diseases (Sweasey and Patterson, 1974), the same is not true in 
ME7-affected VM mice, despite the presence of a 300% elevation of cholesteryl 
esters. Indeed the percentage proportion of cholesteryl oleate appears similar in 
control VM mice, ME7/VM mice and the 90 day old piglet. 
The previous discussion of demyelination and cholesteryl ester accumulation 
focuses on the role of microglia and/or macrophages as the 'lipid-scavenging' 
cells of the central nervous system. These cells operate in the presence of 
inflammatory mediators to phagocytose components of ol igodendrocytes (Zaj icek 
et al., 1992). However, in the absence of an inflammatory response as seen 
during transmissible spongiform encephal opathy pathogenesis (Bolton & 
Bendheim, 1988), does the same mechanism operate? Growing evidence is 
accumulating that astrocytes assume the function of microglia in attempting to 
repair neuronal damage in the absence of inflammation (Diedrich et al., 1991). 
As such these cells produce high levels of apolipoprotein E, presumably in an 
attempt to retain myelin breakdown products, i.e. lipids, at the site of injury 
(Mahley, 1988). Assuming that astrocytes also perform the function of 
microglialmacrophages in the phagocytosis and processing of cholesterol to 
cholesteryl esters, is it not possible that subtle changes in intracellular metabolic 
pathways may produce cholesteryl esters in different proportions to those 
normally produced by rnicroglialmacrophages in Wallerian degeneration? In 
support of this hypothesis is the finding that in the scrapie fraction the proportion 
of cholesteryl oleate is unchanged and that of cholesteryl linoleate (C18 2) is 
markedly reduced relative to control levels. Detectable changes were also 
present in the proportions of minor cholesteryl esters, notably: cholesteryl 
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myristate (c14:u),  cholesteryl arachidate (C20j), cholesteryl arachidonate (C204) 
and cholesteryl docosahexaenoate (C22:6) (Table 3. 3. 2). To our knowledge the 
investigation of intracellular lipid accumulations in astrocytes during scrapie 
pathogenesis has not been performed but presents an area for future research. 
The relationship between the accumulation of cholesteryl esters and 
demyelination was investigated by measuring the activity of the myelin-specific 
enzyme neutral cholesteryl ester hydrolase (EC. 3.1.1 .13) in ME7/VM mice at the 
terminal stage of the disease. This was performed in conjunction with the 
determination of lactate dehydrogenase activity for comparative purposes 
(Section 3. 4). 
In addition to the above, the relationship between changes in cholesteryl ester 
concentrations and neuropathological damage was assessed by the comparison of 
cerebral cholesteryl esters in a total of eight murine-scrapie models (each at the 
terminal stage of disease). Changes, if present, were correlated with site-specific 
vacuolation scores, the degree of wet brain weight reduction, and the scrapie 
incubation period (Bruce et al., 1991; Fraser and Dickinson, 1968) (Section 3. 3. 
2). 
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3. 3. 2 Cholesteryl Ester Concentrations and Neurological Lesions in Eight 
Murine Models of Scrapie. 
Results. 
The ME7, 87V and 301  scrapie strains were propagated in VM (Sinc p7p7 
genotype) mice to investigate the relationship between neurological damage, 
changes in lipid composition (as assessed in vitro) and the in vivo MRS 
multicomponent resonance described by Bell et al. (199 1) during the progression 
of the disease. The ME7/VM model was sampled at 40, 180, 300 and 346 days 
post injection (p.i.), the 87V/VM model at 47, 85, 200 and 288 days p.i., and the 
301 V/VM model at 25, 50, 75 and 106 days p.i. 
None of the above murine-scrapie models displayed significant changes in 
cholesterol, phospholipids or glycolipids at any time during the disease (data not 
shown). Changes were however detected in concentrations of cholesteryl esters 
in the ME7/VM and 87V/VM models; these abnormalities occurring in the 
ME7/VM model at 300 and 346 days p.i. and in the 87V/VM model at 288 days 
p.i. A comparison of the cerebral lipid composition in these three murine-scrapie 
models at their respective terminal stages of disease is shown in Table 3. 3. 1. 
Five other murine-scrapie models, exhibiting different degrees of neurological 
damage, were examined for elevated concentrations of cerebral cholesteryl esters. 
The ME7, 79A, 22A and 22C scrapie strains in SV and C57BL mice were chosen 
for comparison, as these produce extremes of vacuolar damage in well defined 
neuroanatomical regions (Bruce et al., 1991). The results of the analysis of 
cholesteryl ester levels in eight murine-scrapie models relative to wet brain 
weight, degree of neurological damage, and disease incubation period, are 
displayed in Table 3. 3. 3. Significant elevations were detected in cholesteryl 
ester concentrations in the ME7/VM, 87V/VM, 79A/SV and 79A1C57BL models 
in the late clinical stage of the disease, in contrast significant changes were not 
observed in the 301 V/VM, ME7/SV, 22A/SV and 22C/C57BL models. 
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Lesion profiles in VM mice affected with the 
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Figure 3. 3. 4 Lesion profiles in eight murine-scrapie models. 
The vacuolar degeneration scores (lesion profiles) are based on the Fraser and Dickinson (1968) 
system. The grey matter areas are: I, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 
4, hypothalamus; 5, medial thalamus; 6, hippocampus; 7, septum; 8, medial cerebral cortex at the 
level of the thalamus; 9, medial cerebral cortex at the level of the septum. The white matter areas 
are: 1,  cerebellar white matter; 2*,  white matter of the mesencephalic tegmentum; 3*,  pyramidal 
tract. 
Figures reproduced with permission. 
Inferences. 
The absence of appreciable changes in prominent cerebral lipids in mice 
terminally-affected with scrapie is consistent with past results (Dees et al., 1985; 
Guan et al., 1996; Kimberlin and Millson, 1967). However, the detection of 
changes in cerebral cholesteryl esters, although reported in human patients with 
CJD (Ando et al., 1984; Tamai et al., 1978), has not been described in murine-
scrapie models. 
In the following discussion extensive reference is made to murine-scrapie model 
'lesion scores' in specific brain regions (Bruce etal., 1991; Fraser and Dickinson, 
1968). In order to clarify the reader's understanding of the lesion score concept, 
a brief summary of the various scores is given in relation to the extent of vacuolar 
damage. A lesion score of: (1.0) - indicates "a few vacuoles, widely and unevenly 
scattered", (2.0) - indicates "a few vacuoles evenly scattered", (3.0) - indicates 
"moderate numbers of vacuoles, evenly scattered", (4.0) - indicates "many 
vacuoles with some confluence", and (5.0) - indicates "dense vacuolation with 
most of the field confluent" (Fraser and Dickinson, 1968). 
The ME7/VM model, in which the initial cholesteryl ester elevation was 
identified, exhibits lesion scores > 3.0 in the hypothalamus, medial thalamus 
(4.21), septum (4.10) and medial cerebral cortex at the level of the septum, at the 
terminal stage of the disease (346 days p.i.) (Figure 3. 3. 4). As such, this degree 
of neurological damage is consistent with the proposed relationship between 
neurodegenerative changes and an elevation in cerebral cholesteryl esters. The 
same model sampled at 300 days p.i. also shows significant changes in cholesteryl 
esters (180 ± 60 ig/g wet brain weight). Although neurological damage at this 
time is not as extensive as later on in the disease, lesion scores of 2.10 and 2.40 
are present in the hypothalamus and septum respectively. It is proposed that the 
prolonged progression of spongiform damage in the ME7/VM model (Fraser and 
Dickinson, 1968) contributes to the accumulation of cholesteryl esters in 
appreciable quantities, which in other models with a more rapid incubation 
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period, may not have sufficient time to occur. This concept is expanded below in 
the discussion relating to neurodegenerative damage in grey matter regions, 
secondary demyelinatiori and elevated levels of cholesteryl esters. 
The 87V scrapie strain in VM mice also displays a significant elevation in cerebral 
cholesteryl ester concentrations at the terminal stage of the disease (180 ± 20 
1g/g wet brain weight; 288 days p.i). The finding that the ME7/VM and 
87V/VM models show reductions in wet brain weight of the magnitude 12% and 
9% respectively undoubtedly reflects the severe degenerative changes which 
occur in the brains of these animals. In view of these findings, it is perhaps 
unsurprising that cerebral cholesteryl esters are elevated. 
The 301V/VM murine-scrapie model does not exhibit marked neuropathological 
changes; lesion scores are < 2.0 in all brain regions except the dorsal medulla 
(2.7). Significant changes are not detected in concentrations of cerebral 
cholesteryl esters, nor in post mortein wet brain weight. Thus, in this model at 
least, limited neurological damage coupled with the short incubation period (110 
± 2 days p.i.) does not favour an accumulation of cholesteryl esters. 
Comparison of the above three murine-scrapie models reveals a clear relationship 
between the degree of neuronal vacuolation, the disease-related reduction in wet 
brain weight and the scrapie incubation period. In those murine-scrapie models in 
which the development of brain lesions occurs over a prolonged period of time, 
the accumulation of cerebral cholesteryl esters is more readily detected. In the 
classical experiments investigating secondary demyel ination (Walleri an 
degeneration) as a result of nerve crush or section in the peripheral nervous 
system, elevated levels of cholesteryl esters reach statistical significance at about 
the eighth day post section (Johnson et al., 1949). During the next 24 days as 
rnyelin degeneration releases increasing quantities of cholesterol, the cholesteryl 
ester concentration rises dramatically (Mezei, 1970). One can envisage that a 
similar process exists in the above murine-scrapie models, but with a few 
additional provisos. The histopathological studies of Fraser and Dickinson 
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(1968) report that the primary insult in these murine-scrapie models is to the 
neuronal cell body. In examples of unrelated diseases of the CNS (e.g. rabies) the 
interval between nerve cell necrosis, axonal degeneration and dernyelination 
typically approaches 10 to 21 days (Walt, 1996). Thus in relation to the above 
murine-scrapie models, a period of approximately five to seven weeks may lapse 
between neuronal death and the detection of appreciably elevated levels of 
cholesteryl esters. In this respect, the relatively long incubation periods in the 
ME7/VM and 87V/VM murine-scrapie models coupled with the progression of 
vacuolar damage over approximately 45 to 50% of the incubation period (i.e. 25 
weeks, ME7/VM; 21 weeks, 87V/VM) is believed to favour the accumulation of 
cholesteryl esters, making their detection possible. 
Comparison of the ME7/VM and ME7/SV models illustrates the effect that the 
Sinc gene product has on both neuropathology and cholesteryl ester changes in 
mice which are otherwise genetically identical (Bruce et al., 1991). In the 
former, cholesteryl ester levels reach 250 ± 35 ig/g wet brain weight at 346 ± 3 
days p.i. and a 11.7% reduction in post mortein brain weight is recorded. In 
contrast, the ME7/SV model does not display significant changes in cholesteryl 
esters or post mortem brain weight, and does not exhibit as striking 
neuropathological features as the ME7/VM model (Figure 3. 3. 4), it also has a 
much shorter incubation period (178 ± 1 days). 
Significant changes in cerebral cholesteryl esters are also found in SV and C57BL 
mice affected with the 79A scrapie strain. Both models display limited damage to 
grey matter legions with vacuolation scores barely reaching a value of 2.0 in two 
(SV) and three (C57BL) areas (Figure 3. 3. 4). In contrast, damage to white 
matter regions in both models is highly significant with lesions scores > 3.0 in the 
cerebellar white matter and pyramidal tract in the 79A/SV model, and a lesion 
score> 3.5 in the pyramidal tract in the 79A/C57BL model. Although a lesion 
score of > 3.5 is only found in the pyramidal tract of the 79A1C57BL model, 
neurological damage must be extensive as construed from the highly significant 
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reduction in wet brain weight at the terminal stage of the disease (C57BL, 405 g; 
79A/C57BL, 291 g). This change is mirrored by a cholesteryl ester elevation in 
scrapie brain in excess of 500% of control levels (C57BL, 60 Jg/g wet brain 
weight; 79A/C57BL, 340 jig/g wet brain weight). Thus, although these two 
models have fairly similar lesion profiles in grey matter regions, and for that 
matter similar incubation periods, they differ in the degree of vacuolar damage to 
white matter regions and in the severity of brain atrophy as determined by 
terminal wet brain weight. In this respect the changes in cerebral cholesteryl ester 
levels in these two models would appear entirely consistent with demyelinating 
events. 
The 87V/VM and 22C/C57BL models display similar neuropathological features 
as illustrated by the lesion score studies (Bruce et at., 1991 ).  In the same, lesions 
scores < 3.0 are present in all grey matter regions and negligible vacuolation is 
present in white matter areas. In addition both models exhibit similar reductions 
in post morteni wet brain weight (87V/VM, 8.8%; 22C/C57BL, 9.3%), but in the 
former cholesteryl ester levels are significantly raised, whereas in the latter they 
are not. The explanation for this disparity between cholesteryl ester levels 
presumably lies in the difference between incubation periods in the two diseases 
(87VIVM, 290 ± 4 days p.i.; 22C/C57BL, 170 ± 1 days p.i.). It is proposed that 
in the latter model, changes in grey matter pathology occur at such a speed that 
insufficient time is available for cholesteryl ester levels to reach significant levels 
before death ensues. It is noted that in the 79A/SV and 79A/C57BL models, 
which display slightly shorter incubation periods than the 22C/C57BL model (153 
± 2 days p.i. and 161 ± 2 days p.i. respectively), the primary insult is to white 
matter, thus the interval between neuronal cell death and subsequent degeneration 
of myelin is not present and cholesteryl ester concentrations rise in close parallel 
with demyelinating events. 
Vacuolar damage in the 22AISV is largely restricted to grey matter regions with 
lesions scores below 2.0 in all areas except the medial thalamus (2.1). Changes in 
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cholesteryl ester concentrations are insignificant, although a 9.5% reduction in 
wet brain weight is recorded at the terminal stage of the disease (441 ± 2 days 
p.i). In view of the relatively limited vacuolar damage in this model, the absence 
of an elevation in cerebral cholesteryl esters is not unexpected. In addition the 
reduction in brain weight in these 441 day old mice may partly be attributed to 
normal aging processes (Greenfield, 1976). 
Suninzary 
The above analysis suggests that the scrapie-related cerebral cholesteryl ester 
elevation is directly related to the degree of neurological damage, more 
specifically in white matter regions. In those murine-scrapie models in which 
significant daniage is present in grey matter regions, e.g. ME7/VM and 87V/VM, 
and in which the disease incubation period is particularly prolonged, cholesteryl 
ester levels are similarly raised. The process culminating in the elevation of 
cholesteryl esters in the latter murine-scrapie models is believed to involve nerve 
cell necrosis, axonal degeneration, and subsequent secondary demyelination. In 
this respect, the importance of a lengthy incubation period to the accumulation of 
cholesteryl esters is evident. In those models in which the interval between 
neuronal degeneration and secondary demyelination exceeds the incubation 
period of the disease (22C/C57BL), cholesteryl ester levels are not significantly 
altered. 
Although the presence of demyelination in the 79A!SV and 79A/C57BL murine-
scrapie models is supported by histological studies (Bruce et at., 1991), evidence 
for extensive axonal degeneration/demyelination is not found in the ME7/VM 
model (Fraser, 1969). Thus, in order to clarify the proposed relationship between 
neuronal damage and secondary demyelination in the latter model, the activity of 
myelin-specific neutral cholesteryl ester hydrolase was assayed in scrapie and 
control mice at the terminal stage of the disease. A discussion of the findings is 
given in Section 3. 4. 
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3. 4. 1 Neutral Cholestervi Ester Hvdrolase Studies in Mouse Brain. 
Myelin was believed to be a relatively inert membrane as a result of its metabolic 
stability and apparent absence of enzymes. More recently this concept has 
received extensive revision with the discovery of a whole host of myelin-
associated enzymes (Ledeen, 1984). It would appear that the myelin sheath 
undergoes a dynamic cycle of degradation and remodeling, in which many of the 
breakdown products are re-utilized for membrane biosynthesis. Although a 
number of enzymes have been found to be associated with myelin, only two of 
these are myelin-specific, namely neutral cholesteryl ester hydrolase (Eto and 
Suzuki, 1973; Johnson and Shah, 1978) and 2,3-cyclic nucleotide 3'-
phosphohydrolase (Kurihara and Tsukada, 1967). 
The activity of cholesteryl ester hydrolase is closely associated with myelinating 
events. In diseases in which demyelination is a prominent feature, a strong 
negative correlation exists between the activity of this enzyme and the 
accumulation of cholesteryl esters (Ghosh and McLean Grogan, 1991; Johnson 
and Shah, 1978; Mezel, 1970; Shah and Johnson, 1980). Conversely, during the 
recovery or active myelination stage of experimental allergic encephalomyelitis 
(Grosh and McLean Grogan, 1991), or for that matter during active myelination 
in the foetal nervous system (Ghosh and McLean Grogan, 1990), the opposite is 
seen. It would therefore appear that any insult to the myelin sheath causes a 
significant reduction in cholesteryl ester hydrolase activity. In view of the 
intimate association between neutral cholesteryl ester hydrolase and myelin, the 
relationship between a cholesteryl ester elevation and demyelinating events was 
investigated in the ME7/VM murine-scrapie model. 
Results. 
In the first set of experiments using the procedure attributed to Eto and Suzuki 
(1973), cholesteryl ester hydrolase activity was not detected in either the crude 
brain homogenate or the 900 g supernatant in either scrapie or control brains 
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relative to the sucrose blanks (results not shown). Similar results were obtained 
using the experimental approach described by Shah and Johnson (1980). The 
former of these two procedures was repeated using authentic cholesteryl ester 
hydrolase, again no activity was recorded (results not shown). 
The activity of authentic cholesteryl ester hydrolase was measured employing the 
method described by West and Shand (1991). This procedure differed from the 
above in containing a 50mM Tris-50mM MES buffer (pH 7.0) system, (i) with or 
(ii) without the addition of bovine serum albumin (1%, w/v). The activity of the 
hydrolase enzyme was investigated with taurocholate concentrations ranging 
from 0 to 10 mlvi. All assays were performed in duplicate. In the absence of 
BSA, 102  units of authentic cholesteryl ester hydrolase activity reached a 
maximum value of 0.37 nmol/rninute (taurocholate 10 mM), whereas at the same 
taurocholate concentration and with BSA, 10-2  units of authentic cholesteryl ester 
hydrolase activity reached a value of 2.33 nmol/rninute; a 530% increase in 
activity. As such this analysis illustrates the importance of bovine serum albumin 
in the incubation mixture. 
The above procedure (West and Shand, 1991) was repeated with crude 
homogenate and 900 g supernatant from control VM brain. Taurocholate was 
included at 4 mlvi in agreement with the optimum concentration reported by Eto 
and Suzuki (1973). Neither the crude homogenate nor the 900 g supernatant 
showed appreciable cholesteryl ester hydrolase activity relative to sucrose blanks 
(results not shown). 
The presence of a hydrolase inhibitor was investigated by the addition of crude 
brain homogenate to authentic cholesteryl ester hydrolase in the West and Shand 
assay system described above. The results of the analysis reveal that a factor(s) in 
crude mouse brain homogenate markedly inhibits authentic cholesteryl ester 
hydrolase. Prior heat treatment of the brain homogenate (95°C x 5 minutes) 
abolishes about 4% of the effect of the inhibitor. The inhibitor was not identified. 
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Inferences. 
The initial two procedures (Eto and Suzuki, 1973; Shah and Johnson, 1980) gave 
poor activity in both crude brain homogenate and the 900 g supernatant. The 
reason for this was not clear, although West and Shand also had difficulty 
obtaining satisfactory results with the same assay systems (personal 
communication). Following the adoption of the latter author's procedure (West 
and Shand, 1990), satisfactory activity was achieved with authentic cholesteryl 
ester hydrolase, albeit at less than optimum levels. It was noted that the inclusion 
of bovine serum albumin at a concentration of I % (wlv) markedly assisted the 
dispersion of cholesteryl oleate in the taurocholate detergent. This may partly 
explain the improved activity of cholesteryl ester hydrolase in the latter incubation 
mixtures as a result of improved enzyme-substrate presentation. 
Although the greatest enzyme activity was achieved with 10 limol of taurocholate 
in these studies, Eto and Suzuki found optimum enzyme activity in crude brain 
homogenate with 4 mM of detergent (Eto and Suzuki, 1973). The latter 
taurocholate concentration was therefore adopted in our studies using brain 
homogenate as the crude enzyme source. 
When crude brain homogenate and 900 g supernatant were assessed for 
cholesteryl ester hydrolase activity in the above assay system, none was detected. 
It was therefore proposed that an inhibitor of cholesteryl ester hydrolase was 
present in brain homogenate. Indeed evidence in support of this hypothesis was 
found when authentic cholesteryl ester hydrolase incubation mixtures were 
'spiked' with a small quantity of brain homogenate. Pretreatment of the brain 
homogenate by heating at 95°C for five minutes had little effect on the activity of 
the mouse brain cholesteryl ester hydrolase inhibitor. This is markedly different 
to a heat-labile rat liver cytosolic cholesteryl ester hydrolase inhibitor described 
previously (Shand and West, 1992). Inhibition was not believed to be an artefact 
due to dilution of the radiolabelled cholesteryl oleate with endogenous brain 
cholesteryl esters (the latter constituting approximately 0. 16% of total cholesteryl 
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esters present in the reaction mixture). However it is possible that the presence 
of cellular debris had a detrimental effect on the presentation of cholesteryl oleate 
to the hydrolase enzyme. Fractionation and characterization of the mouse brain 
cholesteryl ester hydrolase inhibitor was not attempted. 
Although an elevation in cholesteryl esters may be explained by myelin 
destruction, it may equally be the result of diminished cholesteryl ester hydrolase 
activity without an associated change in cholesteryl ester hydrolase concentration. 
In this respect the presence of a cholesteryl ester hydrolase inhibitor in mouse 
brain was viewed with some interest. Studies were subsequently performed in 
collaboration with Dr. David West and Mr. John Shand (Hannah Research 
Institute, Ayr. Scotland) to investigate whether clinically-ill scrapie brain 
(ME7/VM) contained more inhibitor than age- and sex-matched controls. A total 
of five scrapie and five control brains were examined, however no difference was 
detected in inhibitor concentrations between the two groups (Dr. David West, 
personal communication). 
Unfortunately growing restrictions on the availability of research time at this 
stage of the study necessitated further studies of cholesteryl ester hydrolase to be 
discontinued. Thus, although the preceding experiments served as a limited 
exercise in experimental enzymology, the purpose for which they were performed 
was not realized. As such a relationship between the cholesteryl ester elevation 
and secondary demyelination in the ME7/VM murine-scrapie model was not 
confirmed - nor was it disproven. 
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3. 4. 2 Lactate Dehvdrogenase Studies in the ME7/VM Murine-Scrapie 
Model. 
Results. 
The activity of lactate dehydrogenase was assessed in parallel with studies of 
neutral cholesteryl ester hydrolase for comparative purposes. A 900 g 
supernatant was used in order to exclude the major proportion of cellular debris, 
and had a protein concentration of approximately 6 mg/ml. This was diluted by a 
factor of 250-fold to give aliquots from which enzymatic activity was assessed, 
with protein concentrations of approximately 24 Jg/ml. A calibration curve of 
lactate dehydrogenase activity was produced with various quantities of pyruvate 
substrate (Sigma Procedure 500) and the absorbance measured at 450 nm. The 
coefficient of linear regression for this calibration curve was -0.997, allowing the 
formulation of the calibration equation: 
absorbance = 0.905 - (5.0 x 10-3)  activity (BB units) 
from which lactate dehydrogenase activity in brain homogenate was calculated. 
Inferences. 
Studies of lactate dehydrogenase in brain and spinal cord regions from a human 
Cm-affected patient revealed reduced activity in diseased material (Friede and 
DeJong, 1964; Robinson, 1969). This biochemical change was confined to 
neurons and preceded neuronal degeneration (Friede and DeJong, 1964). In our 
studies the activity of lactate dehydrogenase was assessed in ME7-affected VM 
mice at the late clinical stage of the disease, when neuronal loss is most extensive 
(Fraser, J. et al., 1995). Although the aforementioned experiments imply a 
pathological failure of oxidative enzyme supply to neurons in CJD, we questioned 
whether the same mechanism is present in scrapie-affected mouse brain. 
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The activity of lactate dehydrogenase in heat-treated (95°C x 10 minutes) brain 
supernatant was found to be negligible. Scrapie brain homogenate had a lactate 
dehydrogenase specific activity of 1.12 ± 0.08 lirnol pyruvate 
hydrogenated/minute /mg protein, and control homogenate 1.03 ± 0.09 pmol 
pyruvate hydrogenated /minute/rng protein at 25°C. Student's t-test provided 
evidence for no statistical difference between the two groups. Thus, although 
brain atrophy as determined by reduction in wet brain weight is highly significant 
in scrapie-affected mice at the terminal stage of the disease, significant changes in 
lactate dehydrogenase are absent relative to total protein concentrations. 
Interestingly this conclusion is supported by in vitro measurements of cerebral 
lactate concentration by 'H magnetic resonance spectroscopy (Section 3. 1. 2). 
In these, lactate/creatine levels were 290.3 ± 61.8 intensity units in scrapie 
animals and 236.9 ± 31 .0 intensity units in controls (Table 3. I. 2). The means of 
these values were not statistically different. As such, the two sets of results 
illustrate the complementary and diagnostic application of MRS to biomedical 
studies. 
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3. 5 Studies of Lipids Associated with GPI-anchored Proteins in Control 
and Scrapie Isolates. 
Over the past decade overwhelming evidence has accumulated for the central role 
of PrP in the pathogenesis of spongiform encephalopathies (reviews see 
Bendheim et at., 1991; Hope and Baybutt, 1991; Prusiner, 1991). Susceptibility 
to this class of diseases appears critically dependent on the formation of a 
protease-resistant form of the normal cellular protein, PrP (Büeler et at., 1993), 
which is derived from PrP' by an unknown post-translational process. Whilst this 
change confers distinct biochemical and biophysical properties to PrP (Meyer ci 
al., 1986; Prusiner et al., 1983), it does not appear to involve chemical 
modifications to PrPc structure (Stahl etal., 1993). 
The normal cellular isoform is anchored to the extracellular surface of neurons 
and lymphocytes at its carboxyl-terminus by a glycosyiphosphatidyl inositol (GPI) 
moiety (Cashman ci' al., 1990; Stahl ci at., 1987). This intimate association 
between PrP and the lipid membrane is believed to be responsible for the highly 
hydrophobic nature of the protein (Safar et at., 1990). Interestingly PrPc  and 
PrP differ in their susceptibility to GPI anchor cleavage by phosphatidylinositol-
specific phospholipase C (PIPLC), PrP being resistant to release (Caughey ci' 
al., 1990; Stahl ci' al., 1990). Safar and colleagues speculated that this abnormal 
property of the scrapie isoform may be the result of a structural change in the GPI 
anchor (Safar et al., 1991), however this hypothesis was subsequently invalidated 
by mass spectrometry studies (Stahl ci' al., 1992). An alternative hypothesis 
proposed a conformational difference between membrane/phospholipid-bound 
PrPc and PrP molecules (Safar ci' al., 1991). Whilst support for significant 
changes in the tertiary structure of PrPc  and  PrPw  have been found (Pan et al., 
1993; Safar ci al., 1993), studies of membrane lipids associated with the two PrP 
isoforms have not received attention. 
The studies described here were therefore undertaken to investigate the 














Figure 3. 5. 1 HPTLC analysis of lipids associated with cerebral GPI-anchored proteins. 
Cerebral lipid fractions were analyzed as described in Experimental. Lanes 1, 2, 5 - 8 cerebral 
float fractions which did not contain protein as determined by SDS-PAGE and silver staining. 
Lanes 3 and 4 contained GPI-anchored proteins as determined by SDS-PAGE and silver staining. 
Lanes 9 - 11, authentic lipid standards. Gb5, Forssman antigen. Other lipid abbreviations are as 
previously listed. Note the presence of lipid asociated with the GPI-anchored protein fraction. 
brains and provide a comparison of the same in control and scrapie-affected 
animals. 
Results. 
Detection of lipids associated with GPI-anchored proteins. 
Isolation of GPI-anchored proteins was performed at the B.B.S.R.C. & M.R.C. 
Neuropathogenesis Unit following the procedure described by Safar et al., 1990, 
but omitting phosphatidyl inositol-specific phosphol ipase C (PIPLC) digestion. 
GPI-anchored proteins were separated by sucrose gradient centrifugation and 
subsequently fractionated to give six 'float fractions'. These fractions were 
individually analyzed by sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and silver staining for the study of protein 
components and by high performance thin layer chromatography for the study of 
lipids. 
Our investigations revealed that two of these fractions contained appreciable 
quantities of lipid (see lanes 3 and 4, Figure 3. 5. 1). Sphingomyelin, 
phosphatidyl choline, phosphatidyl ethanolamine and cerebroside I (a-hydroxy 
fatty acid) were identified in both fractions by co-migration with authentic 
standards. The presence of an extremely polar lipid band near the origin was 
speculated to arise from Forssman antigen (Gb5) on the basis of similarities 
between its elution coefficient and previous results (Brown and Rose, 1992). In 
addition to the above polar lipids, a prominent band was observed at the solvent 
front corresponding to non-polar lipid constituents; these were identified in 
subsequent studies. The absence of acidic lipids in these fractions was noted in 
marked contrast to the aforementioned neutral lipid components. 
SDS-polyacrylamide gel electrophoresis and silver staining of the above fractions 
was performed by colleagues at the B.B.S.R.C. & M.R.C. Neuropathogenesis 
Unit. Protein constituents were detected in fractions 3 and 4, whilst negligible 
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respectively) associated with cerebral GPI-anchored proteins in PrP. PrP'°  
and PrP°'° mice. 
Cerebral lipid fractions were analyzed as described in Experimental. Lanes I and 2, PrP; 
lanes 3 and 4, PrP °; and lanes 5 and 6 PrP°'°, GPI-anchored protein float fractions. Lanes 7 - 9, 
authentic lipid standards. Lipid abbreviations are as previously listed. 
amounts were detected in the other fractions (results not shown; Dr. James Hope, 
personal communication). The two protein-containing fractions exhibited 
banding at 33-35 kDa as well as at both higher and lower molecular weights. The 
33-35 kDa protein band immunostained with the rabbit anti-mouse PrP antibody 
I134, demonstrating the presence of PrP' in this otherwise heterogeneous GPI-
anchored protein fraction. 
A comparison of lipids associated with GPI-anchored proteins from PrP-
hoinozvgote. -heterozvgote and -null mice. 
Having demonstrated the presence of lipids associated with a diverse population 
of GPI-anchored proteins, it was questioned whether more specific information 
could be gathered on those lipids exclusively associated with PrP. For this 
purpose GPI-anchored proteins were isolated from selected genotypes of 
transgenic mice in which the PrP gene had been genetically ablated. 
Analysis of the neutral lipid fractions provided information on the composition of 
non-polar lipids associated with GPI-anchored proteins in addition to the polar 
lipid profiles obtained above. The neutral fractions contained appreciable 
quantities of cholesterol, cholesteryl esters, sphingomyeli n, phosphatidyl choline, 
phosphatidyl ethanolamine and cerebroside I (Figure 3. 5. 2). The acidic lipid 
fractions contained phosphatidyl inositol, phosphatidyl serine, sulfatides I and II, 
free fatty acids and minor quantities of cardiolipin (Figure 3. 5. 2). An additional 
band was observed on the acidic fraction h.p.t.l.c. plate near the solvent front 
which we speculated to arise from cholesteryl esters which for unknown reasons 
failed to elute in the neutral fraction. This may have been the result of 
overloading the ion exchange chromatography material with excess cholesteryl 
esters in the crude lipid extract or signify the detection of an as yet unidentified 
cerebral lipid species. In view of the high concentration of cholesteryl esters 
present in the neutral lipid fractions the first hypothesis was favoured. 
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Figure 3. 5. 3 HPTLC analysis of polar and non-polar lipids (top and bottom figures 
respectively) associated with cerebral GPI-anchored proteins in control and 
scrapie-affected mice. 
Cerebral lipid fractions were analyzed as described in Experimental. Lanes I - 3, PrPc;  lanes 4 - 
6, PrP, GPI-anchored protein float fractions; lane 7, SAP. Lipid abbreviations are as previously 
listed. Note in the top plate the presence of elevated levels of cerebroside I in scrapie isolates. 
Also note the reduction in cholesteryl ester levels in scrapie isolates in the bottom plate. 
Interestingly the SAF sample displayed a similar non-polar lipid profile to the PrP isolates but 
contained negligible cholesterol. 
Comparison of neutral and acidic lipids associated with GPI-anchored protein 
from PrP-hornozygote (), -heterozygote 
(+10)  and -null (010)  mice revealed 
insignificant differences between the three groups. The results of the quantitative 
analysis are displayed in Table 3. 5. 1. Interestingly the concentration of 
cholesteryl esters is highly enriched in the above GPI-anchored protein fractions 
comprising in the order of 12% of total neutral lipids and representing an 
approximate 250-fold increase in the cholesteryl ester/cholesterol ratio relative to 
similar determinations in crude brain lipids. The significance of this finding and 
the apparent absence of differences between the three PrP genotypes is discussed 
below. 
A comparison of lipids associated with GPI-anchored proteins in scrapie and 
control isolates and a scrapie-associated fibril fraction. 
Although the detection of discrete lipid changes associated with PrP was not 
realized, the potential to examine the composition of total lipids located within 
caveolae microdomains in both control and scrapie-disease states was recognized 
as a feasible objective. For this purpose, lipid studies were performed on GPI-
anchored protein fractions from scrapie-affected and control mice as well as an 
isolate of scrapie-associated fibrils. 
The non-polar lipid profiles in the three fractions were essentially very similar 
with some noteworthy exceptions. All fractions contained cholesteryl esters, 
triglyceride, diglyceride and fatty alcohol, however whilst cholesterol was present 
in appreciable quantities in the two 'float fractions' it was almost completely 
absent in the SAF isolate (Figure 3. 5. 3). In agreement with the results above, 
cholesteryl esters were present in markedly elevated concentrations in all 
fractions, representing a highly significant enrichment in this non-polar, neutral 
lipid relative to cerebral levels of cholesterol. In addition, a statistically 
significant difference in cholesteryl esters was present between scrapie and 
control float fractions (cholesteryl esters (jig) per float fraction: 30 ± 7, control; 
14 ± 2, scrapie; P < 0.001), with a similar reduction in cholesteryl esters being 
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Lipid PrP' GPI-anchored 
protein fraction 




Cholesteryl esters 41.4±0.1 41.5± 1.5 40±0 
Cholesterol 82.8± 11.0 80.8± 11.3 62±10.4 
Cerebrosidel 4.6±0.4 4.1 3.4±0.7 
Phosphatidyl 44.3 ± 9.0 
ethanolamine  
31.0 ± 2.4 28.4 ± 11.2 
Phosphatidyl choline 156.7 ± 43.7 131.5 ± 21.3 103.7 ± 31.9 
Sphingomyelin 40.8 ± 14.5 39.8 ± 17.4 31.5 ± 9.4 
Cardiolipin 8.9±2.9 3.3 ±0.3 2.7± 1.2 
Sulfatide I 4.9 ± 1.7 2.8 ± 0.7 2.9 ± 1.0 
Sulfatide 11 4.4 ± 1.8 2.4 ± 0.2 2.1 ± 0.4 
Phosphatidyl serine 17.7±4.2 10.4±0.6 5.8±3.4 
Phosphatidyl inositol 6.3 ± 1.9 3.2 ± 0.2 1.9 ± 0.7 
Lipid Pi-P' GPI-anchored 
protein fraction 
PrP GPI-anchored 
protein fraction  
SAF 
Cholesteryl esters 30 ± 7 14 ± 2 12 
Triglyceride 9 ± 1 9 ± 1 7 
Diglyceride 46±6 46±17 43 
Fatty alcohol 3 ± 1 3 ± I 3 
Cholesterol 8±3 10±4 nd 
Table 3. 5. I Lipids associated with GPI-anchored protein fractions from control and scrapie 
affected mice. 
Values are expressed as mean ± scm in pg lipid/l/2 brain equivalent. Each value in the PrP' 
to PrP°'°  series represents the mean of two samples per group. The values in the PrPc  and 
PrP series represent the mean of three samples per group. 
observed in the SAF isolate. The results of the quantitative analysis are displayed 
in Table 35.1. 
Analysis of the polar lipid components revealed the presence of sphingomyelin, 
phosphatidyl choline and cerebroside I in addition to what was speculated to be 
Forssman antigen (Gb5) (with an elution coefficient (R,) value of 0.025). There 
was an almost complete absence of polar lipids in the SAF sample apart from a 
translucent band which migrated with an R1  value of 0.84 and a charred band with 
an R, value of 0. 10. Neither of these were identified but were speculated to be 
SAF isolation procedure artefacts on the basis that no authentic cerebral lipids 
migrate at these positions. A highly significant difference was observed in levels 
of cerebroside I between scrapie and control OPT-anchored protein fractions, with 
the former containing appreciable quantities whilst the latter did not (Figure 3. 5. 
3). Unfortunately lipid quantification was not performed on this h.p.t.l.c. plate 
and thus absolute values for this lipid changes are not available. 
The absence of phosphatidyl ethanolamine in both scrapie and control samples 
and the almost complete absence of cerebroside I in the control sample is 
markedly different to the lipid profiles obtained in the studies described above. 
The reason for this difference is not believed to be simply the result of lipid 
fraction dilution (compare Figures 3. 5. 1 and 3. 5. 3), and must therefore 
represent subtle changes in the composition of the OPT-anchored protein isolates 
obtained from the B.B.S.R.C. & M.R.C. Neuropathogenesis Unit. It was noted 
that the total amount of lipid supplied in the above samples was significantly less 
than that provided in the initial studies (Tables 3. 5. 1). Whether this reflects a 
slight modification of the GPI-anchored protein isolation procedure in the latter 
studies is not known. 
Regardless of questions raised concerning discrepancies between the above 
isolation protocols, the latter isolates, which were chronologically prepared under 
identical conditions, clearly demonstrate highly significant changes in the 
concentrations of two lipids closely associated with GPI-anchored proteins in 
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scrapie and control material, namely cholesteryl esters and cerebroside I. In view 
of the intimate relationship between lipid composition and the structural and 
functional properties of caveolae microdomains, it may be inferred that the above 
lipid abnormalities would produce a detrimental effect on caveolae function. The 
speculated significance of the above lipid disturbances in relation to cellular PrP 
metabolism is discussed below. 
Discussion. 
The central event underlying transmissible spongiform encephalopathy 
pathogenesis is believed to be the conversion of the cell surface protein PrP to a 
protease-resistant isoform (Caughey and Raymond, 1991; Czub et al. 1988; 
Prusiner, 1991). The mechanism by which this transformation process produces 
two distinct isoforms differing in physiochemical properties (Meyer et al., 1986; 
Prusiner et al., 1983) and tertiary structure (Pan et al., 1993; Safar et al., 1993) 
has not been elucidated. However within the last year cholesterol-rich 
membraneous microdomains have been implicated as key structures in which this 
transformational process occurs (Taraboulos et al., 1995). As such, Taraboulos 
and colleagues showed that cholesterol -depletion of scrapie-affected 
neuroblastorna cell cultures slowed the degradation of ppC  and inhibited the 
formation of PrP". Cholesterol depletion of Madin-Darby canine kidney 
(MDCK) cell lines is known to have a detrimental effect on the number and 
structural integrity of caveolae (Anderson ci' al., 1992). Thus it is inferred that 
PrP by nature of its GPI moiety is directed to these membraneous microdomains, 
in both normal and scrapie-affected cells, where its metabolism is dependent on 
the structural and functional integrity of the same. 
Our results demonstrate that PrP co-purifies with a diverse population of GPI-
anchored proteins in a sucrose gradient float fraction. The finding that these 
proteins partition at an unusually low density in the sucrose gradient was taken as 
evidence in support of their intimate association with membrane lipids. The lipids 
associated with these GPI-anchored proteins were determined by high 
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performance thin layer chromatography. Similarities in lipid composition were 
observed in cholesterol, phosphatidyl ethanol amine, sphingomyelin and Forssrnan 
antigen (Gb5) between cerebral caveolae and MDCK cell lines described 
previously (Rose and Brown, 1992). However the report of high concentrations 
of cholesteryl esters in the former is unprecedented, raising intriguing questions 
as to the significance of this lipid in cerebral caveolae. It is possible that 
cholesteryl esters perform a role in the maintenance of caveolae structure and 
function akin to that attributed to cholesterol. Levels of cholesteryl esters 
associated with these GPI-anchored proteins amount to approximately 75% of all 
cerebral cholesteryl esters. Mechanisms must exist to regulate and maintain the 
high concentrations of cholesterol and cholesteryl esters present in caveolae. In 
this regard it is tempting to speculate that caveolae microdomains contain GPI-
anchored proteins which perform functions of receptor-mediated cholesterol 
endocytosis and cholesterol esterification (Section 4, Future Directions). 
A comparison of lipids associated with GPI-anchored proteins in the three 
transgenic PiP genotypes PrP, PrP' and PrP °'° indicates that partial or 
complete absence of PrP does not have a significant effect on caveolae lipid 
composition. It is not possible to infer whether the absence of PrP has a 
detrimental effect on the function of these lipid microdomains, however the 
apparent absence of adverse conditions in PiP-null mice would suggest otherwise 
(BUeler et al., 1992). The known association between caveolae and folate 
potocytosis (Anderson et at., 1992; Chang et at., 1992; Rothberg et at., 1990) 
presents an opportunity for investigating the functional integrity of caveolae 
during scrapie pathogenesis, thus providing clarification in this area (Section 4, 
Future Directions). 
Studies by Safar and colleagues have shown PrP', PrP and infectivity to be 
associated with the most hydrophobic components of synaptosomal and 
microsornal membranes (Safar et at., 1990). This is perhaps unsurprising when 
one considers that PrP' is directed to caveolae niicrodomains in which 
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concentrations of cholesteryl esters are markedly elevated. Cholesteryl esters are 
the most non-polar lipid present in murine cerebral lipid extracts and may 
therefore make an important contribution to the hydrophobicity of the two PrP 
isoforms. Safar and colleagues speculated that conformation differences between 
membrane/phospholipid-bound PrPc  and PrP molecules may contribute towards 
the resistance of PrP to phosphatidyl inositol-specific phospholipase C (PTPLC) 
cleavage (Safar etal., 1991). In this respect we report significant changes in the 
lipid composition of GPI-anchored proteins in scrapie-affected mice. It is 
interesting to speculate that reduced concentrations of cholesteryl esters and 
increased levels of cerebroside I may produce localized changes in caveolae 
microenvironment sufficient to cause inhibition of PIPLC activity. Interestingly 
the inability of PTPLC to induce GPI-anchor cleavage applies to both PrPc  and 
PrP in scrapie-affected hamster synaptosomal/microsomal membranes (Safar et 
al., 1991). This would suggest that disrupted caveolae structure and/or function 
rather that a conformational change in PrP protein structure is responsible for 
resistance to PJPLC cleavage. 
The cellular concentration of PrP' appears to be critically important to the rate at 
which scrapie disease progresses. This has been elegantly demonstrated in PrP °  
heterozygote mice, which although susceptible to scrapie, accumulate PrP and 
develop disease after a much longer incubation period than their wild-type 
counterparts (Büeler et al., 1993). Transgenic studies suggest that the 
production of PrP involves the formation of an intermediate complex in which 
Pi.Psc and PrP' interact (Prusiner et al., 1990; Scott et al., 1993). This association 
must involve intimate contact between the two isoforms. In view that caveolae 
concentrate GPI-anchored proteins (Rothberg et al., 1990), it seems highly 
probable that these plasmalemmal structures provide a microenvironment in 
which interaction between the two PrP isoforms is favoured and the post-
translational modification of PrPc  to PrP' takes place. It follows that a reduction 
in cellular PrP concentration by genetic ablation of a PrP gene would reduce the 
frequency with which PrP molecules interact, thus slowing down the formation of 
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PrP and delaying the onset of clinical disease. A similar situation would 
presumably exist in cholesterol-depleted cells in which the ability of caveolae to 
concentrate GPI-anchored proteins is adversely compromised as a result of 
disruption to caveolae number, structure and function (Anderson et at., 1992). 
Amphotericin B, a polyene antibiotic used in the treatment of fungal diseases, has 
been shown to delay the onset of clinical signs in golden Syrian hamsters 
experimentally infected with the 263K strain of scrapie (Pocchiari et at., 1987). 
In this model, amphotericin B treatment slows both the scrapie agent replication 
rate (Pocchiari et al., 1989) and the formation of PrP (McKenzie et at., 1994). 
Amphotericin B has a high affinity for membrane sterols causing lethal 
permeability changes in susceptible cells by the formation of transmembrane ion 
channels (Bolard, 1986). In view of the adverse effect that cholesterol depletion 
has on PrP' formation (Taraboulos etal., 1995), we propose that amphotericin B 
has its anti-scrapie effect by causing a disruption in the structural and functional 
integrity of caveolae. In consideration of the discussion above, such action would 
be expected to reduce PrP oligomeric interactions and inhibit the mechanism by 
which PrP" is formed (Hope et at., 1988). Interestingly, initiating amphotericin B 
treatment two weeks prior to scrapie inoculation prolongs the incubation period 
of the disease by a much greater extent than administration of the therapeutic 
agent one week after infection (Pocchiari et at., 1989). This observation has been 
suggested to be attributable to modification of a hypothetical receptor molecule 
(Pocchiari et al., 1989), however in view of the above discussion, we believe that 
this phenomenon can be explained by cell membrane dissolution of caveolae and 
reduced availability of PrP' for prion transformation. The PrP conformational 
change produces protein-lipid complexes of greater stability as demonstrated by 
the inability of PIPLC to cleave PrP from the lipid bilayer (Safar etal., 1991), it 
is therefore proposed that the reduced effect of amphotericin B one week after 
infection is the result of greater stability or tighter binding of lipids to PrP 
molecules within caveolae microdornains. In this respect the observed changes in 
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caveolae cholesteryl esters and cerebroside I may have functional significance to 
the physiochemical properties of caveolae in the priori biotransformation process. 
This section would not be complete without some consideration of the fact that 
amphotericin B does not have any therapeutic value in the alleviation of 139A or 
139H scrapie in hamsters, 263K scrapie in mice (Xi et at., 1992), hamster-
adapted DY transmissible mink encephalopathy (Bessen and Marsh, 1992), or 
clinical cases of human Creutzfeldt-Jacob disease (Masullo et at., 1992). 
Assuming that the therapeutic effect of amphotericin B is directly related to its 
disruptive effect on caveolae structure and function, the inability to ameliorate 
TSE pathogenesis in the above models may be the result of subtle changes in 
caveolae structure, reduced concentrations of cholesterol or increased 
concentrations of PrP within the same, or increased affinity between PrP-lipid 
complexes making their destabilization less possible. In view that different strains 
of the scrapie agent exhibit different pathological profiles and areas of PrP 
accumulation (Bruce et at., 1991; Fraser and Dickinson, 1968), it has been 
proposed that amphotericin B has its therapeutic effect on hamsters affected with 
the 263K scrapie strain by selectively targeting those cell types in which PrPsc 
propagation occurs (McKenzie et at., 1994). An explanation for the mechanism 
by which such selective action may occur was not given. 
Although disruption of caveolae structural and functional integrity presents a 
particularly attractive mechanism for the therapeutic effect of amphotericin B, we 
cannot discount the possibility that amphotericin B has a direct inhibitory 
influence on PrP transformation as a result of non-selective protein binding. 
Although less elegant than the above hypothesis, this mode of action may account 
for the disease-specific effect of amphotericin B in 263K-hamsters. As such, it is 
proposed that amphotericin B exerts its effect by competitively inhibiting the 
interaction between cellular PrPc  and 263K prions, thus slowing the molecular 
transformation process by which PrP is formed. Whether this involves direct 
binding of amphotericin B to PrPc  or destabilization of the PrPPrP  oligomeric 
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complex is not known. However in the models for which amphotericin B 
treatment is not therapeutic, it is speculated that PrPc  has greater affinity for 
infectious prions than it does for amphotericin B. Amphotericin B may also bind 
the scrapie infectious agent (assumed to be PrP), thus presenting a subtle 
variation by which interaction between the two isoforms may be sterically 
hindered. However, in view of the finding that treatment with amphotericin B 
prior to scrapie infection has a greater therapeutic effect than when given 
afterwards (Pocchiari et al., 1989), interaction between amphotericin B and PrP 
may be of greater inhibitory significance than that between amphotericin B and 
PrP. 





4. Future Directions. 
The application of NMR spectroscopy to the non-invasive study of cellular 
metabolism during scrapie pathogenesis presents a novel approach to the 
investigation of disease-related disturbances. Unfortunately the full potential of 
MRS was not realized during these studies. An important area for future 
research could utilize '3C isotopically-enriched compounds to study brain 
metabolism in normal and diseased animals. Whilst studies in vivo may be limited 
by the selective permeability of the blood-brain barrier, the availability of in vitro 
cell cultures, which propagate scrapie infection, presents an attractive and more 
readily manipulated alternative. If aberrant metabolism is observed in scrapie-
affected tissue, the ability to determine this metabolite(s) intracerebrally could be 
developed into techniques which would allow the localization of 
neurodegenerative lesions to be determined in vivo. For example, if metabolism 
of an isotopically-enriched compound is diminished in diseased tissue, this 
compound may be expected to accumulate in those regions of the brain which 
experience the greatest neurological damage, albeit after a specific lag period. 
Regions of neurodegeneration could then be identified using a combination of in 
vivo MRS and MRI techniques, following irradiation of the brain at an excitation 
frequencies similar to that of the '3C resonance in the exogenous compound. The 
observation of significantly elevated levels of inositol in scrapie-affected mice 
(ME7/VM) and parietal white matter regions in patients suffering from 
Creutzfeldt-Jacob disease (Bruhn et al., 1991), suggests that cerebral inositol 
metabolism is adversely affected in TSE disease. Inositol may therefore present a 
suitable metabolite for application to the above studies. The above techniques 
could also provide a non-invasive means by which therapy aimed at alleviating 
such disorders may be assessed. 
Studies of lipids associated with GPI-anchored proteins in PrP, PrP ° and 
PrP°'° mice did not reveal striking differences between the three groups. Thus, in 
view of the intimate association between lipid composition and the structural and 
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functional integrity of caveolae (Chang et al., 1992; Rothberg et at., 1991), it was 
proposed that the absence of PrP does not produce a detrimental effect on 
caveolae homeostatic functions. The observation that PiP-null mice develop and 
behave in a similar manner to their wild-type counterparts (Bfleler et al., 1992) 
supports this inference. In view of the finding that caveolae serve an important 
role in the endocytosis of small molecules such as folate (Anderson et al., 1992), 
the effect that PrP-ablation has on caveolae functional integrity may be assessed 
by the investigation of folate potocytosis in the above transgenic mouse models. 
In contrast to the above studies, a comparison of control and scrapie-affected 
mice demonstrated marked abnormalities in the composition of lipids associated 
with GPI-anchored proteins. In view of the above discussion, it is speculated that 
the structural and functional integrity of caveolae is disrupted in scrapie-affected 
mice. Again, evidence in support or disproof of this hypothesis may be provided 
by studies of folate potocytosis. In view of the essential function of folic acid in 
cellular amino acid and DNA synthesis, the hypothesized disturbance of folate 
potocytosis in scrapie-affected neuronal cells may present an elaborate 
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